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ABSTRACT OF THE DISSERTATION
Dissection of Affective Catecholamine Circuits Using Traditional and Wireless Optogenetics
by
Jordan Gary McCall
Doctor of Philosophy in Biology and Biomedical Sciences
Neurosciences
Washington University in St. Louis, 2015
Professor Michael R. Bruchas, Chair

Parsing the complexity of the mammalian brain has challenged neuroscientists for
thousands of years. In the early 21st century, advances in materials science and neuroscience
have enabled unprecedented control of neural circuitry. In particular, cell-type selective
manipulations, such as those with optogenetics and chemogenetics, routinely provide answers to
previously intractable neurobiological questions in the intact, behaving animal.
In this two-part dissertation, I first introduce new minimally invasive, wireless
technology to perturb neural activity in the ventral tegmental area dopaminergic system of freely
moving animals. I report a series of novel devices for studying and perturbing intact neural
systems through optogenetics, microfluidic pharmacology, and electrophysiology. Unlike
optogenetic approaches that rely on rigid, glass fiber optics coupled to external light sources,
these novel devices utilize flexible substrates to carry microscale, inorganic light emitting diodes
(µ-ILEDs), multimodal sensors, and/or microfluidic channels into the brain. Each class of device
can be wirelessly controlled, enabling studies in freely behaving mice and achieving previously
untenable control of catecholamine neural circuitry.
xviii

In the second part of this dissertation, I apply existing cell-type selective approaches to
dissect the role of the locus coeruleus noradrenergic (LC-NE) system in anxiety-like and
aversive behaviors. The LC-NE system is one of the first systems engaged following a stressful
event. While LC-NE neurons are known to be activated by many different stressors, the
underlying neural circuitry and the role of this activity in generating stress-induced anxiety has
not been elucidated until now. I demonstrate that increased tonic activity of LC-NE neurons is
both necessary and sufficient for stress-induced anxiety; a behavior which is driven by LC
projections to the basolateral amygdala. Furthermore, this activity and behavior is elicited by
corticotropin releasing hormone-containing afferent inputs into the LC from the central
amygdala. These studies position the LC-NE system as a critical mediator of acute stress-induced
anxiety and offer a potential intervention for preventing stress-related affective disorders.
Together these two objectives provide a rich technological toolbox for neuroscientists
and yield important knowledge of how small catecholamine structures with widespread forebrain
innervation

can

selectively

mediate

xix

higher

order

behaviors.

Chapter 1

Introduction

1

INTRODUCTION
The living mammalian brain is a soft, squishy entanglement of millions of different cells.
This declarative statement is the impetus for the following work. That single sentence captures
two of the greatest challenges faced in neuroscience. The soft nature of the brain limits how we,
as scientists trying to understand its functions, can interact with its intact form. The complex
arrangement of the cells in the tissue poses incredible hurdles in understanding the anatomical
and functional organization of the organ as a whole. These two challenges are not new,
neuroscientists and anatomists have been tackling them for thousands of years, but only recently
has our mastery of materials and genetics converged to allow increasingly detailed understanding
of the soft, squishy entanglement we know as the brain. The following dissertation will introduce
new tools for studying the intact circuitry of the living brain and apply a battery of existing
techniques towards understanding the role of the locus coeruleus noradrenergic (LC-NE) system
in complex negative affective behaviors.
The power of cell-type selective neural manipulations
The complex nature of the brain has long puzzled those who sought to understand its
function. As early as 1700 B.C., observations were recorded documenting the observable
structure of brain anatomy (Risse, 1972). While these early observations remained as such for
many hundreds of years, ever-diligent anatomists slowly began to establish the gross anatomy of
the human brain (Arráez-Aybar et al., 2015; Schmitt, 2009). However, the ability to evaluate the
function of brain anatomy remained elusive. One of the first major insights into how the nervous
system functions came in 1791 when Luigi Galvani discovered that electricity could be used to
stimulate nerve fibers in dissected frog legs (Parent, 2004). What is now considered a simple
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observation (indeed one regularly taught in undergraduate physiology courses around the world)
was at the time a paradigm-shifting discovery: electrical stimulation can be used to exogenously
elicit function from neural tissues. Over the next two hundred years, the electrical nature of the
central nervous system was exploited to an elegant degree both in understanding the cellular
properties of the neuron (Hodgkin and Huxley, 1945) and the functional organization of the
cortex (Rasmussen and Penfield, 1947a). In the latter case, very early studies using electrical
stimulation gave functional information to the previously established anatomy (Penfield, 1947;
Rasmussen and Penfield, 1947a, 1947b). However, the more sophisticated neurochemical and
genetic tools became, the more complex the brain appeared to be. So much so that harnessing the
power of electricity now seemed too limiting in scope to perturb and observe neuronal function.
This limitation arises in large part due to the non-selective nature of exogenously applied current.
When a stimulating microelectrode is placed in the brain, the current delivered to the probe
agnostically perturbs all of the electrically excitable membranes near it (Figure 1.1). These
excitable membranes could be neuronal cell bodies, passing axons, axon terminal or dendrites.
For gross functional anatomy mapping (i.e. can x brain region elicit y behavioral response?) and
some therapeutic approaches (Clark, 2015; Giugni and Okun, 2014) this approach proved
sufficient, however to understand the complex circuitry of the mammalian brain, more selective
tools would be necessary.
By the early 21st century, the need for tools that could selectively modulate particular
genetically defined neuronal subtypes became clear and numerous groups provided potential
answers (Adamantidis et al., 2007; Arenkiel et al., 2007; Armbruster et al., 2007; Banghart et al.,
2004; Güler et al., 2012; Lima and Miesenböck, 2005; Zemelman et al., 2002, 2003). Though a
complete review of the possible solutions presented is outside the scope of this introduction, it is
3

important to note that two major solutions emerged from this challenge: one using photons to
target exogenously expressed channels, pumps, and receptors (optogenetics) (Yizhar et al., 2011)
and one using highly selective ligands to target exogenously expressed channels and receptors
(chemogenetics) (Sternson and Roth, 2014). In both such schemes, advances in viral gene
delivery enabled, for the first time, cell-type selective targeting of neurons and their projections
(Adamantidis et al., 2007; Arenkiel et al., 2007; Krashes et al., 2011). These approaches now
enable dynamic control of various types of cellular activity including stimulation (Arenkiel et al.,
2007), inhibition (Berndt et al., 2014), modulation (Airan et al., 2009; Siuda et al., 2015),
intracellular signaling (Zhang and Cui, 2015) and gene expression (Konermann et al., 2013;
Polstein and Gersbach, 2015). Perhaps the most powerful application of these tools is in awake,
behaving animals where new fundamental insights into neural function are being made at an
extraordinary rate (Tye and Deisseroth, 2012).
The ventral tegmental area dopamine system as a model for progress in neuroscience
In the age of cell-type selective neural manipulations, few brain systems have received as
much scientific attention as the ventral tegmental area dopamine (VTA-DA) system (for review
see Britt and Bonci, 2013; Ikemoto and Bonci, 2014; Lammel et al., 2014; Nieh et al., 2013;
Stamatakis and Stuber, 2012; Tye and Deisseroth, 2012; Walsh and Han, 2014). The VTA-DA
system is one of the main sources of dopamine for the forebrain (Björklund and Dunnett, 2007).
The VTA-DA system has long been known for its critical role in reward processing (Bozarth and
Wise, 1981; Hollerman and Schultz, 1998; Miliaressis and Cardo, 1973; Wise, 1984), but it was
not until the rise of optogenetics that the true complexity of this system was revealed. Diverse
heterogeneity of cell-types (Tan et al., 2012; Yamaguchi et al., 2015; van Zessen et al., 2012),
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Figure 1.1 Schemes for in vivo manipulation of neural circuitry. (A) Electrical
microstimulation stimulates all cells, terminals, and fibers of passage near the electrode. (B)
Optogenetics can selectively target genetically-defined cell-types, such as the red cells here.
Only cells expressing the opsin (depicted as green outline) will be sensitive to photostimulation.
(C) Chemogenetics also selectively targets genetically-defined cell-types, but uses a selective
ligand (here as CNO), rather than light, to perturb neural activity. Figure 1.1 layout inspired by
(Carter and de Lecea, 2011).
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afferent inputs (Lammel et al., 2012; Watabe-Uchida et al., 2012), and efferent projections with
non-canonical neurotransmission (Lammel et al., 2011; Root et al., 2014; Stamatakis et al., 2013;
Zhang et al., 2015)regulates and contributes to motivation, reward, and emotional regulation with
elegant detail.
One of the first studies implementing optogenetics in vivo answered a fundamental
question about the VTA-DA system (Tsai et al., 2009): how do different phasic or tonic firing
patterns contribute to reward-related behaviors? Not only did this study demonstrate that
photostimulation could be used to manipulate affective neural circuitry, but it showed that
modulation of firing profiles specific cell-types of neurons could be used to drive different
behaviors. Several groups have carried on from these findings to clearly define the role of phasic,
but not tonic, VTA-DA activity as a neural substrate of reward (Kim et al., 2012b; Lammel et al.,
2011; Tan et al., 2012; Witten et al., 2011; van Zessen et al., 2012).
The rich literature of the VTA-DA system provides a model for this two-part dissertation.
First, we will utilize our existing knowledge of the VTA-DA system as a testing ground for new
technology. The implementation of new technology that interfaces with neural tissue must
functionally demonstrate that it can achieve results consistent with what is understood about the
brain. Ideally new neural interface technologies will also expand our knowledge of neural
function. In Part 1 of this dissertation, I report a series of novel devices for studying and
perturbing intact neural systems through optogenetics, microfluidic pharmacology, and
electrophysiology. This technology will be demonstrated with proof-of-principle experiments in
the VTA-DA system.
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Though the VTA-DA system has been well characterized with modern tools, the same
cannot be said for other major monoamine structures such as the dorsal raphe (5hydroxytryptamine/serotonin) or locus coeruleus (norepinephrine). Recent work has begun to
unravel the circuit-level details of the dorsal raphe serotonergic system in motivation and
affective procressing (Bruchas et al., 2011; Cohen et al., 2015; McDevitt et al., 2014; Miyazaki
et al., 2014; Ogawa et al., 2014; Qi et al., 2014), but very limited work has focused modern tools
on the role of locus coeruleus noradrenergic (LC-NE) system (Carter et al., 2010, 2012; Hickey
et al., 2014; Vazey and Aston-Jones, 2014) and no so far in these such behaviors. Part 2 of this
dissertation will focus on understanding the role of tonic activity of the LC-NE system in the
mediation of stress-induced and stress-related behaviors such as anxiety-like and aversive
behaviors. The experimental approaches used by the VTA-DA field will provide a template for
how to proceed in dissecting this important catecholamine brain system.
Motivation for the development of flexible, wireless devices for manipulation of intact
mammalian neural circuitry
Though much progress can and has been made with traditional approaches to
optogenetics (i.e. fiber optics implanted directly into the brain), there remain limitations to the
implementation of these approaches in freely behaving animals. An immediate concern is that
light delivery with traditional fiber optic approaches requires the animal to be tethered to an
external laser or LED light source (Zhang et al., 2010). While this limitation does not prevent
study in awake, behaving animals it does limit the scope and type of behaviors one can assess.
Interrogation of endogenous neural function is best done in the context of natural behaviors. Any
handling or tethering of mice disrupts their natural behavior (Sorge et al., 2014), an observation
that can be clearly made from any actogram of behavior following a cage change (Aton et al.,
7

2005). Furthermore, any obstrusive headstage or cabling would more than likely cause a
significant confound in the study of social behavior (Shah et al., 2013). Therefore a conscious
effort should be made towards reducing both experimenter and technical interference during the
study of animal behavior. To achieve this goal wireless systems present a promising alternative
to tethered designs. Wireless observation of neural activity has been achieved by a number of
groups (Bertrand, 2015; Harrison et al., 2010; Szuts et al., 2011; Yin et al., 2014), but at the
outset of the work presented here no one had yet achieved wireless photostimulation.
Another crucial limitation of traditional fiber optic implants is in controlling the path of
light. While there now exist a few options for guiding light at different angles and points along
the dorsal-ventral axis of a brain structure (Tye et al., 2011; Zorzos et al., 2010, 2012), basic
fiber implants can only deliver light dorsal to the brain structure of interest. This can be
problematic when a brain structure is oriented vertically in the dorsal-ventral plane of the brain
(i.e. the locus coeruleus) as illuminating the entire structure would either require implanting
deeper or increasing the power of the light source. Both of these solutions can cause excess
damage to tissue (Yizhar et al., 2011). Therefore developing implantable light sources that can
approach brain structures from multiple and unique angles can greatly empower functional
dissection of the intact living brain.
The need in the neuroscience community for untethered devices with modular angles of
light delivery comes at time when the materials science community has begun to solve many of
these issues. Wirelessly powered devices traditionally rely on battery-powered operation,
however, batteries traditionally pose two immediate challenges to integration into electronics for
small mammals: 1) the batteries must be changed and 2) the batteries add weight to whatever
device the animal is required to support. In answer to these challenges, electrical engineers have
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devised power harvesting strategies that convert ambient energy into usable electrical energy
(Anton and Sodano, 2007). While these strategies are often seen as alternative renewable energy
sources, the same approach can be used with purposefully broadcasted radiofrequency (RF)
signals used to increase the ambient RF energy available for scavenging (Anton and Sodano,
2007; Olgun et al., 2010; Sample and Smith, 2009). This strategy is one that we employ in
Chapter 2 & 3 to create fully untethered devices for wireless photostimulation. These batteryfree devices can be powered in most environments without the need to contact the animal.
A second key advance in materials science has been the development of micro-scale
light-emitting diodes (µ-ILEDs) (Kim et al., 2010, 2012c). These light sources are small enough
that they can readily be transferred to flexible materials (Kim et al., 2012a) which provide ideal
material properties for interfacing with biological tissue. µ-ILED technology presents as an
excellent solution for spatial targeting in optogenetics. µ-ILEDs can be made that are on the size
scale of a few individual cell bodies (as small as 625 µm2) (Kim et al., 2012c) and while the light
from these devices spreads further than a single cell, localized activation within a brain structure
is an attainable goal. Importantly, µ-ILEDs are extremely efficient (i.e. they convert electrical
energy into light without losing too much energy to heating) which is critical for implanting
electronics into neural tissue. Chapter 2 details experiments and modeling (the latter done by
collaborators) to ensure that these implanted light sources do not deleteriously heat the tissue.
Finally, because of the flexible nature of the fabrication of these µ-ILEDs, they can be implanted
on ultrathin substrates that cause substantially less damage to the soft tissue of the brain than
conventional implants.
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The devices introduced in Chapters 2 & 3 serve as first generation prototypes of
technology that can be used to observed physiology (electrical, optical, and thermal properties)
or wirelessly perturb physiology (electrical or optical). These devices lack, however, an interface
for delivery of fluids such as viral vectors, therapeutic drugs, or other pharmacological agents.
Chapter 4 presents a new generation of device that maintains the ability to wirelessly
photostimulate, but adds fluid delivery capabilities. These optofluidic neural probes represent
one of many different possible second generation wireless µ-ILED devices and will serve as a
powerful tool for further dissection of neural circuitry.
Motivation for understanding the role of the LC-NE system in negative affective behavior
Anxiety is the manifestation of a complex set of behavioral and physiological responses
that can be either beneficial or detrimental to an individual. Under a state of stress and fear,
anxiety helps to maintain the arousal and vigilance required to maintain attention and accomplish
necessary tasks. After prolonged stress, however, anxiety can become pathological, interfering
with an individual’s ability to function normally (Gross and Hen, 2004). This neuropsychiatric
form of anxiety affects nearly 20% of the U.S. population during their lifetime and leads to
significant economic impacts, including loss of productivity and increased health care costs. Part
2 of this dissertation seeks to establish a greater understanding of the neurobiological basis of
anxiety and stress-induced behavioral disorders.
Norepinephrine, stress, and anxiety
The LC-NE system is a small, tightly packed pontine brain region that sends numerous
projections to the forebrain and spinal cord. This system is involved in a broad number of
physiological functions including arousal, memory, cognition, and stress reactivity (Berridge and
Waterhouse, 2003; Snyder et al., 2012; Valentino and Van Bockstaele, 2008). NE acts at
10

postsynaptic (Gs-coupled ! and Gq-coupled "1) and presynaptic (Gi-coupled "2) adrenergic
receptors throughout the forebrain (Figure 1.2) (Berridge and Waterhouse, 2003). The LC-NE
system is known to increase activity in response to a wide array of environmental stressors
including social and predator stress (Berridge and Waterhouse, 2003; Bingham et al., 2011;
Cassens et al., 1981; Curtis et al., 2012; Francis et al., 1999; Snyder et al., 2012; Valentino and
Van Bockstaele, 2008). The response of the LC-NE system to stress is particularly important in
the context of stress-induced human neuropsychiatric disorders such as posttraumatic stress
disorder (PTSD). Noradrenergic neurons within the LC-NE system exhibit three distinct
activation profiles: low tonic, high tonic, and phasic activity. It is believed that these neurons
function differently in determining behavioral flexibility to various environmental challenges.
Low tonic LC discharge (1-2 Hz) is thought to be consistent with an awake state (Aston-Jones
and Bloom, 1981a; Carter et al., 2010, 2012), whereas phasic burst activity results from distinct
sensory stimuli (Aston-Jones and Bloom, 1981b). Stress and stress-related neuropeptide release
(such as corticotrophin-releasing hormone, CRH) is thought to shift LC activity towards a high
tonic mode of firing (3-8 Hz) while simultaneously decreasing phasic firing events, whereas
endogenous opioid transmission is thought to return tonic firing to baseline (Curtis et al., 2012;
Snyder et al., 2012; Valentino and Foote, 1988). Taking a cue from the VTA-DA system, the
first study into LC-NE function in affective behaviors will examine different activity profiles of
these neurons (Tsai et al., 2009). Chapter 5 will focus on examining the effects stress-induced
and optogenetically-evoked high tonic activity of LC-NE neurons.
Amygdala-LC circuitry and the modulation of stress-induced anxiety-like behavior
There is some evidence that neuropeptidergic inputs to the LC from the central nucleus of
the amygdala (CeA), including those containing CRH, may become activated in response to
11

stressors (Figure 1.2) (Curtis et al., 2012; Francis et al., 1999; Valentino et al., 1992). Recent
anatomical data further support this notion using tract tracing studies and electron microscopy to
confirm that CRH containing amydalar monosynaptic projections from the CeA terminate in the
LC (Valentino et al., 1992). Given the importance of CRH in stress-induced behavioral responses
these projections are situated to significantly impact LC neuronal activity, yet their functional
consequences remain unresolved. Engagement of the CRH system has been implicated in stressinduced depression, anxiety, and negative affective responses including dysphoria (Bruchas et
al., 2009). Taken together, the prior body of work strongly implicates CeA-LC neural circuit
activation in mediating the stress response of the LC-NE system, emphasizing the need for
continued dissection of these circuits and systems. The second half of Chapter 5 focuses on
CRH-containing afferent inputs to the LC from the CeA. These studies demonstrate that CRH
neurotransmission increases tonic LC-NE activity and drives anxiety-like and aversive
behaviors.
Downstream effectors of LC-mediated negative affective behaviors
The LC-NE system has rich and complex combination of receptor and anatomical
projection targets. There are at least nine different adrenergic receptors and most have had some
implication in anxiety-like behaviors (Brunner et al., 2014; Dixit et al., 2014; Hanke et al., 2012;
Kuteeva et al., 2008; Le Maître et al., 2013; Mantsch et al., 2010; Raskind et al., 2007; Wohleb
et al., 2011). Furthermore, the LC has a widespread projection network throughout the
mammalian forebrain and spinal cord (Berridge and Waterhouse, 2003; Sara, 2009). Of
particular interest are the dense projections to the basolateral amygdala, a critical structure in
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Figure 1.2 Simplified, putative LC-NE system involved in negative affective behaviors. The
diagram illustrates CeA neurons terminating in the LC to release CRH and drive increased tonic
LC-NE firing causing release of NE into the BLA to drive possibly drive anxiety-like behaviors.
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generating negative affect (Berridge and Waterhouse, 2003; Davis, 1992; Valentino and AstonJones, 2010). While the anatomical projections from the LC and their cell types have beenstudied
for several years, the precise mechanisms by which the LC generates its influence over
basolateral amygdala (BLA) function remain undefined. Chapter 6 will focus on how the LCBLA projection induces affective behavioral responses via specific receptor systems and cell
activity. Understanding the next substrates beyond LC activity will be important for a clear
comprehension of how this system produces certain behaviors.
Together, Part 1 and Part 2 provide a novel series neural interfacing devices for
neuroscientists and off important insight of how small, widely projecting catecholamine
structures selectively mediate affective behaviors.
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SUMMARY
Successful integration of advanced semiconductor devices with biological systems will
accelerate basic scientific discoveries and their translation into clinical technologies. In
neuroscience generally, and in optogenetics in particular, an ability to insert light sources,
detectors, sensors and other components into precise locations of the deep brain could yield
versatile and important capabilities. Here, we introduce an injectable class of cellular-scale
optoelectronics that offers such features, with examples of unmatched operational modes in
optogenetics, including completely wireless and programmed complex behavioral control over
freely moving animals. The ability of these ultrathin, mechanically compliant, biocompatible
devices to afford minimally invasive operation in the soft tissues of the mammalian brain
foreshadow applications in other organ systems, with potential for broad utility in biomedical
science and engineering.
INTRODUCTION
Electronic systems that integrate with the body provide powerful diagnostic and
therapeutic capabilities for basic research and clinical medicine. Recent research establishes
materials and mechanical constructs for electronic circuits, light-emitting diodes (LEDs),
sensors, and other components that can wrap the soft, external surfaces of the brain, skin and
heart, for diverse functions in analytical measurement, stimulation and intervention (Kim et al.,
2010, 2011; Mannsfeld et al., 2010; Ordonez et al., 2012; Qing et al., 2010; Sekitani and
Someya, 2012; Sekitani et al., 2009; Takeuchi et al., 2004; Tian et al., 2010; Viventi et al.,
2010). A significant constraint in operating these devices, however, follows from their surfacemounted configurations and inability to provide direct interaction into the volumetric depths of
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the tissues. Passive penetrating electrodes or optical fibers with interconnections to externally
located electronic control and/or acquisition systems or light sources can be valuable in many
contexts, particularly in neuroscience, engineering, and surgery (Anikeeva et al., 2011; Kim and
Romero-Ortega, 2012; Mattis et al., 2012; Ordonez et al., 2012; Stark et al., 2012; Takeuchi et
al., 2004). Direct biological integration is limited by challenges from tissue lesions during
insertion, persistent irritation, and engineering difficulties in thermal management,
encapsulation, scalable interconnection, power delivery, and external control. Many of these
issues constrain attempts to insert conventional, bulk LEDs into brain tissue (Cao et al., 2013)
and to use semiconductor nanowire devices as cellular probes or active, in vitro tissue scaffolds
(Tian et al., 2010, 2012). In optogenetics, engineering limitations of conventional, tethered fiber
optic devices restrict opportunities for in vivo use and widespread biological application. As a
solution, we developed mechanically compliant, ultrathin multifunctional optoelectronic systems
that mount on releasable injection needles for insertion into the depths of soft tissue. These
wireless devices incorporate cellular-scale components ranging from independently addressable
multicolored microscale, inorganic light-emitting diodes (µ-ILEDs) to colocated, precision
optical, thermal, and electrophysiological sensors and actuators.
RESULTS
A scanning electron micrograph (SEM) of an isolated gallium nitride (GaN) µ-ILED, as a
constituent component of these systems, is presented in Figure 2.1A, as well as an epifluorescent
image of a device among cultured human embryonic kidney (HEK293) cells, to illustrate the
similar sizes. Each such “cellular-scale” µ-ILED (6.45 µm thick, 50x50 µm2) uses high-quality
epitaxial material grown on sapphire, processed to establish contacts (15x15 µm2 square pads in
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the corners, and an L-shaped current spreading layer for the p-contact) and then released, to
allow transfer printing onto narrow, thin plastic strips. The µ-ILEDs are less than one-thousandth
the size of conventional LEDs (typically 100 µm thick, with lateral dimensions of 1 mm2) and
fiber optic probes, as discussed below (Kim et al., 2012b). The small sizes of µ-ILEDs allow for
spatially precise, cellular-scale delivery of photons, highly effective thermal management,
reduced tissue damage, and minimized inflammation for prolonged use in vivo.
Combining µ-ILEDs with electronic sensors and actuators yields multifunctional
integrated systems that can be configured in single or multilayer formats. The latter option is
illustrated in Figure 2.1B and C, in which the sensors and/or actuators include a Pt
microelectrode for electrophysiological recording or electrical stimulation (Layer #1; a 20x20
µm2 exposure defines the active area), a microscale inorganic photodetector (µ-IPD) based on an
ultrathin silicon photodiode (Layer #2; 1.25 µm thick, 200x200 µm2), a collection of four µILEDs connected in parallel (Layer #3) and a precision temperature microsensor or microheater
(Layer #4; Pt serpentine resistor) (more details in Figure 2.2-2.4). Each layer is processed on
separate substrates shaped to match a releasable, photolithographically-defined epoxy
microneedle (Figure 2.5). A thin layer (~500 nm) of epoxy joins each of the layers in a precisely
aligned, stacked configuration. The microneedle bonds to the bottom layer with a thin, bioresorbable adhesive based on a film of purified silk fibroin, which enables removal of the
microneedle after implantation (Figure 2.1D and Figure 2.6). The microelectrodes measure
extracellular voltage signals in the direct vicinity of illumination and can also be used for
stimulation (Figure 2.15H). The temperature sensors determine the degree of local heating, with
a precision approaching ~1 mK, and can also be used as microheaters. The µ-IPD can measure
the intensity of light from the µ-ILEDs while implanted deep in brain tissue and/or can enable
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basic spectroscopic evaluations of absorption, fluorescence, diffuse scattering, and so on (for
detailed information see Figure 2.7 and 2.8.
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Figure 2.1 Injectable, cellular-scale semiconductor devices, with multifunctional operation
in stimulation, sensing and actuation. (A) Left, colorized SEM (left) of a GaN µ-ILED (~6.45
µm thick, and 50x50 µm2; contacts – gold; spreading layer – red). Right, fluorescent image of a
!-ILED (blue) with cultured HEK293 cells that express an eYFP tagged transmembrane protein
(green). (B) A multifunctional, implantable optoelectronic device, in a tilted exploded view
layout illustrating various components. The system includes layers for electrophysiological
measurement (#1; Pt contact pad, microelectrode), optical measurement (#2; silicon µ-IPD),
optical stimulation (#3; µ-ILED array), and temperature sensing (#4; serpentine Pt resistor), all
bonded to a releasable structural support for injection (microneedle). (C) Top view of the
integrated device shown in (B). (D) Process of injection and release of the microneedle. After
insertion, aCSF (center) dissolves the external silk-based adhesive. The microneedle is removed
(right) leaving only the active device components in the brain. (E) SEM of an injectable array of
µ-ILEDs. The total thickness is 8.5 µm. Inset shows rigid device before coating with a
passivation layer. (F) Integrated system wirelessly powered with RF scavenging. Insets show a
connectorized device unplugged (top) and plugged into (bottom) the wireless power system. (G)
Healthy, freely-moving mice with lightweight, flexible (left) and rigid (right) wireless systems
powering GaN µ-LED arrays in the VTA.
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Figure 2.2 Schematic illustration of steps for fabrication (A) thin (2.5 or 6.0 µm thick)
microneedle-shaped polymeric template laminated on a PDMS coated substrate, (B) µ-ILEDs
integrated by transfer printing, (C) patterned passivation layers and interconnects, and (D)
removal of the device from the PDMS coated substrate and transfer printing onto a releasable,
injection microneedle substrate.
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Figure 2.3 Schematic illustration of a printed multifunctional µ-ILED system.
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Figure 2.4 Photograph of µ-ILED layout
Photograph of four printed µ-ILEDs next to the tip of a ballpoint pen (right), to set the scale.
Each µ-ILED has lateral dimensions of 100 x100 µm2, with two 25x25 µm2 metal pads for
contacts and an L-shape current spreader.

32

Figure 2.5 Images of injection microneedles
Images of injection microneedles defined photolithographically using a UV-curable epoxy (250
µm thick, SU-8 100). (A) Photolithographic patterning of epoxy on a pre-patterned glass
substrate (B) microneedles delaminated by mechanical force from the glass substrate. (C) Tilted
optical microscopic image of a single microneedle.
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Figure 2.6 Demonstration of silk as an adhesive for injection microneedles
Demonstration of silk as a water soluble, bio-resorbable, releasable adhesive for injection
microneedles. (A) Image of a device at the initial stages of silk dissolution, after 3 min and (B)
after full dissolution and mechanical separation, after 15 min.
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Figure 2.7 Relationship between temperature and resistance of temperature sensors
(A) Change in resistance with temperature. (B) Fractional change in resistance as a function of
temperature, for three different devices.

35

Figure 2.8 Current-voltage (I-V) characteristics of a µ-IPD
Current-voltage (I-V) characteristics of a µ-IPD exposed to different light intensities generated
by operation of four µ-ILEDs. Electrical DC input powers into the µ-ILEDs were 0, 6.0, 9.5,
13.5 mW.
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Injection of such flexible devices into the brain follows steps shown in Figure 2.1D. The
injected multifunctional optoelectronic systems, have a total thickness of ~20 µm. This
exceptionally thin geometry, low bending rigidity, and high degree of mechanical flexibility
(Figure 2.1E and 2.1F) allow for minimally invasive operation. Wired control schemes use
standard transistor-transistor logic (TTL) and are therefore compatible with any readily available
electrical commutator. Details on wired powering strategies and demonstration of wired
optogenetic functionality in rodent behavioral assays are presented in Figures 2.9, 2.10, and
2.11. Implementation of a wireless power module based on radiofrequency (RF) scavenging is
shown in Figure 2.1F. A custom flexible polyimide film-based lightweight (~0.7 g) power
scavenger or a rigid printed circuit board-based scavenger (~2.0 g) (Figure 2.1G and Figure
2.12) can be temporarily mounted on freely moving animals for short-term experimentation
without constraint in natural animal behavior (Figure 2.1G). The entire system consists of a
wireless power transmitter and RF signal generator; an RF source (910 MHz; power output
between 0.02 and 0.1 mW); a power supply; an RF power amplifier (gain of 49 dB at 910 MHz;
power output between 1.6 and 7.9 W); and a panel antenna (gain of 13 dBi), as in Figures 2.12
and 2.13. The low-frequency signal generator provides user-controlled amplitude modulation for
programmed operation. The RF power that reaches the animals, under normal operating
conditions at a distance of ~1 m, is between 0.15 and 0.77 mW/cm2, which is substantially
smaller than the maximum permissible exposure limits (3.03 mW/cm2) for humans in controlled
environments. Wireless control allows access to complex and ethologically relevant models in
diverse environmental settings, including social-interactions, homecage behaviors, wheel
running, complex maze navigation tasks, and many other behavioral outputs (Figure 2.1G and
2.14).
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Figure 2.9 Images of connection between power supplies and µ-ILED systems
Images of the plug-in geometry of the connection between power supplies and penetrating µILED systems, for the case of a wired supply (A) and RF wireless units (B and C).
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Figure 2.10 !-ILED devices drive a conditioned place preference using standard TTL
signals. To demonstrate wired functionality, we selectively targeted ChR2(H134)-eYFP to VTADA neurons (Figure 2.26A) and tested that phasic activation (20, 5 ms pulses every minute) of
cells with a !-ILED device is sufficient to drive robust place preference behavior without a
change in locomotor activity. Animals were conditioned over three days for 30 minutes. !-ILED
devices were powered and controlled using standard function generator (Tektronix, AFG3022B
or AMPI, Master-9). (A) Left, Diagram of three-chambered conditioned place preference
apparatus. Right, representative heat maps of activity during the post-test, hotter colors represent
longer duration at every location in the apparatus. (B) Place preference scores, calculated as posttest minus pre-test on the light stimulation-paired side (n = 4-6/group; *p<0.05 t test compared to
AAV5-DIO-eYFP controls). (C) Total activity during the pre- and post-tests shows no difference
between the two groups. All bars represent means ± SEM.
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Figure 2.11 Real-time assessment of reward seeking or aversion
Real-time assessment of reward seeking or aversion is possible by pairing an animal’s behavioral
response with self-triggered stimulation or inhibition (Figure 2.19-2.21). Real-time conditioning,
animals allowed free access to the apparatus from fig. S18A learn to self-trigger stimulations
when 10, 5 ms pulses at 20 Hz light is delivered contingent on entry into the paired chamber. (A)
Animals did not express either a real-time or conditioned place preference under this
experimental design. (B) AAV5-DIO-ChR2 mice, however, did have increased numbers of
passive, entry-triggered self-stimulations. (C) Passive self-stimulation is learned over the course
of each trial. (D) Importantly, this difference is not due to a change in activity between the two
groups (n = 3/group, **p<0.01 t test compared to AAV5-DIO-eYFP controls). (E) Animals
could receive subsequent stimulations if they remained in the stimulus-paired chamber for 60
seconds. ChR2 mice did not learn to remain in the chamber for these subsequent stimulations.
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Figure 2.12 Circuit diagrams and pictures if RF powering scavenger
Circuit diagrams for each RF powering scavenger and pictures of RF powering scavenger (left)
and RF antenna (right), in a miniaturized PCB layout (A) and on polyimide film (B). The RF
power scavenger contains a RF antenna that works at 910 MHz, an impedance matching
inductor, a voltage multiplexer with cascaded combination of Schottky diodes and capacitors,
and blue LEDs. The circuit of the RF power scavenger for (A) is on two stacked PCB boards that
are connected with each other by a PCB connector. For RF power scavenger for (B), Au prepatterned PI film supports all of components connected by silver epoxy.
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Figure 2.13 Key components for wireless operation using RF power delivery
(A) Photo and diagram explaining the components of the system and demonstrating wireless
power. Headstage antennas on PCB board (B) and on bent PI (C). (D) A mouse with a
chronically implanted device. The nature of the interconnect allows for temporary coupling to
either form of headstage antenna or a wired power source. (E,F,G) Mice with acutely mounted
headstage antennas.
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Figure 2.14 Demonstration of wireless capabilities
For all panels the same environment is shown with wireless lit !-ILEDs (left) and wirelessly
stimulated mice (right). (A) Wireless mice can explore circular environments with no need for
commutators or adaptations to the behavioral apparatus. (B) RF modulation can be used to power
devices through covered arenas as seen here with a mouse in a traditional homecage
environment. (C) Multiple wireless devices can be controlled using a single antenna. Here, two
implanted mice are receiving identical optical stimulation simultaneously on a standard rotaroda rotating wheel that provides numerous barriers for use with tethered animals.
The electrical, optical, and thermal characteristics of the devices when operated in
biological environments are important for optogenetics and other biomedical applications. The
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total optical power density of the four µ-ILEDs in this device as a function of electrical input
power is shown in Figure 2.15A (more details in Figure 2.16 and 2.17. This performance is
comparable to similarly designed, state-of-the-art conventional GaN LEDs (Kim et al., 2012b).
Many optogenetic constructs can be activated with ~1 mW/mm2, at wavelengths near 450 nm
(Mattis et al., 2012). These conditions are well matched to the output of the GaN µ-ILEDs. Input
power of ~1.0 to 1.5 mW (Figure 2.15A) is sufficient for both activation of the
channelrhodopsin-2 [ChR2(H134)] ion channel and precise control of intracellular signaling
[adenosine 3’5’-monophosphate (cAMP and extracellular signal-regulated kinase (ERK 1/2)] via
an optically sensitive heterotrimeric guanine nucleotide-binding (G-protein)-coupled receptor
(OPTO-!2) (Airan et al., 2009) (Figure 2.23C and D, Figure 2.18 and 2.19). Wirelessly, at a
distance of 1 m, the RF scavenger puts out 4.08 mW of electrical power resulting in a 7
mW/mm2 optical power density. Other wavelengths are possible using different types of µILEDs, either in multicolored or uniform arrays. An example of the latter, with blue and red
(GaAs) µ-ILEDs, and the former, with green devices (produced using fluorescein sodium salt
phosphor on a blue GaN µ-ILED) are shown in Figure 2.15B.
µ-ILED induced changes in temperature determined by infrared imaging and by
analytical calculation, respectively, are shown in Figure 2.15, C and D. The µ-ILEDs were
implanted 0.3 mm into an explanted piece of brain tissue held at 37 oC. The time-averaged
temperatures measured at light-pulse (10 ms) frequencies of 3, 5, 10, and 20 Hz with peak light
output of 17.7 mW/mm2 are 37.17º, 37.22º, 37.31º, and 37.46oC, respectively. These results are
similar to calculated time-averaged temperatures of 37.20º, 37.34º, 37.68º, and 38.37oC,
respectively. Note that, the input power used in these tests is 10 times what is necessary to
activate many optogenetic constructs (Mattis et al., 2012). The cellular-scale dimensions of the
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µ-ILEDs enable high rates of passive thermal spreading, and the brain tissue itself operates as an
efficient heat sink. The latter is apparent in studies of the dependence of operating temperature
on tissue thickness, operating power, and frequency (Figure 2.15E). As in Figure 2.15D, the
experiment and theory agree remarkably well in spite of the indirect correlation between infrared
imaging results and temperature at the location of the devices (details appear in Figure 2.20 and
2.21. Perfusion in living tissue further increases the efficacy of these biological heat sinks.
Changes in temperature measured in vivo using an integrated temperature sensor (Figure 2.7)
compared with calculated results are shown in Figure 2.15F. Collectively, these results indicate
that changes in temperature associated with operation of µ-ILEDs can be less than 0.10 oC for
pulse frequencies less than 20 Hz, typical of many neuronal firing rates. These values are much
lower than those that occur in human deep brain stimulation (DBS) regulation, ~2oC (Elwassif et
al., 2006). Furthermore, in wireless operation, there is no appreciable change in temperature
associated with operation at the headstage antenna or the skull (Figure 2.22).
Other components of this multifunctional platform exhibit similarly good characteristics.
To demonstrate functionality of the silicon µ-IPD, Figure 2.15G shows photocurrents generated
by different intensities of light from µ-ILEDs at different pulse frequencies. Finally, the Pt
microelectrode has a 400 µm2 exposure site with ~1.0 M$ impedance at 1 kHz capable of
measuring extracellular potentials on the microvolt scale necessary to distinguish individual
action potentials (Figure 2.15H), as demonstrated with clear clustering in the principal
component analysis of spike data (Figure 2.15I).
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Figure 2.15. Optical, thermal, and electrophysiological studies with corresponding
theoretical analyses. (A) Total optical power density as a function of electrical input power
applied to an array of four GaN µ-ILEDs; optical images show operation at 3, 20 and 40 mW.
(B) A single device has one 675 nm GaAs !-ILED and four 450 nm GaN !-ILEDs that can be
activated independently (upper left and upper right) or concurrently (lower left). The same
device is coated in a fluorescein sodium salt phosphor for 530 nm light (lower right). (C)
Measured and (D) calculated temperatures in explanted brain tissue near implanted µ-ILEDs at a
depth of 0.3 mm and operated at 17.7 mW/mm2 of light output power. (E) Temperatures in a
system similar to that of (C, D), as a function of duty cycle in the operation of the µ-ILEDs and
at three different implantation depths (0.3, 1.0, 2.0 mm) and two different light output powers
(17.7, 23.5 mW/mm2). (F) Change in brain temperature as a function of time, measured using an
integrated temperature sensor co-located with an array of four µ-ILEDs in a lightly anesthetized
mouse. Results evaluated at a peak input electrical power of 8.65 mW, in 3, 5, 10, and 20 Hz
pulses (10 ms duration). The vertical dashed lines indicate onset (at 60 s) and offset (at 240 s) of
the µ-ILEDs. Colored dashes lines correspond to theoretical models for the temperature. The
right frame shows the time dynamics as the device is powered. (G) Change in photocurrent as a
function of time, measured using an integrated µ-IPD, for three different light output powers to
an array of µ-ILEDs: 5.0 mW/mm2 (blue trace), 16.2 mW/mm2 (red trace), and 21.9 mW/mm2
(black trace) at different pulse frequencies (10 ms pulses at 3, 5, 10, and 20 Hz). (H) 5 s
extracellular voltage trace of spontaneous neuronal activity gathered using the integrated Pt
microelectrode. (I) The same data is filtered and sorted using principal components analysis to
identify single units.
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Figure 2.16 Electrical and optical properties of an array of four µ-ILEDs connected in
parallel. (A) Current-Voltage (I-V) characteristics, (B) light output power and radiant efficiency
as a function of electrical input power, and (C) light emission intensity as a function of
wavelength.

48

A

Optical fiber for
LIV
measurement

tissue thickness

Brain tissue

LEDs
Penetrated needle

#(#*#
#(#")
#(#"#
#(#')

Light transmittance (%)

#(#*)

#(#'#
#(##)
#(###
!#(##)

!"

#
"
$
%
& '# '"
Electrical input power (mW)

&!
%!
$!
!

C

!)+ +
!$+ +
!*+ +
!"+ +
!'+ +
!#()+ +
!,-.-,-/0 -

!

Light output power (mW)

B

!

!

#(#$#

#!
"!
!
!

'$

"

#
$
%
Tissue thickness (mm)

&

with 2 mm thick brain tissue

D

1.61 µW (0.5 mA)

3.55 µW (1.0 mA)

8.01 µW (2.0 mA)

13.1 µW (3.0 mA)

Figure 2.17 Information related to tests of light penetration depth
(A) Schematic illustration of the experimental scheme, (B) light output-current and voltage
(LIV) results collected using slabs of brain tissue with various thicknesses (0.5, 1, 2, 3, 4, 5 mm)
and (C) their light transmission through the thickness of the tissue. (D) Light extraction through
2 mm thick slabs of brain tissue at various applied powers.
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Figure 2.18 !-ILED-induced activation of cAMP and ERK phosphorylation in Opto! 2
expressing cells. (A) Opto!2 cells co-expressing pGlo show a rapid and transient increase in
cAMP following light (450 nm, 5 sec, 0.5 W/cm2 pulse) stimulation (n=3). HEK293 cells
expressing pGlo show no response to the same light stimulation (n=3). Data are expressed as
mean ± sem. (B). Representative pERK and actin Western Blots for Opto!2 and HEK293 cells
following light (450 nm, 1 min, 0.5 W/cm2 pulse) stimulation (n=3). (C). Quantitation of pERK
normalized to actin in light stimulated Opto!2 and HEK293 cells. (*p<0.05, unpaired, two-tailed
t-test).
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Figure 2.19 !-ILED-induced modulation of in vivo neuronal activity in the VTA via
ChR2(H134)-eYFP expressing neurons. (A) Representative peri-light raster plot and histogram
demonstrating increased cell firing within 20 ms of onset of a 450 nm, 0.5 W/cm2 light pulse. (B)
Raster plot showing activity from the same neuron (A) time locking with various frequencies of
light delivery. Each light pulse is centered at 0 ms, the effects of prior and subsequent pulses are
apparent in each line of the 2000 ms raster plot.
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Figure 2.20 Surface temperature of µ-LEDs on an injection microneedle, during operation
at various power levels in open air. (A) Measured (dots) and calculated (lines) temperatures of
µ-ILEDs at various pulse duty cycles and at DC power levels. All calculated temperatures
(lines) are obtained by time-average results at 37 oC background temperature. The duration time
(width) for all pulsed cases is 10 msec. (B) Measured (left) and calculated (right) temperatures
at 15 and 10 mW applied power. The measured (calculated) temperatures are 37.44 (39.31) and
36.15 (38.54) oC, respectively, with a 3 Hz pulse. (C) Measured (left) and calculated (right)
temperature at 15 and 10 mW DC applied power. The measured temperatures (calculated) are
84.01 (86.95) and 86.31 (70.30) oC, respectively, with a 3 Hz pulse.
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Figure 2.21 Thermal imaging with a calibrated IR camera. (A) Schematic illustration and (B)
pictures of the IR camera stage and µ-ILED devices injected in brain tissue. (C) Measured and
(D) calculated tissue temperature with µ-ILEDs injected into a 0.3 mm thick slab of tissue,
evaluated at the surface for the case of 10 mW DC input power. Measured and calculated
temperatures are 42.09 and 43.82 oC, respectively.
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Figure 2.22 IR images of a phantom skin sample and the surrounding environment during
prolonged exposure to RF radiation. IR images (left) and extracted average temperatures
(right) of a phantom skin sample and the surrounding environment during prolonged exposure to
RF radiation, starting at time=0 s. The results indicate no observable effects of heating due to
RF. The temperature variations in the phantom skin are small, and mostly due to variations in the
environment, without any observable effect, even under constant RF power (B) IR images (left)
of a RF power scavenger circuit during exposure to constant RF radiation for various times. The
images show changes in temperature when RF power is applied, and the µ-ILEDs are turned on,
for 0 (left), 60 (right, top), and 120 (right, bottom) min. Spatially averaged changes in
temperature (right) of the RF power scavenger circuit and connector during prolonged exposure
to constant RF radiation, starting at time=0 s. The temperature change is less than 0.5ºC during
this 2 hr period. (C) IR images (left) of a thin, lightweight flexible RF power scavenger circuit
during exposure to pulsed (10 Hz) RF radiation for various times: 1 (left), 30 (middle), and 60
(right) min. There is no temperature change (right) in the thin, lightweight flexible RF power
scavengers (near the antenna and the connectors) during prolonged exposure to pulsed RF
radiation at 10 Hz.
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For use in optogenetics, such devices eliminate the need for lasers, bulk LEDs, fiber
coupling systems, tethers, and optomechanical hardware used in conventional approaches
(Figure 2.9). Furthermore, the fundamental optics of µ-ILEDs are very different from typical
fiber optic implants. Absorbing and reflecting structures around the emissive areas of the µILEDs enable precise delivery of light to cellular sub-regions. Figure 2.23A and B compare
relative size and the different patterns of light emission from µ-ILEDs to fiber optic probes.
Fiber optics typically approach brain structures dorsally. This approach preferentially illuminates
cells in the dorsal portion of the targeted region with greater light intensity near the point of light
escape (Aravanis et al., 2007) (Figure 2.23B left, & Figure 2.24). Targeting ventral cell bodies
or terminals requires lesion of dorsal regions or the use of substantially greater, and potentially
phototoxic (Yizhar et al., 2011), amounts of light to the site of interest. Neither option protects
the intact architecture of a complete brain locus. Although recent advances have spatially
restricted light from implanted fiber optics (Tye et al., 2011; Zorzos et al., 2012), these
approaches require the use of invasive metal cannulae (Figure 2.23E) or rely on sophisticated
and sensitive optomechanical engineering that may limit their use in awake, behaving animals.
The architecture of the !-ILEDs enables light delivery medial or lateral to the intended target
brain region. Native light escape from !-ILEDs is nearly omni-directional (Figure 2.23B,
center) but can be restricted to a wide range of angles with absorbing or reflective structures on
the device (Figure 2.23B, right).
We implanted both µ-ILEDs and fiber optics into animals expressing ChR2(H134)-eYFP
(fused with enhanced yellow fluorescent protein) in the locus coeruleus (LC) (Figure 2.24). One
hour of output-matched photostimulation induced c-fos expression (Carter et al., 2010), a
biochemical marker of neuronal activation, in both groups of ChR2(H134)-eYFP-expressing
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mice that was not seen in green fluorescent protein (GFP) expressing controls (Figure 2.23C
and D). The spatial distribution of c-fos expression, however, differed markedly between the
fiber optic and !-ILED groups. !-ILED devices produced significantly greater activation in the
ventral LC (Figure 2.23D).
The physical sizes and mechanical properties of the µ-ILED systems reduce lesioning,
neuronal loss, gliosis, and immunoreactivity. Glial responses are biphasic with an early phase
featuring widespread activation of astrocytes and microglia and a late, prolonged phase
hallmarked by restriction of the gliosis to the area closest to the implanted substrate (Szarowski
et al., 2003). The µ-ILED devices produced substantially less glial activation and caused smaller
lesions than metal cannulae and fiber optics, at both early (2 weeks) and late (4 weeks) phases
(Figure 2.23E). Furthermore,
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µ-ILED on microneedle !µ-ILED on ultrathin PET!

encapsulated sensors and µ-ILEDs, which maintain function over several months (Figure 2.25).
Figure 2.23 !-ILED devices improve spatial targeting and reduce gliosis. (A) Colorized
SEM (left) of a !-ILED mounted on a standard 200 !m fiber optic implant. (B) Left, a dorsalventral oriented light cone (outlined in white) from a 200 !m bare fiber implant (blue dash)
emitting 465 nm light in 30 !M fluorescein water. Center, near omnidirectional light escape
from a !-ILED device (blue dash) with four 450 nm !-ILEDs. Right, lateral light escape
(outlined in white) from a modified !-ILED device (blue dash) to allow unique spatial targeting
including flanking positions along the dorsal-ventral axis of brain loci. (C) Confocal
fluorescence images of 30 !m brainstem slices containing the LC show staining for tyrosine
hydroxylase (TH) and c-fos in control (left), fiber optic implanted (center), and !-ILED device
implanted (right) animals following 1 hour 3 Hz photostimulation (15 ms pulses, 5 mW output
power). Scale bar = 100 !m. (D) Fiber optic and !-ILED treatments specifically increase coimmunoreactivity. Ventral portions of the LC the !-ILED devices express a higher proportion of
tyrosine hydroxylase (TH, blue) and c-fos (red) co-immunoreactive neurons than fiber optic or
control groups (n = 3 slices per brain from 3 brains for each group; Two-way ANOVA with
Bonferroni post-hoc; All error bars represent means ± SEM; *p < 0.05, **p < 0.01). (E)
Confocal fluorescence images of 30 !m striatal slices show staining for astrocytes (GFAP, red)
and activated microglia (Iba1, green) at the ventral tip of each implanted device (dashed outline).
Gliosis is smallest with the µ-ILED device at both two- and four-week time points.
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Figure 2.24 Cartoon depicting the experimental strategy used in Fig. 3B & 3C. !-ILED
devices allow for unique spatial targeting of brain structures (here the locus coeruleus) to provide
consistent illumination along the entire dorsal-ventral plane of the structure.

58

Figure 2.25 The durability of the devices and the constituent
A

component following chronic implantation. (A) Survival curve
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Table 2.1 Detailed information on the attrition and censoring of devices from Figure 2.25A.
The last working day after implantation was recorded as 0 if the damage occurred prior to or
during implantation.
Device ID

Reason for attrition/censor

Last working day after implantation

S1

Testing period ended, sensor working

21

S2

Testing period ended, sensor working

21

S3

Testing period ended, sensor working

21

S4

Testing period ended, sensor working

21

S5

Testing period ended, sensor working

21

S6

Testing period ended, sensor working

220

S7

Interconnect failure

0

S8

Testing period ended, sensor working

7

L1

Structural damage during implantation

0

L2

Testing period ended, !-ILEDs working

220

L3

Animal died, device damaged on removal

183

L4

Testing period ended, !-ILEDs working

220

L5

Testing period ended, !-ILEDs working

220

L6

Testing period ended, !-ILEDs working

220

L7

Testing period ended, !-ILEDs working

220

L8

Testing period ended, !-ILEDs working

220

L9

Testing period ended, !-ILEDs working

220

L10

Testing period ended, !-ILEDs working

220

L11

Testing period ended, !-ILEDs working

220

L12

Testing period ended, !-ILEDs working

30

L13

Animal died, device damaged on removal

164

L14

One or more !-ILED failure

186

L15

Testing period ended, !-ILEDs working

90

L16

Testing period ended, !-ILEDs working

90

L17

One or more !-ILED failure

220

L18

One or more !-ILED failure

220

L19

One or more !-ILED failure

220

L20

One or more !-ILED failure

220
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We next implemented a fully wireless system for dissecting complex neurobiology and
behavior. Phasic neuronal firing of ventral tegmental area (VTA)-dopaminergic (VTA-DA)
neurons encodes salient stimuli and is sufficient for behavioral conditioning (Adamantidis et al.,
2011; Kim et al., 2012a; Tsai et al., 2009; Witten et al., 2011). We selectively targeted
ChR2(H134)-eYFP to VTA-DA neurons (Figure 2.26A) and tested whether mice would engage
in wireless, optical self-stimulation (20 5-ms pulses every nose poke) of their dopamine reward
pathway. To increase the contextual salience of the stimulation and to demonstrate wireless
function of the µ-ILED devices, the mice were free to explore a complex environment (Figure
2.27A-C). In the absence of physical reward, the same stimulation of VTA-DA neurons that
drives a traditional conditioned place preference (Figure 2.10) (Adamantidis et al., 2011; Tsai et
al., 2009) is actively sought with a cued nose poke when paired within a discrete environmental
context. ChR2(H134)-eYFP mice learned to self-stimulate their dopamine neurons (Figure
2.26B and C) and, furthermore, developed a robust place preference (Figure 2.26D and E) for
the environmental context containing the active nose poke for VTA-DA stimulation.
ChR2(H134)-eYFP animals showed strong correlation (r = 0.8620, p = 0.0272) between the
number of active nose pokes and the magnitude of conditioned place preference that was absent
in eYFP controls (Figure 2.26F and Figure 2.27E). In addition, we examined the effects of
wireless tonic stimulation of VTA-DA neurons on anxiety-like behavior. Tonic stimulation (at 5
Hz) reduced anxiety-like behavior, whereas phasic activation of VTA-DA neurons did not have
an effect on anxiety-like behavior (Figure 2.28). These findings are consistent with the
anxiolytic actions of nicotine on VTA-DA neurons, as well as the behavioral phenotypes seen in
the Clock%19 mice that have increased tonic firing of VTA-DA neurons (Coque et al., 2011;
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McGranahan et al., 2011) and further establish the utility of wireless optogenetic control in
multiple environmental contexts.
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Figure 2.26. Wirelessly powered !-ILED devices operantly drive conditioned place
preference. (A) Cell-type specific expression of ChR2(H134)-eYFP (green) in dopaminergic,
TH (red) containing neurons of the VTA. For clarity, inset shows TH channel alone. All scale
bars = 100 !m. (B) Operant learning curve on the active (left) and inactive (right) nose poke
devices over 5 days of 1-hour trials in the Y-maze. Active pokes drive 1 s of 20 Hz light (5 ms
pulses) from the !-ILED device on a fixed-ratio-1 schedule (n = 6-8 mice/group; Two-way
ANOVA with Bonferroni post-hoc; **p < 0.01). (C) Mean number of nose pokes ± SEM across
all five conditioning sessions. (*p < 0.05 One-way ANOVA with Bonferroni post-hoc) (D) Heat
maps of activity during the post-test, hotter colors represent longer duration in a location in that
part of the apparatus. (E) Left, place preference scores calculated as post-test minus pre-test in
the active nose poke-paired context. Five days of self-stimulation significantly conditioned a
place preference that developed over the course of the training sessions and remained during the
post-test (right; *p < 0.05 t-test compared to controls; *p < 0.05 Two-way ANOVA with
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Bonferroni post-hoc). All error bars represent means ± SEM (F) Scatter plot demonstrating
positive correlation (r = 0.8620, p = 0.0272) between post-test preference and total number of
active nose pokes during training in the ChR2(H134)-eYFP group.
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Figure 2.27 Wireless !-ILED devices drive an operantly conditioned place preference. (A)
Cartoon and (B) photo of Y-Maze with contexts and nose poke devices, red zones were not
accessible during pre/post-tests. (C) Timeline of experimental approach. (D) Total activity
during the conditioning shows increase in total ambulation of the ChR2 mice during the first four
days of training. (E) Scatter plot demonstrating no correlation (r=-0.1707, p=0.6861) between
post-test preference and total number of active nose pokes during training in the AAV-DIOeYFP injected controls.
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Figure 2.28 Tonic, not phasic, activation of VTA-DA neurons induces anxiolytic-like
behavior. (A) 5 Hz activation of VTA-DA neurons induces an anxiolytic-like behavioral
response in an elevated zero maze independent of (B) locomotor effects (n=6-9; *p<0.05 t test
compared to AAV5-DIO-eYFP controls). (C) Phasic (20, 5 ms pulses of 20 Hz light every
minute) stimulation does not influence anxiety-like behavior or (D) locomotor activity in the
open field test (n=6-8/group).
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DISCUSSION
These experiments demonstrate that these devices can be readily used in optogenetic
experiments. Future possible uses are in closed-loop operation, where actuators (e.g. heat, light,
and electrical) operate in tandem with sensors (e.g. temperature, light, and potential) for altering
light stimulation in response to physiological parameters, such as single-unit activity, pH, blood
oxygen or glucose levels, or neurochemical changes associated with neurotransmitter release.
Many of the device attributes that make them useful in optogenetics suggest strong potential for
broader use in biology and medicine. The demonstrated compatibility of silicon technology in
these injectable, cellular-scale platforms foreshadows sophisticated capabilities in electronic
processing and biological interfaces. Biocompatible deep-tissue injection of semiconductor
devices and integrated systems, such as those reported here, will accelerate progress in both basic
science and translational technologies.
MATERIALS AND METHODS
Preparation of µ-ILEDs
The fabrication began with epitaxially grown GaN on a sapphire wafer (500 µm thick
double polished sapphire with 2” diameter, Cermet Inc.). The GaN stack layers consisted of
undoped GaN (3.8 µm), n-type GaN (2 µm), spacer (0.4 µm), MQW (0.14 µm), and p-type GaN
(0.2 µm). Residual metal ions and GaN oxide on the surface were removed by rinsing with
diluted HCl (33 %). L-shaped current spreading layers of Ni (15 nm) and Au (15 nm) were
formed by sputter deposition (AJA ATC 2000), followed by annealing at 500 oC for 5 min in an
oxygen and nitrogen atmosphere to form an ohmic contact. After exposing n-type regions
defined using photolithography (40 x 40 µm2 recessive square with thick AZ 2035, Microchem
Inc) and etched using chorine based-inductively coupled plasma reactive ion etching (ICP RIE,
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Plasmatherm, SLR-770), both n- and p- contact pads, each 25 x25 µm2 in dimension, of 15 nm of
Cr and 300 nm of Au were deposited by electron beam evaporation (Temescal, FC-1800). To
define the lateral dimensions of the devices (100x100 µm2), chorine based ICP RIE was used to
remove GaN down to the sapphire substrate, with negative tone photoresist as an etching mask
(AZ 2070, Micorchem Inc).
After deposition of a passivation layer of SiNx (200 nm) by plasma enhanced chemical
vapor deposition (PECVD; STS, Mesc Multiple) the processed substrate was bonded to a silicon
wafer using a layer of palladium (Pd)-indium (In) chemical alloy, followed by laser lift off (KrF,
intensity,~0.9 J/cm2) to remove the sapphire from the µ-ILEDs. Here, the laser light triggered
thermal decomposition at the GaN-sapphire interface, allowing easy mechanical removal of
sapphire substrate upon heating to 70 oC on a hotplate. Wet etching with 5 wt% diluted HCl
selectively removed the underlying unalloyed In layer, leaving residual porous structures of InPd alloy that served as anchors to tether the µ-ILEDs to the silicon wafer. In this configuration,
the devices were easily lifted onto the surfaces of microstructured (3 µm in diameter, 1.2 µm in
height, and 5 µm in space) slabs of poly(dimethylsiloxane) (PDMS; Sylgard 184, Dow Corning)
via the action of van der Waals forces. Etching the exposed unalloyed Pd and passivation layer
(SiNx) removed all of residual metal on the µ-ILEDs. The result was an array of µ-ILEDs on
microstructured PDMS, suitable for manipulation by transfer printing, for integration onto
microneedles.
Fabrication of releasable, injection microneedles
To fabricate penetrating polymeric microneedles, suitable shapes were first defined in layers
of Cr (15 nm) and Au (300 nm) deposited on a glass slide (5 x 3.5 cm2) by photolithography and
wet etching. Photo-curable epoxy (SU-8 100, Microchem Inc) was then spin cast (1100 rpm for
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250 µm and 1800 rpm for 150 µm thickness) on the slide, and ultraviolet light was passed (380
mJ/cm2) through the backside to define a pattern of exposure in the epoxy, with the geometry of
the microneedle. Developing away the unexposed regions followed by thermal annealing (150
o

C for 10 min) defined and fully cured the epoxy to complete the fabrication of microneedles,

typically in array geometries. Poor adhesion between the glass and the epoxy allowed easy
mechanical removal of the microneedles, with tweezers, stamps or other implements. The left
image of Figure 2.6 shows an array of epoxy microneedles on glass. The left and right three
microneedles were removed before this image was collected.
To fabricate 6 µm thick (or 2.5 µm thick for µ-ILED) polyester device substrates (Mylar®
film, Chemplex® industries) with similar microneedle layouts, the films were first laminated on a
PDMS coated substrate. Patterns of Cr (100 nm thickness) in microneedle geometries were used
as etching masks for oxygen plasma RIE (March polymer RIE) of the exposed regions of the
films. Wet etching of the Cr completed the fabrication.
Fabrication of sensors
For microelectrodes and temperature sensors, 6 µm thick, patterned polyester films on
PDMS coated glass, formed according to procedures described above, were used. To fabricate
the electrophysiological sensor, 100 µm wide and 100 nm thick lines of Pt were formed on the
needle by photolithography and lift-off using negative tone resist (AZ 2070, Microchem Inc). To
measure electrophysiological signals from a single neuron, an epoxy passivation layer (SU-8 2,
Microchem Inc.) defined 20 x 20 µm2 openings to the underlying Pt, as the sensing locations. For
temperature sensors, 20 nm thick and 20 µm wide Pt serpentine structures served as resistors,
connected by Au electrodes at both ends.
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For the photodetectors, the top silicon layer of an silicon on insulator (SOI) wafer (1.25
µm thick silicon on a 400 nm thick layer of silicon dioxide on a silicon substrate, Soitec) was pand n- doped sequentially through masking layers of silicon dioxide (900-nm thick) deposited by
plasma-enhanced chemical vapor deposition and patterned by photolithography and etching. For
p-doping, the sample was exposed to a boron source for 30 min at 1000 oC in an N2 environment.
The n- doping used a phosphorous source under the same conditions for 10 min. A single cell
had a size of 200 µm x 200 µm including p- and n- doped parts with 200 µm x 40 µm (active
area: 200 µm x 120 µm), isolated by reactive ion etching through the silicon layer in a geometry
patterned by photolithography. The buried oxide layer of the SOI wafer was partially etched to
slightly undercut slicon layer. Next, photolithography defined photoresist structures at the four
corners of each square cell to hold the silicon layers to the underlying silicon wafer during
complete removal of the silicon dioxide layer with HF.
Measurements on µ-IPD
The current responses of µ-IPDs at different current injection levels (0 to 9 mA) into four
blue µ-ILEDs, in an array, were measured at biases of -5V to 5V. For time-dependent light
response measurements, AC current with four different frequencies (i.e., 3, 5, 10, and 20 hz)
were applied to the µ-ILEDs using a pulse generator (Global Specialities®). The current resonse
of the µ-IPDs at a bias of -3V were measured for 8 s with a sampling rate of 160 Hz.

Impedance measurements on microelectrode
Impedance was measured using a potentiostat (Gamry instruments, reference 600) with
phoshate buffered saline (PBS, Sigma-Aldrich). The PBS solution was diluted in 1 liter
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deionized water for 0.01 M, pH 7.4 at 25 oC. To measure impedance, we appied frequency
ranging from 11.0 KHz to 1 KHz.
Fabrication of µ-ILED arrays and interconnects on microneedles
1.

A PDMS stamp with posts (100 & 100 µm and heights of 100 µm) was positioned

above µ-ILEDs on a structured PDMS slab and then used to remove an µ-ILED, one at a time,
for integration onto a thin UV curable adhesive coated on a 2.5 µm thick microneedle shaped
substrate (patterned polyester film on PDMS coated glass, fabricated using steps similar to those
described above for the sensors). The printing was performed using a modified mask aligner
(Karl Suss, MJB). To form interconnected arrays of µ-ILEDs, the SiNx passivation layer was
first removed by reactive ion etching (RIE; Plasmatherm 790).

Coating with an adhesion

promoter (Dow, AP3000) and then a layer of photosensitive benzocyclobutene (6 µm thick;
BCB) prepared the devices for backside exposure to ultraviolet light, through the transparent
substrate. This light exposed the BCB in all regions except those above the opaque n-, and pcontact pads. Developing away the unexposed BCB (Advanced Developer, DS2100) and
blowing with a stream of N2 removed the residual developer, to complete the patterning process
for via holes. After fully curing the BCB in an Ar atomosphere in a glove box at 210 oC for 3 hr,
remaining BCB residues on the contacts were removed by oxygen RIE. To form metallization
lines to the contacts, 15 nm of Cr and 300 nm of Au were sputter deposited, and then wet etched
through a photopatterned layer of photoresist. Finally, an epoxy layer (2 µm thick, SU-8 2
Microchem) was spin cast and cured to form insulating coatings on the electrodes.
Forming multi-functional µ-ILED systems on releasable injection microneedles
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Separately fabricated thermal and electrophysiological sensors and printed µ-ILEDs, each
on polyester thin film substrates, were stacked in an aligned configuration on a penetrating epoxy
microneedle substrate using a modified mask aligner (Karl Suss, MJB). A thin layer of UV
curable epoxy (SU-8 2) served as an adhesive for bonding the sensors and the µ-ILEDs. For
bonding the entire stack to the penetrating microneedle, a thin layer of purified silk (7 wt%) was
used, to allow release of after implantation. After curing or drying, the adhesives in all cases
have thicknesses of a few hundred nanometers.
Characterization of optical and thermal properties
Optical measurements of the emission spectra and light output were obtained with a
spectrometer (HR4000 and FOIS-1 fiber optics integrating sphere, Ocean Optics). Thermal
measurements were performed using a MWIR-based InDb thermal imager (InfraScope, GFI)
with a base temperature of 37oC.

Wired powering
µ-ILED devices were connected to a function generator (AMPI, Master-9 or Tektronix,
AFG3022B) and TTL modulation (low 0V, high 4V) was used to power the !-ILEDs at the
stated frequencies and pulse widths.

Wireless powering and RF powering scavenger
The wireless power transmitter includes a low-frequency signal generator, an RF signal
generator, a power supply, a RF power amplifier, and a panel antenna. The low-frequency signal
generator outputs an amplitude modulation signal to modulate the RF power generator. The RF
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power amplifier that is powered by the power supply enlarges the modulated RF signal from the
RF signal generator. The RF power is then transmitted from the panel antenna on 75 µm thick
polyimide layer or commercialized PCB board. The RF signal generator has a power output from
-10 to -17 dBm at 910 MHz, which corresponds to a power ranging from 0.1 mW to 0.02 mW.
The power amplifier has a gain of 49 dB, thus the power output from the power amplifier is from
1.6 to 7.9 W. Under an antenna gain of 13 dBi and at a distance that is approximately 1 meter
away from the antenna, the RF power that reaches the mice is approximately 4 mW, given an
exposure area of the mice of ~32 cm2. Mice with chronically implanted µ-ILED devices were
acutely connected to the headstage antenna immediately prior to any wireless photostimulation.

Numerical modeling of temperature in the µ-ILEDs
A three dimensional (3D) model was established to study the temperature distributions in
the system in the pulsed mode and DC mode. Eight-node, hexahedral brick elements in the
finite element software ABAQUS were used to discretize the geometry. The µ-ILEDs are
modeled as heat sources. The bottom surface of device was set as a constant temperature, while
the other surfaces are free heat convection boundary with the convection heat transfer coefficient
25 W/(m2'K). The initial temperature of the device was set as the environmental temperature

T! .

The dimensions and layout of the device can be found in the main text.

The

microelectrodes and the sensors were neglected in the finite element simulations due to their
small thickness (~300 nm) compared to that of other layer (~6 µm). The thermal conductivity,
density and thermal capacity are 317 W/(m'K), 19300 kg/m3 and 130 J/(kg'K) for Au, 0.2
W/(m'K), 1190 kg/m3 and 1200 J/(kg'K) for epoxy (Solano et al., 2008), 0.15 W/(m'K), 1050
kg/m3 and 1270 J/(kg'K) for polyester (Mattsson et al., 2007), 230 W/(m'K), 2330 kg/m3 and
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700 J/(kg'K) for µ-ILEDs (Kim et al., 2012b), and 0.29 W/(m'K), 1050 kg/m3 and 2180 J/(kg'K)
for BCB (Modafe et al., 2005).
Figure 2.18A shows the time-average temperature of µ-ILEDs operated in pulsed modes
(3, 10, and 20 Hz) and DC mode at 5, 10, 15 and 20 mW input power when the background
temperature is T! = 37 oC. The finite element results (line) agree well with the experimental
measurements (dot). Figure 2.18B and C show the surface temperature distribution from
experiments and finite element simulations. They agree reasonably well with each other and the
discrepancy is due to the assumption of heat source only for µ-ILEDs since other parts (e.g., Au
interconnect) may also serve as heat sources.
Analytical modeling of temperature in the tissue
An analytical model was established to obtain the steady temperature in the tissue when the
device is inserted into the mouse brain tissue. The µ-ILED is modeled as a disk heat source with
a radius r0= L

! corresponding to the same area of µ-ILED (L&L) and a heat generation of

Q(t). Since the thickness of tissue (~4 mm) is much larger than that of device (~100 µm), we
ignore the device structure in the analytical modeling. Once we have the temperature due to a
single µ-ILED, the temperature due to four µ-ILEDs can be obtained by the superposition
theorem.
The heat transfer equation in cylindrical coordinate with the origin as the center of µ-ILED
is

" 2T 1 "T " 2T c ! "T
+
+
#
=0
"r 2 r "r "z 2 k "t
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(1)

where k is thermal conductivity of tissue, ! is density of tissue, c is specific heat capacity of
tissue. The thermal diffusivity of tissue is ! = k / (c " ) . By setting ! = T # T" , where T! is the
remote temperature, the above equation becomes

# 2! 1 #! # 2!
#!
+
+ 2 ="
2
#r
r #r #z
#t

(2)

Boundary conditions involve the adiabatic condition on the top surface (z=-h0) and a constant
temperature T! = 37 oC on the bottom surface (z=h1).

At the µ-ILED interface (z=0),

discontinuous heat flow Q(t) is assumed as a means to introduce the input pulsed power. Let’s
consider a unit pulsed power P(t) for time between 0 an t0 with a period T, which can be
expanded into Fourier Series
"
"
$1 0 < t # t0
P(t ) = %
= a0 + ' an cos n!t + ' bn sin n!t
n =1
n =1
&0 t0 < t # T

where ! = 2" / T , a0 = t0 / T , an = 2sin ( n!t0 ) / (n!T ), bn = 2[1 # cos(n!t0 )] / ( n!T ) .

(3)

For each

cos(nwt) [or sin(nwt)] in the power expression of Eq. (3), we can assume the solution of Eq. (2)
to be ! (r , z, t ) = " (r , z ) exp(n#ti) . Equation (2) then becomes

" 2! 1 "! " 2!
+
+ 2 # q 2! = 0
2
"r
r "r "z
where q 2 =

n!i

"

(4)

. Equation (4) can be solved by applying the Hankel transformation. For

!h0 " z " 0 , we obtain the solution as
+#

! (r , z; n" ) = ) A0 $exp( z s 2 + q 2 ) + exp(& z s 2 + q 2 & 2h0 s 2 + q 2 ) % J 0 ( sr ) sds ,
0

'

(
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(5)

where A0 =

1 ! exp(!2h1 s 2 + q 2 )

r0 J1 ( sr0 )

2ks s s 2 + q 2 1 + exp(!2h0 s 2 + q 2 ! 2h1 s 2 + q 2 )

.

The temperature increase due to the power of cos(nwt) [or sin(nwt)] is then equal to

! (r, z; n") cos ( n"t + #n ) [or ! (r, z; n") sin ( n"t + #n ) ] where tan(!n ) = Im(" ) / Re(" ) . The
temperature due to the power P(t) in Eq. (3) is given by
$

$

n =1

n =1

! (r , z, t ) = a0! (r , z;0) + % an ! (r , z; n" ) cos ( n"t + # n ) + % bn ! (r , z; n" ) sin ( n"t + # n ) (6)
The temperature due to the four µ-ILEDs with total power Q(t)=Q0*P(t)/4 can then be given by

! tot (r , z, t ) =

Q0
4

4

"! (r, z, t )
i

(7)

i =1

In vitro experiments, the thermal conductivity k of the issue is 0.6 W/(m'K), the density ! is
1040 Kg/m3, the specific heat c is 3650 J/(kg'K)(Elwassif et al., 2006). The predicted surface
temperature (z=-h0) agrees well with experimental measurement as shown in Figure 2.19 and
Figure 2.15D and E. In vivo experiments, there is a heat loss due to blood flow and we fit an
effective power to be 0.62 mW at 3Hz. Then the predicted the time-averaged temperature at the
location of temperature sensor (z=-6 µm) agrees very well with that in experiments at other
frequencies with ~5% error. To further verify the analytical solution in Eq. (7), a full 3D finite
element model for the device/tissue system is also established. The time history of average
temperature in Figure 2.15F shows a good agreement between finite element simulation and
experimental measurement.
Preparation of phantom skin and IR measurement of RF scavenger
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The potential localized heating effect of RF power is characterized using a phantom skin
sample that is placed in the RF field. The phantom skin (Esler et al., 2010; Ito et al., 2001) is a
gelatin-based material that is made of the combination of water, agar, polyethylene, sodium
chloride, sodium azide (Sigma-Aldrich Co.), and TX 151 (Oil Center Research), and has similar
electrical properties as animal skin at the RF range. The thermal imaging is taken using an
infrared camera (A655sc, FLIR Systems, Inc.), which has high resolution and a measurement
accuracy at ±2% of the reading value.
Experimental subjects
Adult (25–35 g) male C57BL/6J and TH::IRES-Cre backcrossed to C57BL/6J mice were
group-housed, given access to food pellets and water ad libitum (except where noted) and
maintained on a 12 h:12 h light:dark cycle (lights on at 7:00 AM). All animals were held in a
facility in the lab 1 week prior to surgery, post-surgery and throughout the duration of the
behavioral assays to minimize stress from transportation and disruption from foot traffic. All
procedures were approved by the Animal Care and Use Committee of Washington University
and conformed to US National Institutes of Health guidelines.
Viral preparation
Plasmids coding pAAV-EF1a-DIO-EFYP, pAAV-EF1a-double floxed-hChR2(H134R)EYFP-WPRE-HGHpA, and pLenti-EF1a-hChR2(H134R)-EYFP-WPRE were obtained from
Addgene (Addgene.org) originally from the Deisseroth Laboratory at Stanford University. The
DNA was amplified with a Maxiprep kit (Promega) and packaged into AAV5 serotyped viruses
by the WUSTL Hope Center Viral Core. LV-PGK-GFP was provided by the WUSTL viral core
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facility. The final viral concentration was 2-5 x 1012 genome vg/mL for the adeno-associated
viruses and 1.1-1.3 x 108 IU/ml for all the lentivirus used.
Table 2.2
Plasmid

Source

Packaged by

Serotype

Titer

pAAV-EF1aDIO-EFYP

Deisseroth
Laboratory
(Stanford)

WUSTL
Center
Core

Hope AAV5
Viral

5 x 10^12 vg/ml

pAAV-EF1aDeisseroth
double
floxed- Laboratory
hChR2(H134R)- (Stanford)
EYFP-WPREHGHpA

WUSTL
Center
Core

Hope AAV5
Viral

2 x 10^13 vg/ml

pLenti-EF1ahChR2(H134R)EYFP-WPRE

Deisseroth
Laboratory
(Stanford)

WUSTL
Center
Core

Hope N/A
Viral

1.1 x 108 IU/ml

pRRLsinPGKGFPppt

Sands
Laboratory
(WUSTL)

WUSTL
Center
Core

Hope N/A
Viral

1.3 x 108 IU/ml

Stereotaxic surgery
After the animals were acclimatized to the holding facility for seven to nine days, they
were anaesthetized in an induction chamber (4% Isolflurane) and placed in a stereotaxic frame
(Kopf Instruments, Model 1900) where they were maintained at 1-2% isoflurane. A craniotomy
was performed and mice were injected with 1ul of AAV5-DIO-ChR2 or AAV5-DIO-eYFP, LVEf1"-ChR2-eYFP, or LV-Ef1"-GFP unilaterally into the VTA (stereotaxic coordinates from
bregma: -3.20 anterior-posterior (AP), +/(0.50 medial-lateral (ML), (4.90 mm dorsal-ventral
(DV)), LC (-5.45 AP, +/- 1.25 ML, -4.00 DV), or the ventral striatum (1.3 AP, +/- 1.0 ML, -4.00
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DV). Mice were then implanted with metal cannula (PlasticsOne; coordinates adjusted from viral
injection 0.00 AP, +/- 0.25 ML, +1.00 DV), fiber optic implants (coordinates adjusted from viral
injection 0.00 AP, +/- 0.25 ML, +1.00 DV)(Sparta et al., 2011), or a !-ILED device (same
coordinates as viral injection). Custom adapters (WUSTL Instrument Machine Shop) for the
Kopf cannula holder (Model 1966) were used to implant the fiber optics and the !-ILED devices.
For biodissolvable samples, the device was implanted at the desired target, ACSF was applied to
the portion of the device that remained outside of the skull to facilitate dissolution of the
adhesive, and then the epoxy needle was removed after a delay of 15 minutes. The implants were
secured using two bone screws (CMA, 743102) and affixed with TitanBond (Horizon Dental
Products) and dental cement (Lang Dental). Mice were allowed to recover for 3-5 weeks prior to
behavioral testing; this interval also permitted optimal AAV expression and Cre recombinase
activity.
Immunohistochemistry
Immunohistochemistry was performed as described (Bruchas et al., 2011). Briefly, mice
were anesthetized with pentobarbital and intracardially perfused with ice-cold 4%
paraformaldehyde in phosphate buffer (PB). Brains were dissected, post-fixed for 24 hr at 4 ºC
and cryoprotected with solution of 30% sucrose in 0.1M PB at 4ºC for at least 24 hr, cut into 30
!m sections and processed for immunostaining. 30 !m brain sections were washed three times in
PBS and blocked in PBS containing 0.5% Triton X-100 and 5 % normal goat serum. Sections
were then incubated for ~16 hr at room temperature in rabbit anti c-fos antibody (1:20000,
Millipore), guinea pig anti-GFAP (1:500, Synaptic Systems), rabbit anti-Iba1 (1:300, Wako
Chemicals) and/or chicken anti-TH (1:2000, Aves Labs). Following incubation, sections were
washed three times in PBS and then incubated for 2 hr at room temperature in Alexa Fluor 488
77

goat anti-mouse IgG (1:500, Invitrogen), Alexa Fluor 594 goat anti-rabbit IgG (1:500,
Invitrogen-), goat anti-chicken Alexa Fluor 633(1:500, Invitrogen) and/or goat anti-guinea pig
Alexa Fluor 546(1:500, Invitrogen) were then washed three times in PBS and followed by three
10-min rinses in PB and mounted on glass slides with Vectashield (Vector Labs) and sealed with
nail polish for microscopy. All sections were imaged on both epifluorescent (Olympus BX61)
and confocal (Olympus Fluoview 500) microscopes. Gain and exposure time were constant
throughout, and all image groups were processed in parallel using Adobe Photoshop CS5 (Adobe
Systems).
Table 2.3
Antibody

Species

Dilution

Source

GFAP

Guinea Pig

1:500

Synaptic Systems

Iba1

Rabbit

1:300

Wako Chemicals

TH

Chicken

1:2000

Aves Labs

c-fos

Rabbit

1:20,000

Millipore

Alexa Fluor 488 anti- Goat
mouse IgG

1:500

Invitrogen

Alexa Fluor 594 anti- Goat
rabbit IgG

1:500

Invitrogen

Alexa Fluor 633 anti- Goat
chicken IgG

1:500

Invitrogen

Alexa Fluor 546 anti- Goat
guinea pig IgG

1:500

Invitrogen

Alexa Fluor 594 anti- Goat
chicken IgG

1:500

Invitrogen

Cell culture and transfection of NOPR-YFP expressing, HEK293 Cells
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A single 50 x 50 x 6.45 !m !-ILED was printed onto a standard glass coverslip
(Fisherbrand, 12-545-80). The glass was coated with Poly-L-lysine (Sigma-Aldrich, P4707) to
facilitate cell adhesion. Stable HEK293 cells expressing pcDNA3 containing nociceptin opioid
peptide receptor-YFP (NOPR-YFP) were generated as previously described (Zhang et al., 2012).
The NOPR-YFP expressing cells were grown on the coverslip in a 24-well plate and placed in a
37 °C 5% CO2 incubator. Cells were washed three times with PBS and then fixed in 4%
paraformaldehyde for 20 min, washed in PBS, washed in 0.1 M PB, and mounted using
VECTASHIELD (Vector Laboratories) and sealed with clear nail polish. Images were captured
using Metamorph 7.6 (Molecular Devices) and processed with ImageJ 1.44o (NIH).
cAMP Assay
HEK293 cells were co-transfected with Opto!2 (Airan et al., 2009) (pGloSensor-22F
cAMP plasmid (Promega E2301) in 96-well format. Using a SynergyMx microplate reader
(BioTek; VT, USA), baseline luminescence recordings were taken. In the presence of 9-cis
retinal (1!M), cells were exposed to !-ILED light (450 nm, 5 sec, 0.5 W/cm2 pulse) and relative
luminescent units taken every 2 sec using GloSensor cAMP Assay (Promega). Relative
luminescent units were normalized to an initial 1 min recording of baseline. Data are expressed
as ± S.E.M.
Immunoblotting
Western blots for phospho-MAPKs were performed as described previously (Zhang et
al., 2012). Briefly, Opto!2 expressing HEK293 cells were serum-starved 4-6 h prior to treatment.
Cells were light treated (450 nm, 1 min, 0.5 W/cm2 pulse), lysed in 70 µl of lysis buffer (50 mM
Tris-HCl, 300 mM NaCl, 1 mM EDTA, 1 mM Na3VO4, 1 mM NaF, 10% glycerol, 1% Nonidet
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P-40, 1:100 of phosphatase inhibitor mixture set 1 (Calbiochem), and 1:100 of protease inhibitor
mixture set 1 (Calbiochem)), sonicated for 20 s, centrifuged for 15 min (14000 x g, 4 °C). 50 µg
of total protein was loaded onto non-denaturing 10% bisacrylamide precast gels (Invitrogen) and
run at 150 V for 1.5 h. Blots were transferred to nitrocellulose (Whatman, Middlesex, UK) for
1.5 h at 30 mV, blocked in TBS/5% bovine serum albumin for 1 hr, incubated overnight at 4 °C
with a 1:1000 dilution of goat-anti- rabbit phospho-ERK 1/2 (Thr-202/Tyr-204) antibody (Cell
Signaling) and mouse actin (1:20,000, AbCam). Following overnight incubation, membranes
were washed 4 x 15 min in TBST (Tris- buffered saline, 1% Tween 20) and then incubated with
IRDye 800- and 700 conjugated affinity-purified anti-rabbit or anti-mouse IgG at a dilution of
1:5000 (pERK) or 1:20,000 (actin) in a 1:1 mixture of 5% milk/TBS and Li-Cor blocking buffer
(Li-Cor Biosciences, Lincoln, NE) for 1 h at room temperature, washed 3 x 10 min in TBST, 1 x
10 min in TBS and analyzed using the Odyssey infrared imaging system (Li-Cor Biosciences).
Band intensity was measured using Odyssey software following background subtraction and
integrated band density in high-resolution pixels calculated. All subtypes of ERK (1 and 2) were
quantified together. All pERK bands were normalized to actin, as an equal protein loading
control and plotted using GraphPad (GraphPad Prism 5.0) software. Statistical significance was
taken as * p < 0.05 as determined by unpaired two-tailed t-test.
In vivo electrophysiology
To demonstrate the ability of the incorporated electrode, spontaneous cellular activity
was monitored in the deep midbrain (Figure 2.15H). For light modulated responses, an array of
16 (35-µm tungsten wires, 150-µm spacing between wires, 150-µm spacing between rows,
Innovative Physiology) was epoxied to a rigid !-ILED device and lowered into the VTA of a
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lightly (~1% isoflurane) anesthetized, TH-Cre mouse expressing ChR2(H134)-eYFP in the VTA
(Figure 2.17). Two skull screws were arbitrarily placed anterior to bregma on either side of the
midline and used to ground the electrode array. In either approach, voltage readings from each
electrode were bandpass-filtered with activity between 250 and 8,000 Hz analyzed as spikes. The
signal was amplified and digitally converted using commercially available hardware and
software (Omniplex and PlexControl, Plexon). Spikes were sorted using principal component
analysis and/or evaluation of t-distribution with expectation maximization (Offline sorter,
Plexon).
Light path visualization
A 200 !m, 0.48 NA diameter fiber optic coupled to a 465 nm blue LED (Plexon) or
devices with four, 100 x 100 x 6.45 !m 450 nm blue !-ILEDs were adjusted to have the same
(~280 !W) light output. The light sources were submerged in 30 !M fluorescein sodium salt
(Sigma-Aldrich, F6377) (Tye et al., 2011) in deionized water and the photos were taken in a dark
room with an exposure of 1/1000 s and an f-number of 5.6 from ~50 cm away for all images.
Each photo was cropped using Photoshop (Adobe Systems), but no other processing was used.
c-fos expression
C57BL/6J mice were injected with LV-Ef1"-ChR2-eYFP or LV-PGK-GFP into the LC
as described above. Three weeks later, animals were anesthetized, mounted on the stereotaxic
instrument, and fiber optics or !-ILED devices were acutely implanted to target the LC. 5 mW, 3
Hz blue light stimulation was delivered for 1 hour (Carter et al., 2010), animals were perfused
immediately following, and immunohistochemistry was performed as above. Slices from the LC
originated from approximately -5.45 mm caudal to bregma were mounted and imaged. For
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quantification, the LC was divided into three (dorsal, central, and ventral) 100 x 100 !m
compartments. TH and c-fos labeled channels were separated, the compartment mask was
applied, an exclusive threshold was set and positive staining for each channel was counted in a
blind-to-treatment fashion using Metamorph. The counts from each channel were then overlaid
and percent TH+ cells expressing c-fos were reported.
Immuno-glial response in implanted tissues
C57BL/6J mice (n=16) were implanted with devices into the ventral striatum and allowed
to recover for either 2 or 4 weeks before perfusion. Immunohistochemistry was performed as
described.
Conditioned Place Preference
VTA injected (AAV5-DIO-eYFP or AAV5-DIO-ChR2-eYFP; n=4-6/group) mice were
trained in an unbiased, balanced three- compartment conditioning apparatus as described
(Bruchas et al., 2011). Briefly, mice were pre-tested by placing individual animals in the small
central compartment and allowing them to explore the entire apparatus for 30 min. Time spent in
each compartment was recorded with a video camera (ZR90; Canon) and analyzed using
Ethovision 8.5 (Noldus). Mice were randomly assigned to light and no-light compartments and
received no light in the morning and light (20, 5 ms pulses every minute) in the afternoon at least
4 h after the morning training on three consecutive days. CPP was assessed on day 5 by allowing
the mice to roam freely in all three compartments and recording the time spent in each. Scores
were calculated by subtracting the time spent in the light stimulus-paired compartment post-test
minus the pre-test.
Real-time Place Preference
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VTA injected (AAV5-DIO-eYFP or AAV5-DIO-ChR2-eYFP; n=3/group) TH-Cre mice
were trained in an unbiased, balanced three-compartment conditioning apparatus as described
(Lammel et al., 2012; Stamatakis and Stuber, 2012; Tan et al., 2012). Mice were trained in the
same conditioning apparatus as described above, and the pretesting phase (day 1) was identical.
However, on days 2–4, mice were still allowed to freely roam all three compartments. On these
conditioning days, entry into one compartment was paired with 20, 5 ms pulses of light that
would repeat every minute the animal remained in the light-paired chamber. On day 5, the posttesting was identical as the above. Scores were calculated by subtracting the time spent in the
light stimulus-paired compartment each day minus the pre-test.
Operantly Conditioned Place Preference
VTA injected (AAV5-DIO-eYFP or AAV5-DIO-ChR2-eYFP; n=6-8/group) TH-Cre
mice were prepared for nose poke training by mildly restricting daily food to four grams to
stabilize body weight and facilitate behavioral responding. Mice were trained in an unbiased,
balanced three-compartment Y-Maze. Each arm of the Y-Maze was 50 cm by 10 cm, a 50 cm2
equilateral triangle connected all three arms (for a total area of 1550 cm2), and each arm was
outfitted with a unique context (white, horizontal black stripes, or vertical black stripes). At the
distal end of each of the striped arms a nose poke device (Med Associates, ENV-313M). On day
1, the headstage antenna was attached and mice were pre-tested by placing individual animals in
the intersection of the three arms and allowing them to explore the entire apparatus for 30 min.
During the pre-test and post-test sessions, a wall was placed to prohibit access to the nose poke
apparatus and the final 15 cm of each arm. On days 2-6, the headstage antenna was attached and
mice were allowed access to the entire Y-Maze for 1 hour. During these conditioning sessions a
cue light was on to indicate a stimulation could be achieved nose poke and turned off for 500 ms
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following a poke on either device. A nose poke on the active device triggered an optical
stimulation (20 pulses, 20 Hz, 5 ms pulse duration) on a fixed ratio-1 schedule, while a poke on
the inactive device resulted in the cue light turning off for 500 ms. Nose pokes were recorded
using a Med Associates TTL-I/O Interface connected to the Noldus Ethovision I/O Box. On day
7, the post-testing was conducted in an identical manner as the pre-test. All activity and position
data was recorded using Ethovision and analyzed using Microsoft Excel and GraphPad Prism
5.0. Place preference scores were calculated by subtracting the time spent in the active nose
poke-paired compartment each day minus the pre-test.
Open Field Test
OFT testing was performed in a sound attenuated room maintained at 23ºC. Lighting was
measured and stabilized at 200 lux, and performed in the afternoon between 13:00–1600 hrs. The
open field was a 55 x 55 cm square enclosure and was cleaned with 70% ethanol between testing
trials. For testing, VTA injected (AAV5-DIO-eYFP or AAV5-DIO-ChR2-eYFP; n=6-8/group)
TH-Cre mice were connected to cables coupled to a function generator and placed in the center
of the open field and allowed to roam freely for 15 min. During the entire trial, animals received
20, 5 ms pulses of photostimulation. Movements were video- recorded and analyzed using
Ethovision. The center was defined as a square comprised of 50% the total area of the OFT.
Time in the center expressed as percentages total time was the primary measure of anxiety-like
behaviors.
Elevated Zero Maze
EZM testing was performed in a sound attenuated room maintained at 23ºC. Lighting was
200 lux, and performed in the afternoon between 13:00–1600 hrs. The EZM (Harvard
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Apparatus) was made of grey plastic (Dimensions: 200 cm in circumference comprised of four
50 cm sections: two opened, two closed. The maze was elevated 50 cm above the floor and had a
path width of 4 cm with a 0.5 cm lip on each open section) and was cleaned with 70% ethanol
between trials. For testing, VTA injected (AAV5-DIO-eYFP or AAV5-DIO-ChR2-eYFP; n=69/group) TH-Cre mice were connected to the headstage antenna and placed at the threshold of a
closed section facing the open section and allowed to roam freely for 9 min. For the first and the
final 3 minutes of each trial there was no photostimulation. For minutes 4-6, animals received 5
Hz, 5 ms width stimulation. Movements were video- recorded and analyzed using Ethovision
(Noldus). Open section times expressed as percentages total time the primary measures of
anxiety-like behaviors.
Data Analysis/Statistics
Data are expressed as means ± SEM. Data were normally distributed, and differences
between groups were determined using independent t-tests or one-way ANOVA, or two-way
ANOVAs followed by post hoc Bonferroni comparisons if the main effect was significant at p <
0.05. Statistical analyses were conducted using Prism 5.0 (GraphPad).
Genotyping of mouse lines
DNA was isolated from tail tissue obtained from weanling mice (21-28 days of age), and
PCR screening was performed using the following primers: Cre recombinase (forward: 5’- GCA
TTA CCG GTC GAT GCA ACG AGT GAT GAG-3’ and reverse: 5’- GAG TGA ACG AAC
CTG GTC GAA ATC AGT GCG-3’) yielding a 400-bp PCR product in Cre positive animals.
Fatty acid-binding protein intestinal primers (forward: 5’- TGG ACA GGA CTG GAC CTC
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TGC TTT CCT AGA-3’ and reverse: 5’- TAG AGC TTT GCC ACA TCA CAG GTC ATT
CAG-3’) were used as positive controls and yield a 200-bp PCR product.
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devices for wireless optogenetics
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SUMMARY
The rise of optogenetics provides unique opportunities to advance materials and
biomedical engineering as well as fundamental understanding in neuroscience. This protocol
describes the fabrication of optoelectronic devices for studying intact neural systems. Unlike
optogenetic approaches that rely on rigid fiber optics tethered to external light sources, these
novel devices utilize flexible substrates to carry wirelessly powered microscale, inorganic lightemitting diodes (µ-ILEDs) and multimodal sensors inside the brain. We describe the technical
procedures for construction of these devices, their corresponding radiofrequency power
scavengers, and their implementation in vivo for experimental application. In total, the timeline
of the procedure, including device fabrication, implantation, and preparation to begin in vivo
experimentation, can be completed in approximately 3–8 weeks. Implementation of these
devices allows for chronic (tested up to six months), wireless optogenetic manipulation of neural
circuitry in animals navigating complex natural or homecage environments, interacting socially,
and experiencing other freely-moving behaviors.
INTRODUCTION
Optogenetics is a relatively new field of neuroscience that gives researchers the ability to
control cellular signaling and neural activity in a cell-type selective manner. In vivo applications
of optogenetics have rapidly aided in the understanding of neural circuit function in behavioral
models (Adamantidis et al., 2007; Carter et al., 2010; Fenno et al., 2011; Jennings et al., 2013;
Kim et al., 2013a; Lammel et al., 2012; Stuber et al., 2011; Tye et al., 2011; Yizhar et al., 2011;
Zhang et al., 2010). Despite the success of these studies, tethered fiber optic approaches have
restricted opportunities for the study of more complex, ethologically relevant behavioral
paradigms such as enclosed homecage behavior, spontaneous pain, wheel-running, and freely91

moving social interactions. Here we present a protocol for the fabrication of flexible devices that
carry wirelessly powered microscale, inorganic light-emitting diodes (µ-ILEDs) and multimodal
sensors to study neural circuitry in awake, freely moving animals. The devices described in this
protocol are robust, self-contained, multifunctional, and capable of wireless operation with
conventional electronics and power supplies. These fully electronic systems eliminate the need
for high-powered light sources, fiber coupling fixtures and optomechanical hardware for in vivo
optogenetic experiments. The following protocol is based on technology and approaches
developed jointly in our two laboratories (See Chapter 2) (Al-Hasani et al., 2013; Kim et al.,
2010a, 2012a, 2012b, 2013b; Li et al., 2013).

Development of the protocol and comparison with traditional light sources
This protocol is the result of advances in material science that have led to the
development of flexible electronics, biodissolvable adhesives, microscale sensors, and high
efficiency µ-ILEDs (See Chapter 2) (Hwang et al., 2012; Kim et al., 2010a, 2012a, 2012b; Tao et
al., 2012). While other groups have successfully implemented wireless schemes and LEDs for
optogenetics (Cao et al., 2013; Iwai et al., 2011; Wentz et al., 2011; Zhao et al., 2009), the
protocol described here provides a completely customizable approach for combining various
materials engineering approaches to design and implement devices that can be optimized for an
individual laboratory’s experimental needs.
The current standard in neuroscience for light delivery into the depth of the brain is to use
chronically implanted fiber optics (Sparta et al., 2011), which offer substantial advantages over
acute delivery of fibers via metal cannulae (See Chapter 2) (Kim et al., 2013b; Zhang et al.,
2010). These chronic implants, however, have their own limitations. Principally, light from fiber
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optic implants can only escape from the tip of the implant to illuminate ventral brain structures.
While adaptations to this ventral light delivery are possible (Tye et al., 2011; Zorzos et al., 2010,
2012) (available commercially at www.doriclenses.com), the range of customizability can be
limited and often restricts the user to only delivering light without the capability of observing
physiology. Furthermore, µ-ILEDs create opportunities to restrict or expand spatial targeting by
selecting from a range of sizes (625-10,000 µm2), altering the number and arrangement of µILEDs, and using reflective materials to direct light. This protocol provides a basis from which
any combination of µ-ILEDs and sensors can direct light within the brain and measure
physiological function without the restriction of enforced light trajectory.
Various strategies have been employed for delivering multiple wavelengths of light into
the same animal (Stark et al., 2012; Zorzos et al., 2010, 2012). These approaches require
establishing an extensive network of optics and tethered optical equipment external to the
behaving animal. Depending on the laboratory behavioral space, such setups can restrict
experimental possibilities and requires advanced experience with optics to maintain optimal
conditions. This protocol may require access to external facilities for some labs, but the end
result is a device that can be operated with basic laboratory equipment already likely to be
present in most neuroscience laboratories. Furthermore, the rescue and recycling of these devices
for re-use is relatively easy, meaning that these devices can be used for several rounds of
behavioral experimentation with different sets of animals. For light-evoked activation of
channelrhodopsin-2 [ChR2 (H134)], optically sensitive seven-transmembrane domain receptors
(i.e. OPTO-"1, OPTO-!2,), and other blue light-sensitive optogenetic constructs, GaN µ-ILEDs
are appropriate (See Chapter 2) (Airan et al., 2009; Kim et al., 2013b; Yizhar et al., 2011). A
device utilizing these 450 nm-emitting µ-ILEDs will be the focus of this protocol. However, it is
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important to note that µ-ILEDs emitting at other relevant wavelengths are also possible to
fabricate for use in other contexts (See Chapter 2) (Kim et al., 2013b; Park et al., 2009) . The
combination of µ-ILEDs of different wavelengths provides the user with access to activation
spectra of multiple optogenetic constructs with a single implanted, electronic device.
Furthermore, the electronic nature of these devices ensures that they can be operated wirelessly.
Wireless optogenetic manipulation of neural circuitry has been achieved by other means (Iwai et
al., 2011; Wentz et al., 2011), but these approaches can restrict behaviors accessible to study
because the animal is required to remain in a fixed environment. By utilizing radiofrequency
(RF) power scavenging, the devices and approaches contained in this protocol free the user of
constraints on behavioral assays, thereby allowing for experimental testing in any space.

Applications of the protocol
While the focus of this protocol is on the creation of devices engineered to deliver µILEDs into the brain for optogenetic applications, this same protocol can be used to fabricate
devices to measure electrophysiological, thermal, and other properties of intact brain tissue (See
Optional Section 3.1 for details). The flexible nature of these devices provides the potential to
extend their application into other intact tissues such as the peripheral nervous system and the
circulatory system/cardiac tissue of larger organisms.

Experimental design
Subjects. This protocol and these devices have been optimized for use in adult (25–35 g) male
C57BL/6J mice and mutant mice backcrossed to the C57BL/6J mouse strain. However, as the
optogenetic toolbox expands to other mammals (Cavanaugh et al., 2012; Diester et al., 2011;
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Gerits and Vanduffel, 2013; Han et al., 2009; Ruiz et al., 2013; Witten et al., 2011) these devices
will likely have broader utility in other animal models. Specifically, larger organisms such as rats
and non-human primates will tolerate the ~700 mg wireless antenna with greater ease than mice.
Unlike animals with polished fiber optic implants, animals with chronically implanted µ-ILEDs
can be housed with other animals, as the metal pin connectors cannot be damaged by cage mates.
Prior to beginning this protocol, all the procedures described herein should be approved by the
Animal Care and Use Committee of the investigating institution and conform to US National
Institutes of Health guidelines regarding animal research. For this protocol, all procedures were
approved by the Animal Care and Use Committee of Washington University and conformed to
US National Institutes of Health guidelines.

Controls As noted elsewhere (See Chapter 2) (Kim et al., 2013b; Sparta et al., 2011; Yizhar et
al., 2011), the proper controls for in vivo optogenetics are mice that express genetically-encoded
fluorescent reporters in the absence of an opsin. These control mice will account for any
disturbance from viral injection, device implantation, heating confounds from light delivery, and
fluorophore fluorescence within the brain. Another important confound to consider when
conducting light-evoked single-unit electrophysiological experiments is the potential for
generating neural activity downstream of retinal stimulation. These devices prevent the external
light escape that is common with fiber optic implants, but activity from the visual system has the
potential to activate the retina and retinal ganglion cells from within the brain, depending on the
brain region (Kravitz et al., 2013). Recordings performed with an external light stimuli can
control for these effects. Additionally, properly counter-balanced within-subject experimental
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designs are possible with these devices by withholding power to the devices during the
behavioral testing period.
Limitations While these devices offer numerous advantages over traditional fiber optic
implants; the technology is not intended to replace protocols that work well to manipulate neural
circuitry in vivo (Sparta et al., 2011; Zhang et al., 2010). The greatest limitation associated with
this procedure is the accessibility to the facilities and the technical skill required to fabricate
these devices and their scavenging antennas. That being said, subsequent recovery and refabrication of the devices is straightforward and accessible to any laboratory. Once the protocol
is followed there are few considerations when designing behavioral experiments. First,
depending on the panel antenna employed, the signal can be polarized. In current designs, both
the panel antenna and the antenna on the scavenger are directional with linear polarization. A
maximum efficiency of power transmission and reception is achieved when the polarizations of
both antennas are aligned. The power transmitted by the panel antenna can typically be adjusted
to accommodate mismatches that can occur in most practical situations. Such issues can be
avoided entirely by use of a transmission antenna with circular polarization or multiple panel
antennas. Care should also be taken to ensure that the animal’s surroundings do not interfere with
the RF signal by powering a free-standing device in the behavioral context (See Chapter 2) (Kim
et al., 2013b). Wireless control of these devices is compatible with a wide-range of behavioral
assays. In our hands, the devices have performed well in tests of anxiety-like behavior (open
field test, elevated zero maze), reward-related behavior (conditioned place preference, operant
behaviors, and self-stimulation), social behaviors (social defeat stress and social aversion), pain
behaviors (Hargreaves test), and homecage behaviors11. In our experience, commonly used
materials for behavioral apparatus (wood, polyvinyl chloride (PVC), Poly(methyl methacrylate)
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(PMMA; Plexiglass/Perspex) and the metal from cage lids) do not interfere with the RF signal,
but can reduce the overall power if they are positioned between the panel antenna and the
headstage scavenger (see Table 3.1).
Second, the current protocol only provides wireless access to power the µ-ILEDs and not
to receive information from the sensors. This backwards data stream restriction is largely one
based on the weight that an animal can endure on the headstage. For a mouse,
electrophysiological, temperature, and photo sensors currently require a wired connection. For
larger mammals, the devices can be integrated with existing telemetry setups, provided they do
not interfere with the RF signal (Harrison et al., 2010; Szuts et al., 2011) (commercially available
at www.plexon.com). Finally, independent control of individual µ-ILEDs is also possible with
these devices, but the described protocol has not been optimized for these conditions in a
wireless control mode. If independent control is a desired feature, it is recommended that smaller
connections featuring a number of channels are employed over the pin connectors that we
present here (many options commercially available at www.omnetics.com).
Upon completion of the protocol presented here, users can expect to have devices with 4
μ-ILEDs that can be wirelessly powered with suitable light output from two meters away. In our
experience, more μ-ILEDs can be added to a single device with relative ease (the maximum we
have tested is 25 (5 x 5) μ-ILEDs from a single power scavenger). Furthermore, the
radiofrequency power scavenging approach is appropriately suited for powering multiple μILED devices (presumably in multiple animals) using a different power scavenging headstage
antenna for each device. The upper limit on the number of simultaneously powered devices is
primarily dependent on the spatial constraints of the experimental space and apparatus to achieve
equal powering to all devices.
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Notes on the materials and equipment used in this protocol: Accurate injection of these
devices into brain tissue requires an stereotaxic adapter for standard cannula holders. The basic
principle of this adapter is that the µ-needle can mounted in-line with the existing stereotaxic
system. The dimensions of such an adapter will vary by stereotaxic alignment system make and
model, but most university machine shops should be able to fashion such an adapter. The adapter
presented in this protocol was specifically designed for use with the KOPF Single Cannula
Holder (Model 1966). It is also possible that other commercially available electrode holders may
be capable of accurately targeting the devices (e.g. KOPF Model 1768). More detailed
information on the machining and dimensions of the adapter for the KOPF Model 1966 can be
found in (Figure 3.6).
In order to deliver pulse trains of light, the devices can be controlled using a traditional
function generator to drive amplitude modulation of the wireless powering equipment.
Amplitude modulation is an internal function available on most RF generators. This function
allows an internally or externally supplied modulating signal to control the amplitude of the
output RF signal. The internal modulating signal is usually a sinusoidal waveform with a much
lower frequency compared to that of the RF output. For the positive region of the sinusoidal
signal, the RF generator can output an RF signal whose amplitude is modulated by the low
frequency sinusoidal signal, and change from 0 to the maximum set power and then back to 0.
For the negative region of the modulating signal, the output RF signal maintains at 0. An external
TTL modulating signal is preferable in terms of modulating the amplitude of the output RF
signal. Here, the high state of the TTL causes the RF generator to output a constant set power,
while in the low state of the TTL, the RF generator outputs 0 power. Thus, the TTL modulating

98

method is more suitable for generating constant light intensity during the high state of the TTL.
The pulse width and frequency of photostimulation should be determined and based on
physiologically relevant conditions (Adamantidis et al., 2011; Jennings et al., 2013; Sparta et al.;
Tye and Deisseroth, 2012; Tye et al., 2011)
Post-mortem rescue of the devices for reuse is a delicate, but straightforward process.
The dental cement presented here (Lang Dental) allows for such rescue. Other cements and
bonding agents can inhibit the process and destroy internal components. It may be necessary to
use a stronger bonding agent in some scenarios (see Table 3.1). In such cases, the re-usability
might be compromised.
MATERIALS
Reagents
Preparation of releasable polymer template
•

UV curable epoxy (SU-8 2 & 100 photoresist, Microchem) ! CAUTION Partially cured
or uncured epoxy needle can induce excess chemical contamination in the brain.

•

SU-8 developer (Microchem)

•

Isopropyl alcohol (IPA) !CAUTION Isopropyl alcohol is flammable.

•

Acetone !CAUTION Acetone is flammable.

•

Silk adhesive (Details are shown in other papers (Hwang et al., 2012; Kim et al., 2010a;
Tao et al., 2012), see REAGENT SETUP).

•

BCB (Benzocyclobutene, DS-4022 35, Dow corning)

•

BCB developer (Advanced Developer, DS2100, Dow corning)

•

Water soluble tape (3M)

•

Photoresists (AZ 1518, AZ 2070, Capital Scientific)
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•

AZ 300 MIF developer (Capital Scientific)

•

Hydrofluoric acid (HF) !CAUTION HF is extremely corrosive. Wear gloves and use eye
protectionwhen using HF.

•

Chrome (Cr) etchant, gold (Au) etchant, palladium (Pd) etchant (Transene Inc.)

•

Polydimethylsiloxane (PDMS, Sylgard184, Dow corning)

•

Polyethylene terephthalate (PET, polyester film, 2.5 and 6 µm thick, Mylar® film,
Chemplex® Inc.)

Preparation of µ-ILEDs
•

Gallium nitride (GaN) LED epitaxial materials grown on sapphire substrates (Cermet
Cop.)

Injection of virus and µ-ILEDs into targeted brain structure
•

Isoflurane, USP (Isothesia, Butler Schein, cat. no. 029405)! CAUTION Prior to
beginning this protocol, the Animal Care and Use Committee of the investigating
institution should approve all procedures and conform to US National Institutes of Health
guidelines regarding animal research. ! CAUTION Ensure proper ventilation and gas
scavenging methods are in place to prevent potential inhalation of excess isolflurane.

•

Betadine solution (Purdue Products, cat. no. 67618015017)

•

Ethanol (Sigma-Aldrich, cat. no. 362808) ! CAUTION Ethanol is flammable.

•

Hydrogen peroxide, 3% USP (Select Medical Products, cat. no. 117)

•

Lidocaine ointment USP, 5% (Fougera)

•

Ophthalmic ointment (Altalube Ophthalmic Product)

•

Adhesive Luting Cement (C&B-Metabond, Parkell Inc., cat. no. S380) ! CAUTION

•

Light cured bonding adhesive (VLC One Step Prime & Bond Adhesive, cat. no. 305-006100

030) ! CAUTION
•

Dental cement (Jet Denture Repair, Lang Dental, cat. no.1223, see REAGENT SETUP) !
CAUTION Methyl Methacrylate Monomer, Stabilized is a flammable liquid. It may also
cause skin irritation; avoid contact with skin, eyes, and clothing. Use with adequate
ventilation.

•

0.9% Sodium Chloride Inj., USP ((9 mg/ml NaCl), Hospira, cat. no. RL-0497(9/04))

•

Enroflaxin (Baytril, Bayer, cat. no. R30901)

•

Antibiotic ointment (Neosporin, Johnson & Johnson, cat. no. 174-73087Q)

•

Viruses of interest (Adeno-associated virus and lentiviruses are available from the
WUSTL Hope Center Viral Core , https://hopecenter.wustl.edu/?page_id=99 and/or the
University

of

North

Carolina

Viral

Vector

Core,

http://genetherapy.unc.edu/services.htm), Herpes Simplex Viruses are available from the
MIT Viral Core, http://mcgovern.mit.edu/technology/viral-vector) ! CAUTION Follow
the appropriate safety precautions pertaining to the particular virus in use. It may be
necessary to obtain a higher Biosafety Level certification prior to use.
•

Artificial cerebral spinal fluid (ACSF; Tocris, cat. no. 3525 or custom, see REAGENT S
ETUP (2011; Zhang et al., 2010)

•

Animal(s) to be injected with µ-ILED device. The procedure describes how to use a µ-IL
ED device with a mouse, as previously described (See Chapter 2) (Kim et al., 2013b). ! C
AUTION Prior to beginning this protocol, the Animal Care and Use Committee of the in
vestigating institution should approve all procedures and conform to US National Institut
es of Health guidelines regarding animal research.

Behavioral procedures using RF power scavenging
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•

Thermal grease (Wakefield Solutions, cat. no. 120-2)

EQUIPMENT
Preparation for µ-ILEDs and Multifunctional Sensors
•

Sputter ((AJA international, ATC 200) metal deposition for Au (gold), Ni (nickel), Pt
(platinum), etc.)

•

Rapid thermal annealing (RTA) !CAUTION High temperature, semi-transparent Lshaped current spreading layer on p-side on GaN LED should be used in thin metal layers
(15/15 nm Ni/Au) followed by 500oC annealing.

•

Mask aligner (Karl Suss, MJB)

•

Inductively coupled plasma (ICP) etcher (PlasmaTherm SLR-700, etching for GaN)

•

Reactive ion etcher (RIE, PlasmaTherm 790, etching for SiNx)

•

Plasma enhancement-chemical vapor deposition (PE-CVD, STS mixed frequency nitride
deposition system)

•

Wafer bonder (Electronic Visions, EV501)

•

Laser lift off (LLO, Krypton Fluoride (KrF)(0.9 J/cm2, 248 nm wavelength, IPG
Photonics (http://www.ipgphotonics.com/microprocessing.htm)) or Yttrium aluminum
garnet (YAG):Nd laser (0.3 J/cm2, 266 nm Single pulse with 5 ns exposure, Sandia
National Lab) ! CAUTION Avoid eye contact with the laser. Always wear eye
protection.

•

Digital multimeter (Fluke 115 or other commercially available multimeter)

•

Printed circuit board (PCB) for headstage connection (General Circuits Co.)

•

Male pins for headstage PCB (2.54 mm spacing male pins (Sunlight Inc, P2540-H254S180).
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Measurement of µ-ILED
•

Ocean Optics (Ocean Optics HR4000) (for measuring wavelength spectrum, light output
power)

•

Probe station (Agilent 4155) (current-voltage (I-V) characteristics).

•

Pulse generator (Global specialties, 4001)

•

Oscilloscope (Agilent , DSOX2004A, 70 MHz)

•

IR camera (QFI InfraScope II)

Injection of virus and µ-ILEDs into targeted brain structure
•

Stereotaxic alignment system (KOPF Model1900) ! CAUTION Prior to beginning this
protocol, the Animal Care and Use Committee of the investigating institution should
approve all procedures and conform to US National Institutes of Health guidelines
regarding animal research.

•

Stereotaxic alignment indicator (KOPF Model 1905)

•

40X Centering Microscope (KOPF 1915)

•

Stereotaxic drill (KOPF Model 1911) and #66 drill bit (KOPF cat. no. 8669)

•

Stereotaxic single cannula holder (KOPF Model 1966)

•

Stereotaxic adapter for cannula holder (See Figure 3.6), WUSTL Machine Shop or other)

•

Anchoring screws (CMA Microdialysis, cat. no. 7431021)

•

Needles (Becton-Dickinson, cat. no. 305111)

•

Micro-injection syringes (Hamilton, cat. no. 88011)

•

Infusion pump and controller (UltraMicroPump III, World Precision Intstruments, cat.
nos. UMP3 and UNC4)
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•

Forceps (Miltex, cat. no. 6-100)

•

Surgical scissors (Miltex, cat. no. 18-1430)

•

Hemostats (Miltex, cat. no. MH7-26)

•

Microspatula (Chemglass, cat. no. CG-1982-12)

•

Electric clippers (Wahl, cat. no. 8064-900)

Behavioral procedures using RF power scavenging
•

RF generator (Agilent, N5181 MXF)

•

Function generator with standard transistor-transistor logic (TTL) (AMPI Master-9 or
other)

•

RF amplifier (Empower RF systems Inc. 1100/BBM2E4AJP)

•

RF antenna (ARC wireless solutions, ARC-PA0913B01, ARC 902-928 MHz 12.5dBi,
Flat Panel)

•

DC power supply (Mastech, cat. no. HY5005E-2)

•

Relevant behavioral assay apparatus (university machine shops, MED Associates,
Harvard Apparatus or other)

•

Wireless headstage antenna (see PROCEDURE)

•

Printed circuit board (PCB) for wireless headstage antenna (General Circuits Co.)

•

Ceramic antenna (W3012, Pulse Electronics)

•

Schottky diode (Digi-Key, cat. no. MMDL301T1G)

•

Power meter (Bird Electronic Corp.,Thruline 43)

•

Two SMA Male to N Male Precision cables (Pasternack, cat. no. PE304-120)

•

Fan-cooled heat sink (Fischer Elektronik, cat. no. LA 17/200 24V)
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Behavioral procedures using a wired connection
•

Animal(s) with injected µ-ILED device ! CAUTION Prior to beginning this protocol, the
Animal Care and Use Committee of the investigating institution should approve all
procedures and conform to US National Institutes of Health guidelines regarding animal
research.

•

Relevant behavioral assay apparatus (university machine shops, MED Associates,
Harvard Apparatus or other)

•

Function generator for standard transistor-transistor logic (TTL) (AMPI Master-9 or
other)

•

BNC cables (Cables to Go, various lengths and catalog numbers)

•

Electrical rotary joint (Moog, cat. no. SRA-73683 (du Hoffmann et al., 2011))

•

BNC-to-banana plug adapter (Fluke BP881 or other)

•

Wire (30 gauge wire, Artistic Wire) and female connector (Single modality devices: TE
Connectivity, cat. no. AMP 3-640441-2; Multimodal devices or independent µ-ILED
control: TE Connectivity, cat. no. AMP 87631-4)

REAGENT SETUP
Silk adhesive Boil cocoons of the Bombyx mori silkworm for 30 minutes in a solution of 0.02M
Na2CO3 to remove the sericin protein. Rinse the extracted fibroin with distilled water and dry in
ambient air for 12 hours. After drying, dissolve the fibroin in a 9.3M LiBr solution at 60

C for

4 hours, yielding a 20 wt.% aqueous solution, and subsequently dialyze the solution against
distilled water using a dialysis cassette at room temperature for 48 hours until the solution
reaches a concentration of 8 wt.%.
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Dental cement The dental cement can be prepared as described elsewhere (Sparta et al., 2011)
by combining the Jet Denture Repair Powder with the Jet Liquid (methyl methacrylate). A
starting point is 350 µl of methyl methacrylate monomer added to 225 mg of powder. In some
cases, the viscosity must be adjusted (by increasing or decreasing the amount of methyl
methacrylate in the mixture) to properly secure the flexible device in place and/or mount the
PCB in the headcap. ▲CRITICAL STEP Adjusting the viscosity alters the working time of the
cement.
Virus Each type of virus has different handling instructions, but all must be stored on ice until
immediately prior to the injection. In some cases, dilution of stock titers requires obtaining more
of the reagent in which the viral prep was initially concentrated.
ACSF If not purchased, the solution can be prepared following the recipes described elsewhere
(2011; Zhang et al., 2010).

EQUIPMENT SETUP
Preparation of amplifier with proper heat sink The RF amplifier (1100/BBM2E4AJP,
Empower RF Systems Inc.) requires an additional cooling system during operation. Thermal
grease applied on top of the heat sink (LA 17/200 24V, Fischer Elektronik Inc.) facilities thermal
contact with the amplifier, which is affixed to the sink using screws. The DC power supply
operates both the amplifier and the fan attached to the heat sink, by supplying power with
voltages of 24 V and 10 V, respectively.
PROCEDURE
Preparation of µ-ILEDs ) TIMING 7 d
1 | Clean the wafer surface of GaN LED stacks (450 nm emission wavelength; p-type
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GaN/multi-quantum well (MQW)/spacer/n-type GaN/undoped GaN) grown on sapphire
substrate with 5 wt % diluted HCl for 5 min. ▲CRITICAL STEP Proper cleaning enables
reduced turn-on voltages and improved efficiencies, both of which minimize production of
heat by the operating µ-ILEDs.
2 | Deposit metals (Ni/Au, 15/15 nm) immediately after cleaning ▲CRITICAL STEP The
deposition should be carried out degree vacuum levels of ~10-6 torr or less.
3 | Form L-shape patterned metals (Ni/Au) onto the p-type GaN semiconductor layer by
photolithography and wet etching with Cr and Ni etchants followed by removal of the
photoresist (PR) with acetone (Figure 3.1A).
4 | Anneal the wafer for 10 min at 500 oC in 20% oxygen and 80% Argon atmosphere to
generate p-ohmic contact. ▲CRITICAL STEP The annealed metal layers should be semitransparent after this step.
5 | Generate 40 x40 µm2 square hole patterns in a negative tone PR (AZ 2070 PR) and etch
(chlorine gas based RIE etching) the p-GaN layer, MQW, spacer to open n-side GaN (Figure
3.1B).
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Figure 3.1 Fabrication procedure for injectable !-ILEDs. (A) L-shape current spreading layer
(patterning of Ni/Au (15/15 nm) layers followed by 500 ºC annealing) is formed on GaN blue
lighting LED stacks grown on sapphire. (B) In order to expose n-type GaN semiconductors, etch
rectangular shape of p-type one, multi quantum well (MQW), and spacer layers by reactive ion
etching. (C) Generation of n- and p-contact pads (Cr/Au (15/300 nm) 25 x25 µm2 squares) on nand p-type GaN sides. (D) Etch 20 µm width trench to define 100 x 100 µm2 or smaller than 100
x 100 µm2 lateral dimensions. (E) Bonding !-ILEDs on sapphire with silicon wafer using In-Pd
metallic alloy bond. (F) Expose laser on sapphire and mechanically remove sapphire from !ILEDs. (G) Wet etch the bonded metallic layer located on wafer. (H) Transfer of all !-ILEDs
onto structured PDMS slabs and selectively pick up single !-ILEDs using a polydimethyl
siloxane (PDMS) stamp. [Part d, f, g and h reproduced with permission from (Kim et al., 2012a)
© 2012 Wiley]
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6 | Generate 25 x25 µm2 square hole patterns in PR for n- and p-type metal contact pads and
deposit Cr/Au (10/300 nm) using an electron beam evaporator. Then, remove PR (Figure
3.1C).
7 | Deposit a low stress layer (200 nm) of SiNx on the substrate, using plasma enhancedchemical vapor deposition (PE-CVD). Next, pattern a negative tone PR (AZ 2070) to serve
as a mask for etching the SiNx and the GaN to define the lateral dimensions of array of µILEDs. Devices with dimensions of 100 x 100 µm2 or less are formed with 20 µm spacings
(Figure 3.1D).
8 | Deposit a layer of SiNx onto the µ-ILEDs to protect the devices and metal pads from further
processes. Bond the LED wafer to a silicon substrate using indium (In)-palladium (Pd)
metallic alloy. This bonding uses Cr/Pd (15 /150 nm) on the LED substrate and Cr/Pd/In
(15/150/900 nm) on the silicon. The bonding occurs on contact with a pressure of 400 bar
and temperature of 220 oC for 2 hr (Figure 3.6E).
9 | Use laser illumination through the sapphire to release the µ-ILEDs (Figure 3.1F). Details of
this laser lift-off (LLO) technique appear elsewhere(Kim et al., 2012a; Wong et al., 2000).
10 |Etch unalloyed metal by immersion in 5 wt% HCl for 30 min (Figure 3.1G).
11 |Retrieve all µ-ILEDs onto substrate of PDMS with patterns of surface relief, in the geometry
of cylindrical pillars with 3 µm diameter and 1.4 µm height and 5 µm spacing. Remove
residual metals, including In-Pd alloy and Crare by Pd and Cr etchants (Figure 3.1H).
12 |Prepare a PDMS stamp with a single relief feature consisting of a post with 100 x 100 µm2
lateral dimensions and 100 µm height. Using a mask aligner for photolithography, retrieve a
single µ-ILED with the stamp and transfer it to a needle shaped structure of PET adhered to a
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thin layer of PDMS on a transparent temporary substrate (Figure 3.2A and B).
13 |Remove passivation layer, SiNx (deposited in procedure 8) with RIE and spin coat a
photosensitive benzocyclobutene (6 µm thick, BCB) onto the µ-ILED.
14 |Pass ultraviolet (UV) light through the backside of the substrate and develop the BCB with
BCB developer (Figure 3.2C) to obtain holes for n- and p-side contacts (Figure 3.2C, lower
inset) !CAUTION Make sure that BCB covers the µ-ILED surface. Non-uniform coatings of
BCB generate interference fringes that are readily visible. (Figure 3.2C, upper inset) After
further curing BCB, anneal the samples at 250 oC on a hot plate for 3 hr. ▲CRITICAL STEP
The annealing should be carried out in Ar atmosphere to avoid high temperature damage to
the BCB and polymeric layers. ?TROUBLESHOOTING
15 |Deposit Cr/Au (15/300 nm) by sputtering, and form metal interconnects using positive tone
PR (AZ 15198) followed by metal etching (Figure 3.2D).
Deterministic device assembly by transfer printing and formation of electrical
interconnects ) TIMING 1 d
16 |Remove µ-ILEDs fabricated on each temporary substrate as shown in Figure 3.2A with
water-soluble tape (Figure 3.2E). Remove water-soluble tapes in DI water (Fig. 2f) and
place the devices on slabs of PDMS (Figure 3.2G). ▲CRITICAL STEP Steps 16-20 describe
device assembly for µ-ILEDs alone. If you are assembling a multifunctional device, follow
the instructions in Optional Section 3.1 before proceeding.
17 |Connect each of the devices with anisotropic conductive film (ACF) cable to a PCB board
(Figure 3.2H). * CRITICAL STEP Apply pressure and high temperature (~150 oC) during
ACF cable bonding. ?TROUBLESHOOTING
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Figure 3.2 Procedure for fabrication of injectable, multifunctional electronics. (A) Thin
(~2.5 µm thick) needle-shaped polyethylene terephthalate (PET) is attached on temporary
Polydimethylsiloxane (PDMS) coated glass substrate. (B) Schematic and photograph
demonstrating the transfer printing of four µ-ILEDs onto the tip of the PET using a PDMS
stamp. (C) Passivation approach with photocurable benzocyclobutene (BCB) polymer. The
backside of BCB coated substrate is exposed to ultraviolet light. The wave pattern in the upper
inset shows ununiformed coating of BCB. The lower inset shows successful uniformed coating.
(D) The metal interconnection (Cr/Au) is generated by sputtering, photolithography and metal
etching to electrically connect the four µ-ILEDs. (E) The connected device is picked up with
water soluble tape. (F) The substrate is separated from the tape after the adhesive is dissolved in
the water. The inset shows the µ-ILEDs on freestanding thin, flexible, needle-shaped PET. (G)
The device is electrically connected to the ACF cable. The PDMS slabs on top and bottom are
compressed using high temperature (~150ºC) to bond the ACF cable. (H) The other side of the
ACF cable is connected to the PCB with pin connector for wireless or wired powering schemes.
(I) The ACF cable and PCB is coated with PDMS for waterproofing. (J) Blue (450 nm) µ-ILEDs
are powered. The µ-ILEDs and electrical connection should be checked prior to injection (K)
The device is assembled with injection µ-needle using biodissolvable silk adhesive. (I) Image of
a completed device ready for injection into brain tissue.
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Injection µ-needle

4th µ-Temp. sensor

3rd µ-ILEDs

2nd µ-IPD

1st µ-electrode

A

B Active devices
Injection µ-needle

Figure 3.3 Multifunctional sensors and optoelectronics. (A) Representative scheme for
multifunctional, injectable electronics formed on injectable needle. The devices include
electrophysiological sensor (m-electrode); 1st layer), silicon photodiode (m -IPD; 2nd layer), four
microscale inorganic light-emitting diodes (m-ILEDs; 3rd layer), and temperature sensor (mtemp. sensor; 4th layer) based on platinum resistor are formed on injectable m-needle fabricated
from epoxy polymer. (B) Side view of such a device reveals the ultrathin nature of the active
components of the device. Scale bar applies to both panels and = 200 mm.
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18 |Assemble all devices onto injection µ-needle formed in SU-8 epoxy. The entire region of
injection device should be electrical insulated for in vivo use. Cover the flexible device with
SU-8 polymer and the other parts with PDMS for waterproofing (Figure 3.2I). Temporarily
fix the device to the PDMS slab. Drop PDMS solution (Sylgard 180, Dow corning, weight
ratio=10:1

(silicone

elastomer

precursor:

curing

agent),

see

details

at

http://www.dowcorning.com/applications/search/default.aspx?r=131en) onto the ACF cable
and PCB except for the pin connection area. After baking the PDMS in the oven at 70℃ for
2 hrs, the entire area except pin adapter is electrically passivated by PDMS.
19 |To check functionality, power the device by connecting to a power supply capable of
delivering more than 1 mW (Figure 3.2J). Use silk adhesive to bond the devices to the
injection µ-needle (Figure 3.2K and l).

Fabrication of wireless power harvester and preparation of wireless operation● TIMING
1d
20 |Build either the robust, PCB-based (option A) or thin, flexible (option B) wireless power
harvester. * CRITICAL STEP Both options perform equally, but each have advantages. The
PCB-based option is more easily contrasted and more durable, but weighs more than the
flexible version. We recommend using the PCB-based harvester for experiments that involve
social interaction, while the flexible version is more ideal for experiments involving only a
single animal.
A)
i.

Construction of the PCB-based wireless power harvester.
Build the wireless power harvester from two stacked PCB circuits (Figure 3.4B);
General Circuits Co., Ltd.). Each PCB includes top and bottom layers that are mostly
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covered by solid copper ground planes.
ii.

Mount the electrical components on the PCB boards through soldering. The first PCB
circuit (labeled as 5 in Figure 3.4B) contains a ceramic antenna (W3012, Pulse
Electronics) operated at 915 MHz with a clearance space of 10.8&8.25 mm to the
surrounding ground plane.

iii.

Connect a capacitor (8.2 pF in capacitance) between the feed line of the antenna and the
ground plane to match the impedance of the antenna with the following circuit. A
secondary PCB circuit (labeled as 6 in Figure 3.4B) contains a voltage multiplier circuit
constructed with 6 pairs of capacitors (47 nF in capacitance) and Schottky diodes
(MMDL301T1G) in cascaded connection (See Chapter 2) (Kim et al., 2013b).

iv.

Mount the connector that is used for the μ-LEDs to the secondary PCB circuit. Join the
PCB circuits and the connector with flexible copper wires (Figure 3.4C), and bond
together with resin epoxy (Figure 3.4D). Figure 3.3I shows a schematic illustration of
the power harvester. The circuit parts, which are labeled with number 5 to 7, correspond
to the same number shown in Figure 3.3B and 3.3E.
B) Construction of the thin, flexible wireless power harvester.

i.

Fabricate the flexible PCB circuit on 75 µm thick Kapton film (Figure 3.4F). Coat the
film with a 6 µm thick layer of copper using electron beam evaporation.

ii.

Pattern the copper to form pads for the electrical components and interconnection. Spin
cast and pattern 1 µm thick polyimide film to expose the electrical contact pads, while
passivating the interconnection (Figure 3.4F).

iii.

Attach a ground plane made of copper tape (Figure 3.4G) to the bottom of the Kapton
film and connect with copper pattern on the top of the Kapton film through channels
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filled with solder. A schematic illustration of the flexible PCB circuit appears in Figure
3.4J
21 |Setup the wireless power transmission system. The system consists of an RF signal generator
(N5181A, Agilent Technologies, Inc.), an RF amplifier (1100/BBM2E4AJP, Empower RF
Systems Inc.), a DC power supply (U8031A, Agilent Technologies, Inc.), an antenna (ARCPA0913B01, ARC Wireless), and a power meter (Thruline 43, bird electronic corp.) (Figure
3.4A). Connect the amplifier to RF signal generator and an antenna using coaxial cables
(SMA Male to N Male Precision Cable Using 160 Series Coax, Pasternack Inc.).The RF
signal generator provides a 915 MHz RF signal with a power of -15 to -20 dBm. The signal
is amplitude-modulated through the internal function of the generator to create a pulsed
signal with frequency of 10 Hz, and a carrier frequency of 915 MHz. Alternatively, an
external TTL function generator can be connected to the RF signal generator to modulate the
pulse width and frequency. This signal is directed to the RF amplifier, which amplifies the
signal to 30 to 33 dBm.
22 |Connect the power supply to the RF amplifier and the exhaust fan of the heat sink of the
amplifier (see EQUIPMENT SETUP) to provide DC voltages of 24 V and 10 V to the RF,
respectively. Measure the intensity of the output power of the amplifier and then connect the
amplifier to the antenna to RF power to power the μ-LEDs at a 1~2 meter distance (Figure
3.4E and H).
Injection of virus and µ-ILEDs into targeted brain structure ) TIMING 1 d
23 |Mount the µ-ILED device in the custom-built cannula holder adapter or other electoral device
holder (see EQUIPMENT SETUP) (Figure 3.5A and 3.6). To do so, grasp the exposed
region of the µ-needle (Figure 3.5B). * CRITICAL STEP The device must be placed along
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Figure 3.4 Wireless operation and equipment. (A) An experimental setup for wireless
power transmission. The setup contains a RF signal generator (1), a RF power amplifier (2), a
DC power supply (3), and a panel antenna (4). Components for the wireless power harvester
for µ-ILED powering with stacked PCB circuits (5: circuit contains a ceramic antenna and a
capacitor is connected between the feed line of the antenna and the ground plane to match the
impedance of the antenna with the next circuit. 6: a second circuit contains a voltage
multiplier constructed with 6 pairs of capacitors and Schottky diodes in a cascaded
connection), before (B) and after (C) connecting with copper wire. A completed wireless
power harvester alone (D) and with (E) connection to µ-ILED device (7) for wireless
operation. Top (F) and side views (G) of a flexible wireless power harvester on Kapton film
with similar components as the wireless harvester on PCB circuits. (H) A completed flexible
wireless power harvester with connection to µ-ILED device for wireless operation. All scale
bars are 5 mm. (I) A schematic of the PCB-based power harvester. The numbered circuit
components correspond to the same number shown in Fig. 3b and 3e. (J) A schematic of the
wireless power harvester.
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the midline of the adapter to achieve proper spatial targeting. ? TROUBLESHOOTING
24 |Anesthetize the mouse in an isoflurane induction chamber using 4% isoflurane and a flow
rate of 1.5 L/min O2. * CRITICAL STEP Prior to beginning this protocol, all procedures
should be approved by the Animal Care and Use Committee of the investigating institution
and conform to US National Institutes of Health guidelines regarding animal research. *
CRITICAL STEP Ensure that the animal is sufficiently anesthetized prior to transferring to
the stereotaxic frame. The animal should have no response to a toe pinch and its breathing
rate should reduce to ~1 Hz.
25 |Transfer the animal to the stereotaxic frame, ensuring proper airflow of isoflurane to the nose
cone (~2.5% isoflurane; 1.5 L/min O2). ▲ CRITICAL STEP Isoflurane levels should be
monitored throughout the surgery to maintain sufficient anesthesia (no toe pinch response)
and breathing (1 Hz). For longer duration surgery, isoflurane levels may be decreased to as
low as 1%. Sterile, aseptic conditions should be used at all times to avoid infection.▲
CRITICAL STEP Proper placement in the stereotaxic frame is required for accurate injection
of virus and devices. ? TROUBLESHOOTING
26 |Apply ophthalmic ointment to protect the eyes during surgery.
27 |Shave a 2 x 1 cm area on the animal’s scalp (Figure 3.5C).
28 |Inject 0.1 mL of Enroflaxin into the hindlimb (i.m.) and 0.3 mL saline solution (0.9% (w/v),
s.c.) to prevent infection and dehydration, respectively.
29 |Using a cotton swab, apply 70% ethanol (vol/vol) and betadine to the shaved area.
30 |Carefully grasp the tissue with the forceps and, using the scissors, make an incision the
length of the shaved area of the animal’s scalp (Figure 3.5D). * CRITICAL STEP Ensure
that all surgical instruments are sterilized prior to each animal surgery.
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31 |After the skin separates, use the forceps and scissors to clean and remove any remaining
periosteum on the skull surface.
32 |Identify the skull sutures, lambda and bregma. Carefully level the skull according to the
manufacturer’s recommend steps for your stereotaxic frame. For the KOPF Model 1900, use
the stereotaxic alignment indicator. It is critical that both lambda and bregma be level, as
well as achieving a level plane laterally across the skull. ? TROUBLESHOOTING
33 |Once the skull is level, move the drill to the coordinates you have selected for anchor screw
placement. Carefully drill a hole with a diameter just wide enough for the screws to catch and
not so deep as to penetrate the skull (Figure 3.5E). * CRITICAL STEP Proper anchoring is
crucial to ensure that the headcap remains affixed to the skull for the duration of the
behavioral experiments. Generally, anchor screws should be placed on either side of the
midline within 2 mm of the site of implantation. ? TROUBLESHOOTING
34 |Use the forceps and microspatula to properly anchor the screws into the skull (Figure 3.5F)
35 |Move the drill above the injection site. Drill a hole that penetrates the skull, but not the dura.
* CRITICAL STEP Drilling through the dura can cause widespread damage, bleeding, and
inflammation under the skull.
36 |Align the infusion pump and lower the injection needle to the dorsal-ventral stereotaxic
coordinates of the targeted structure of interest (Figure 3.5G). * CRITICAL STEP A
beveled needle can penetrate the dura safely. If a blunt needle is used the dura should be
pierced using a sharp, sterile needle.
37 |Using the microcontroller, infuse the virus at a maximum rate of 100 nl/minute. Volume of
virus will vary depending on the brain structure and serotype of virus used (Cardin et al.,
2010; Fenno et al., 2011; Gradinaru et al., 2010; Osakada and Callaway, 2013; Osakada et
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al., 2011; Yizhar et al., 2011; Zhang et al., 2010). * CRITICAL STEP All viruses should be
kept on ice prior, but special care should be taken with lentiviruses and herpes simplex
viruses to prolonged exposure to temperatures above 4ºC. ? TROUBLESHOOTING
38 |Once the infusion is complete, allow the injection needle to remain in place for one minute
for every 100 nl of virus infused. Slowly remove the needle from the injection site.
39 |Position the cannula holder above the drill hole (Figure 3.5H). Take care to orient the µILED/other functionalities in the direction suitable for the experiment in order to properly
illuminate the opsin expressing brain region of interest. * CRITICAL STEP For injection
into rodents, rinse with ethanol to sterilize the device prior to injection. For other mammals
and primates it might be necessary to use room temperature Ethylene Oxide (EtO) gas
sterilization

(http://www.anpro.com/sterilizers/anprolene/indexanprolene.html)

?TROUBLESHOOTING
40 |Slowly lower the device into the brain to the desired dorsal-ventral coordinates.
41 |Using a syringe needle, slowly apply ACSF to the skull to dissolve the silk-based adhesive.
The brain tissue will dissolve the adhesive inside the skull. Wait at least ten minutes to allow
for complete dissolution of the adhesive (Figure 3.5I). * CRITICAL STEP The adhesive
must be completely dissolved prior to µ-needle removal. If not, the final placement of the
flexible substrates will be affected.
42 |Slowly remove the µ-needle. Monitor the position of the flexible substrates to ensure that
zero movement occurs. If the adhesive is completely dissolved, the µ-needle will remove
with ease and without movement (Figure 3.5J).
43 |Prepare the dental cement according the REAGENT SETUP.
44 |Using the microspatula, carefully apply a layer of dental cement directly to point of injection
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to fully secure the placement of the device (Figure 3.4K). * CRITICAL STEP Allow this
layer of cement to completely cure prior to building the structure of remaining headcap.
45 |Once the initial layer of cement is fully cured, position the PCB-based connector in the
desired orientation. Apply a small amount of dental cement to secure it to the base layer
(Figure 3.5l). * CRITICAL STEP The orientation of the connector will determine the
orientation of the RF headstage antenna.
46 |Finish the headstage by completely encapsulating the device-related hardware in dental
cement. Be sure to leave the pins of the connector exposed to allow for connections to RF or
wired functional generator. (Figure 3.5M and N). ? TROUBLESHOOTING
47 |Using a sterile spatula, detach any scalp skin from the cement. If the skin and the cement are
connected, the headstage will be less stable over time.
48 |Liberally apply (~1g) the antibiotic ointment and lidocaine ointment to the entire incision
area.
49 |Remove the animal from the stereotaxic frame and place it in a clean homecage position on
top of a heating pad for recovery. The animal should recover rapidly (<15 minutes) and can
be returned to its homecage once it displays normal, awake locomotor behaviors. Because the
only exposed portion of the devices are the metal connector pins, the animals can be grouphoused for the duration of their experimental lifetime. However, if one chooses, the pins can
be capped using a dummy connector.
50 |The µ-needle should be clear of any components of the device. Remove from the cannula
holder adapter and sterilize for re-use (Figure 3.5O) as described in Optional Section 2 and
Figure 3.8.
Preparation for behavioral testing ) TIMING ~5 days
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51 |House mice until the time at which proteins would be expected to be expressed. The choice
of viral expression system will determine expression time, and hence this wait time prior to
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Figure 3.5 Surgical procedure for injection of virus and µ-ILED devices into mouse brain.
(A) Custom-built adapter for accurate stereotaxic placement of device (see EQUIPMENT
SETUP). (B) Mounted µ-ILED device, ready for injection into the animal. The exposed µ-needle
is grasped with the adapter and a small piece of tape is used to secure the PCB during surgery.
(C) A properly mounted mouse with head shaved and eyes-lubricated is ready for surgery. (D)
Betadine and ethanol is used to prevent infection and the scalp is open to expose the skull. (E)
After leveling the skull, the drill is used to create pilot holes for the bone screws. (F) Forceps and
a spatula or jewelry screwdriver is used to drive the screws into the skull. (G) The syringe needle
is lowered to the desired coordinates to deliver the virus containing the optogenetic construct.
(H) A µ-ILED device prepared to be driven into the brain using the same craniotomy as the viral
injection. Dashed lines outline the shape of the device for clarity. (I) The µ-ILED device is
lowered into the tissue and ACSF is applied to the skull surface to dissolve any external silk
adhesive. (J) After a 15 minute waiting period, the µ-needle is carefully retracted from the skull.
(K) Dental cement is applied directly to the craniotomy site to secure the µ-ILED device in its
targeted position. (L) The PCB connector is secured above the bone screws using a second layer
of dental cement. (M,N) The PCB connector is completely encapsulated in dental cement, taking
care to ensure that no bonds are made directly to the soft tissue. (O) The adapter is shown
following surgery, containing only the µ-needle. All procedures were approved by the Animal
Care and Use Committee of Washington University and conformed to US National Institutes of
Health guidelines.
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Figure 3.6 Machining of the cannula holder adapter. This adapter is specifically designed for
use with the KOPF Model 1966 Cannula Holder. The adapter is fashioned from aluminum with
an 8 mm stalk (3 mm in diameter) that can be held by the Model 1966. The main body of the
adapter is 14 mm in length with a 7 mm diameter. There are two orthogonal bore holes through
the body. The first is a 5 mm hole from which the center slit is created through to the tip of the
adapter. The second is a 2 mm screw-hole so that a screw can be tightened to reduce the size of
the center slit to hold the µ-needle. It is important that the center point of the adapter be in-line
with the center point of the cannula holder itself to ensure accurate device injection. Note that
this adapter is merely a suggestion, but we acknowledge there can be many other solutions to the
problem of accurate injection of the devices. Most stereotaxic instrument manufacturers offer
custom-built holders and it is likely that many standard electrode holders can be modified to suit
the needs of the individual laboratory (e.g. KOPF Model 1768).
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behavioral experimentation. This duration will vary from one to six weeks. For adenoassociated viral expression typical wait times are 2-3 weeks for expression at cell bodies (See
Chapter 2) (Cardin et al., 2010; Kim et al., 2013b; Lammel et al., 2012; Yizhar et al., 2011;
Zhang et al., 2010).
52 |At least five days before experimentation, handle animals to acclimate the animals to
manipulation. In particular, connectors should be fitted to the headstage and any areas of the
body that will be injected should be gently touched in order to habituate the animal to the
manipulations they will experience during behavioral testing (e.g. the nape of the neck for
subcutaneous, the abdomen for intraperitoneal, etc.).
53 |Also habituate animals to the method of powering the devices. If a wired approach is used,
animals should be connected to the wires and allowed to explore a homecage environment
for at least 20 minutes once a day for three days. If a wireless approach is used, the RF
headstage antenna should be connected in the homecage for the same duration. *
CRITICAL STEP To eliminate locomotor confounds, the animals must be habituated to
carrying the added weight of the antennas.
54 |Perform wired (option A) or wireless (option B) behavioral tests. ▲ CRITICAL STEP The t
iming of the photostimulation will depend on the parameters and goals of the study, but the p
ulse generation options are well suited for a wide variety of approaches. Any traditional funct
ion generator can either power the devices or provide TTL input into the RF signal generator
to modulate the pulse width and frequency of the light pulses. If the photostimulation needs t
o be contingent on the animal’s behavior this can be achieved by using live video tracking co
nnected to a TTL output (Noldus Ethovision 9.0 with Trial and Hardware Control and I/O Bo
x or other) or triggering a TTL signal from infrared beam breaks (Med Associates or other).
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A) Wired optogenetic behavioral control ) TIMING variable
i.

Once habituated to the connecting cables, power the devices using a traditional function
generator. The pulse width and frequency of photostimulation should be determined and
based on physiologically relevant conditions (Adamantidis et al., 2011; Jennings et al., 2013;
Sparta et al.; Tye and Deisseroth, 2012; Tye et al., 2011). The timing of the photostimulation
will greatly depend on the parameters and goals of the study.

ii.

Connect the cable to the function generator using the BNC-to-banana plug adapter.

iii.

Route the cabling. For most wired behaviors, the best approach is to route the cabling
through an electrical rotary joint as described previously (du Hoffmann et al., 2011).

iv.

Carefully scruff the animal and connect the free end of the cable to the headstage of the
animal. Place the animal in the behavioral apparatus (Figure 3.7A) and perform desired
behavioral test.

v.

Following the behavioral test, scruff the animal, and remove the cable from the headstage.
B) Wireless optogenetic behavioral control ) TIMING variable

i.

Connect the function generator to the RF Signal generator, the RF signal generator to the RF
power amplifier, and the RF power amplifier to the panel antenna. Be sure that the power
supply is connected to the heat sink (see EQUIPMENT SETUP) to avoid damaging the
amplifier. Connect the power supply to the RF amplifier. It is reasonable to assume that
wireless operation of the devices would be compatible with any behavioral assay in which
the behavioral apparatus itself does not interfere with the RF signal, but care should be taken
to ensure proper powering of the devices in every behavioral apparatus used. CRITICAL
STEP To avoid unnecessary powering of the devices, do not engage the power supply until
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Figure 3.7 Expected results following viral and device injection. Once a device is
injected, the standard connection allows for temporary coupling multiple means of powering
in a variety of behavioral assays: (A) A mouse connected for wired powering in a standard
operant behavioral chamber, (B) the same mouse prepared for wireless powering using the
lightweight, flexible power scavenger in a conditioned place preference environment, (C)
Two mice with implanted devices amongst cage mates. The mouse in the foreground has a
PCB-style RF scavenger for powering in a homecage environment. All procedures were
approved by the Animal Care and Use Committee of Washington University and conformed
to US National Institutes of Health guidelines.
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the beginning of the behavioral session. ? TROUBLESHOOTING.*
ii.

Carefully scruff the animal(s) and attach the RF scavenging antenna(s). Place the animal(s) in
the behavioral apparatus and perform the behavioral test (Figure 3.7B and C).

iii.

Following the behavioral test, carefully scruff the animal and remove the scavenging
antenna.

iv.

After the final behavioral session, if desired kill animals and use tissue for any manner of
post-mortem evaluation (See Chapter 2) (Kim et al., 2013b). ? TROUBLESHOOTING

Optional Section 1| Combining multifunctional sensors and optoelectronics
One hallmark of these devices is their ability to both deliver light into the brain and record
information from the brain. Depending on the experiment, users may wish to outfit the devices
with a variety of multiple and optional modalities. Each different modality can be combined with
any other modality; devices can have between one and four different modalities incorporated.
However, if the electrophysiological sensor is incorporated it should be the outermost layer to
have direct exposure to the tissue. The following steps provide information on adding functional
layers to the devices. If these optional modalities are desired, Optional Section 1 should be
completed prior to Step 16 of the main PROCEDURE.

A) Fabrication of temperature sensors (4th layer shown in Figure 3.3)
i.

Generate PR patterns on a needle-shaped piece of PET (same substrates used in procedure
12) and deposit platinum (Pt, 10 nm) by sputtering. Remove PR by acetone and generate
Cr/Au (15/300 nm) metal lines that connect to the Pt resistor.

ii.

Calibrate the temperature sensor. Dip the temperature sensor into deionized (DI) water and
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measure reference resistance using digital multimeter. With precisely controlled temperature
of the DI water, measure the changes in resistance. Since the resistance change (!R) of the Pt
resistor depends linearly on the temperature change (!T), the formula for estimated
temperature is !!!! ! !! where k is constant.

B) Fabrication of µ-IPDs
CRITICAL (2nd layer shown in Figure 3.3), Additional details of this method are shown in a
previous publication (Kim et al., 2008).
i.

Deposit SiO2 by PECVD on a silicon-on-insulator (SOI) wafer, with a top silicon layer
thickness of approximately 1 µm.

ii.

Generate PR patterns to pattern the SiO2 using hydrofluoric acid (HF).

iii.

Remove PR and clean the wafer surface by RCA cleaning. First perform SC (standard
cleaning)-1

with

1:1:5

solution

of

ammonium

hydroxide

(NH4OH):Hydrogen

peroxide(H2O2):DI water at 80 oC for 15 min. Second remove the SiO2 layer using 1:50
solution of HF:DI water. Finally perform SC-2 with a 1:1:6 solution of hyrdrochloric acid
(HCl):H2O2:DI

water

at

80

o

C

for

15

min

(RCA

Cleaning:

http://inside.mines.edu/fs_home/cwolden/chen435/clean.htm).
iv.

Carry out solid state doping of the silicon to form a p-type region.

v.

Repeat above Steps 4 to 6 from for n-type doping.

vi.

Generate PR hole patterns on the entire wafer surface and etch the silicon layer, to define the
lateral dimensions of the photodetectors.

vii.

Etch the buried oxide (BOx) layer using HF

viii.

Retrieve a ~1 µm thick thin Si membrane photodiode using a PDMS slab and release it onto
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the needle-shaped PET substrate (described in PROCEDURE, Step12)
ix.

Form metal (Cr/Au, 15/300 nm) lines for interconnect.

C) Fabrication of µ-electrode for electrophysiological sensor (1st layer shown in Figure
3.3)
i.

Generate PR (AZ 2030) lift off patterns

ii.

Deposit Pt (30 nm) a needle-shaped piece of PET (described in PROCEDURE Step 12) by
sputtering. Generate a pattern of SU-8 2 (2 µm thick) with 20 x 20 µm2 square opening. ▲
CRITICAL STEP Additional oxygen descum to remove residual PR layer is recommended.
The impedance of the Pt µ-electrode should be ~1.0 M$ at 1 kHz.

Optional Section 2| Recycling the optoelectronic devices for re-use
1 | After sacrificing the animal, use forceps to forcibly remove the headcap from the surface of
the skull. Thoroughly remove any visible biological tissue or other build-up from the sides
and bottom of the headcap. Take care not to damage the flexible aspect of the device. Once
removed and cleaned, the headcap is ready for dissolution (Figure 3.8A).
2 | Place the headcap into a glass beaker and add methyl methacrylate until the headcap is
entirely submerged (Figure 3.8B). Cover the beaker with tin foil and place in a properly
ventilated fume hood overnight. ! CAUTION Methyl Methacrylate Monomer is a flammable
liquid. It may also cause skin irritation; avoid contact with skin, eyes, and clothing. Use with
adequate ventilation.
3 | Following overnight incubation, the dental cement should be completely dissolved. The
device and bone screws should be clearly visible in the beaker (Figure 3.8C). Wearing
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gloves and using forceps, remove these items from the beaker. The screws can be cleaned,
sterilized, and used for another surgery. The device will normally become inactive after
dissolution of the
A

B
Removed!
headcap

Submerged!
headcap
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ACF cable
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with new ACF cable and PCB

133

µ-needle

Figure 3.8 µ-ILED device recycling and re-fabrication for subsequent use. (A) The same
headcap from Fig. 4, removed from the animal post-mortem and cleaned of biological material.
(B) The headcap should then be fully submerged in methyl methacrylate. (C) Following
overnight incubation in the stabilized methyl methacrylate monomer, the PCB, connector, µILED device, and bone screws will be freely available in the solution. (D,E) Both connections
with the ACF cable will also dissolve, rendering the device non-functional. (F) The device
should be checked for reuse. If non-functional, the device should be discarded and a new device
should be fabricated. (G) The working device is reassembled with new ACF cable and PCB. (H)
The electrical connection through the new ACF cable should be checked after the device is
attached with injection µ-needle again.
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4 | headcap due to concurrent dissolution of the adhesive connecting the ACF cable to both the
device and the PCB (Figure 3.8D and E). Prior to proceeding to Step 4, use a multimeter to
check that all µ-ILEDs still function properly (Figure 3.8F). If any of the µ-ILEDs have
electrical failure, discard the device and begin the fabrication process anew.! ?
TROUBLESHOOTING
5 | Discard the original PCB, and reassemble the device as described in Step 17 (Figure 3.2G
and H).
6 | Apply PDMS to the entire device construction to provide passivation and waterproofing for
operation in vivo as in Step 19 (Figure 3.2I).
7 | Attach the µ-needle using the silk adhesive and test the device to ensure proper electrical
connection as done previously in Steps 18 and 20 of the PROCEDURE (Figure 3.2J-L,
3.8G, and H). The device is now ready for injection into a fresh animal starting at Step 24 of
the PROCEDURE.

? TROUBLESHOOTING
Troubleshooting advice can be found in Table 3.1.

) TIMING
Steps 1–22, Preparation of µ-ILEDs, deterministic device assembly, and fabrication of wireless
harvester: 9 d
Steps 22-50, Viral and device injection: 1 d for procedure, 1–6 weeks for expression
Steps 51-63, Behavioral experimentation: 5 d for preparation, variable by experiment
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Optional Section 1, Combining multifunctional sensors and optoelectronics: 1-4 d depending on
modalities
Optional Section 2, Rescuing the optoelectronics for re-use: 2 d

ANTICIPATED RESULTS
Following successful fabrication and implementation of µ-ILEDs, wireless manipulation of
intact mammalian neural circuitry is possible. While our group has demonstrated the feasibility
of using these devices to investigate reward-related and anxiety-like behaviors (See Chapter 2)
(Kim et al., 2013b), nearly any behavioral assay should be accessible with these devices. In
particular, behaviors that require complete freedom of movement such as social interactions,
wheel running, and homecage behaviors are now possible (Figure 3.7C). Users can expect
injected devices to maintain function for many months, as we have tested devices up to six
months following injection and observe that the devices retain their operational functionality
(See Chapter 2) (Kim et al., 2013b). Furthermore, we show here that these devices can be reused
in other animals to avoid the lengthy process of remaking new devices for each experiment.
Depending on the nature of the experiment, a single panel antenna can power numerous
headstage devices. If the stimulation parameters are the same across animals, this approach can
greatly increase the experimental throughput for a variety of behavioral assays. Though not
presented in detail here, a reasonable extension of this protocol would be to incorporate other
existing microscale sensors such as pH, blood oxygen, glucose levels, or neurochemical
detection onto µ-ILED devices (Clark et al., 2009; Kim et al., 2010b). In sum, the protocol
described here should provide researchers the ability to use optogenetics to wirelessly control
and study intact mammalian neural circuitry in a minimally invasive manner.
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Table 3.1 ?TROUBLESHOOTING
Step
14

Problem
Electrical device failure

17,
Optional
Section 2
24

Be certain to apply enough
pressure (~1 or 2 MPa) and
temperature (150 ºC)
Only grasp the upper,
exposed portion of the µneedle. No portion of the
electrical components should
be grasped with the cannula
holder adapter. Be careful to
apply appropriate pressure so
as to avoid crushing the µneedle.
Inaccurate tissue targeting Improperly
aligned Follow
the
instructions
skull
provided
for
your
laboratory’s
stereotaxic
equipment for ear bar
placement and skull leveling.
Species-specific ear bars may
be required. If the suture lines
for
identifying
bregma/lambda on the skull
are difficult to visualize, a
surgical microscope and/or
treating the skull with
hydrogen peroxide can be a
helpful addition. It may be
necessary to wait longer after
penetration prior to removal
of the µ-needle.
Headcap falls off in Insufficient anchoring Dental cement is ideal for
homecage/during
or cement application
reusablility,
but
other
behavior
adhesives such as VLC One
Step Adhesive and C&B
Metabond offer stronger
bonds to the screws and skull
surface. While two screws are
normally sufficient, larger the
PCB interfaces may require
more anchor screws.

25, 32

33, 36

Possible reason
Un-uniform coating of
BCB passivation on µILED
ACF
cable
bonding Insufficient
failure
temperature
and/or
pressure when bonding
Device is damaged prior The
electrical
to or during mounting for components
are
surgery
grasped by the cannula
holder adapter
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Possible solution(s)
Spincoat BCB again and redo
the process.

37, 63

40

54Bi

Little or no expression of Improper handling and Thaw virus as close in time to
the viral construct
injection of the virus
the surgery as possible.
Maintain virus on ice until
the time of injection.
Depending on the promoter
that drives expression, some
systems will not provide
sufficient opsin expression.
This should be empirically
determined prior to any
attempted
behavioral
experiments.
Dissolution
of
silk Too much exposure to Most aqueous solutions will
adhesive
during ethanol
dissolve the silk adhesive. Do
sterilization
not soak the devices in
ethanol as this will promote
dissolution of the adhesive.
In our experience, rinsing the
device with ethanol for ~15
seconds is sufficient to
prevent
widespread
inflammation in mouse brain
tissue (See Chapter 2) (Kim
et al., 2013b). Care should be
taken to use appropriate
sterilization techniques in
higher mammals to avoid
immune responses, such as
EtO gas sterilization.
Insufficient RF power is The
behavioral Connect
a
freestanding
reaching the headstage apparatus is between device to the scavenging
scavenger
the panel antenna and headstage and place it in the
scavenger
(in
an behavioral enclosure. Using
enclosure)
the gain on the RF signal
generator adjust the RF
power until sufficient power
is available to power the µILEDs to the desired light
output. If problems powering
the device persist, consider
reducing
the
distance
between the panel antenna
and the scavenger.

138

Optional
Section 2

Headcap does not fully- Insoluble
dental
dissolve
cement was used, not
enough solvent, or
extend duration of
exposure to solvent

Some dental cements will not
dissolve
in
methyl
methacrylate. Consider using
the
exact
recommended
cements where possible. If
using Jet Denture Repair, add
more solvent or wait a longer
durations for cap to dissolve.
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Chapter 4

Wireless optofluidic systems for programmable in vivo
pharmacology and optogenetics
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SUMMARY
In vivo pharmacology and optogenetics hold tremendous promise for dissection of neural
circuits, cellular signaling and manipulating neurophysiological systems in awake, behaving
animals. Existing neural interface technologies, such as metal cannulas connected to external
drug supplies for pharmacological infusions and tethered fiber optics for optogenetics, are not
ideal for minimally-invasive, untethered studies on freely behaving animals. Here we introduce
wireless optofluidic neural probes that combine ultrathin, soft microfluidic drug delivery with
cellular-scale inorganic light-emitting diode (µ-ILED) arrays. These probes are orders of
magnitude smaller than cannulas and allow wireless, programmed spatiotemporal control of fluid
delivery and photostimulation. We demonstrate these devices in freely moving animals to
modify gene expression, deliver peptide ligands, and provide concurrent photostimulation with
antagonist drug delivery to manipulate mesoaccumbens reward-related behavior. The minimallyinvasive operation of these probes forecasts utility in other organ systems and species, with
potential for broad application in biomedical science, engineering, and medicine.
INTRODUCTION
Fundamental insights into the function of the central and peripheral nervous system often
follow from advances in tools and methodologies for neuroscience research. Technologies for
deep brain optical manipulation of neural activity allow for many types of basic research into
neural circuits (Tye and Deisseroth, 2012), intracellular signaling (Siuda et al., 2015; Zhang and
Cui, 2015), gene expression (Konermann et al., 2013; Polstein and Gersbach, 2015) and other
biological processes. Additional levels of control follow from combined use of such approaches
with pharmacological delivery (Jennings et al., 2013; Stamatakis et al., 2013; Walsh et al., 2014).
Furthermore, the potential of these combinatorial approaches for clinical impact was recently
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demonstrated using combined optical and pharmacological intervention to inform and modify
traditional, electrical deep brain stimulation to be more effective for off-label psychiatric
disorders (Creed et al., 2015). A key technological challenge has been the development of
miniaturized, self-contained systems that are capable of providing such functionality with
wireless control in feely moving, awake animal models. Conventional methods rely on metal
tubes (cannulas) and fiber optic cables to deliver drugs and light, respectively. Typically each
modality requires connection to separately located light and fluid sources that physically tethers
the animals and restricts their natural movement. Recent advances have combined cannulas and
fiber optics into small, multifunctional fibers that have capabilities in fluid delivery and
photostimulation, but which retain similar requirements for multiple, external connections
(Canales et al., 2015). All these technologies use rigid materials as neural interfaces leading to
adverse consequences for chronic use. The tissue benefit of mechanical compliance was recently
demonstrated comparing standard systems against systems that combine soft electrodes and
microfluidic structures in epidural implants (Minev et al., 2015) (See Table 4.1 for feature
comparison).
The approach we report here describes complete platforms that include power supplies,
control electronics, wireless interfaces, active fluidic handling systems and efficient light
sources, into compact, head-mounted devices that interface with thin, mechanically compliant
multifunctional neural probes. The result is a set of unique capabilities in programmed delivery
of multiple types of pharmacological agents and monochromatic light to discretely targeted
regions of the deep brain. These systems, which we refer to as wireless optofluidic neural probes,
create important opportunities in neuroscience research that combines in vivo pharmacology with
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Operation

Wireless

Electronic
dura mater
(Minev et al.,
2015)
Tethered

Modality

Optical &
Fluidic

Fluidic &
Electrical

Optofluidic
neural probes

Programmable
Yes
operation
Soft, flexible
Mechanical
Modulus:
property of the ~ 1 Mpa
probe
Stiffness:
13-18 N/m
Optical
Optically
property
transparent
Number of
independent
4
drug channels
Drug leakage
No leakage
Dimensions

80 um in
thickness

Multifunctional
NeuroMedicator
Fiber (Canales
(Spieth et al., 2012)
et al., 2015)
Tethered
Optical, Fluidic
& Electrical
recording

Tethered

No

No

Yes

Soft, flexible

Flexible

Rigid

Modulus:
~ 1 Mpa

Not reported

Modulus:
~170 GPa

Not reported

Stiffness: 107149 N/m

Not reported

Optically
transparent

Not transparent

Not transparent

1

2

2

No leakage

No leakage
400-700 um in
diameter (for
multimodal
fibers)

Leakage by diffusion

200 um in
thickness

Fluidic only

250um in thickness

Table 4.1. Comparison of various neural probes with related capabilities, related to Figure
4.1.
wireless optogenetics. Examples in awake, freely moving animals demonstrate the sophisticated
levels of spatiotemporal control over neural circuit functions that are possible without physically
contacting the animal. Specifically, optical manipulation of projections from the ventral
tegmental area dopaminergic system into the nucleus accumbens can elicit place preference
behaviors that can be blocked, in a temporally-precise programmable manner, by site-specific
infusion of a dopamine receptor antagonist. These and related studies represent the sort of
versatile, complex experimental options provided by the technology we report here.
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RESULTS
Ultrathin, Soft Neural Probes Have Wireless Capabilities For Programmed Drug Delivery
and Photostimulation
Figure 4.1 A-C show schematic illustrations and photographs of a multichannel, soft
microfluidic system, in which two thin, narrow pieces of the elastomer polydimethylsiloxane
(PDMS) bond together to form a set of four channels each with 10 & 10 µm2 cross-sectional
areas in a platform that has a total thickness of 50 µm. This type of microfluidic probe (Figure 1,
B and C) is transparent (> 95 % throughout across wavelengths from 400 nm to 700 nm) and
mechanically soft (modulus ~1 MPa; bending stiffness 13-18 N/m), thereby enabling both
optical access and minimally invasive use in soft neural tissue (see Chapter 2) (Canales et al.,
2015; Capadona et al., 2012; Jeong et al., 2015; Kim et al., 2013b; Kozai et al., 2012; Minev et
al., 2015; Subbaroyan et al., 2005; Wu et al., 2013). The former characteristic facilitates
integration of microscale inorganic light-emitting diodes (µ-ILEDs) on a filament of
polyethylene terephthalate (PET) with thickness of 6 µm (Figure 4.1D). These µ-ILEDs (each
with thicknesses of 6.54 µm and lateral dimensions of 100 & 100 µm2; Figure 4.1E) (see Chapter
2) (Kim et al., 2013b) provide spatially- and temporally-precise delivery of light in regions
adjacent to the outlets of the microfluidic channels. Active infusion of multiple drugs through
these four individual channels (Figure 4.1F) can be controlled independently from the µ-ILEDs.
This system allows for tandem pharmacological and optogenetic manipulation of neural
circuitry, with potential for application in optopharmacology where the use of light to activate
compounds requires high spatiotemporal control of both drug and light delivery (Kramer et al.,
2013) (Figure 4.1G).
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Figures 4.1G, H and I provide comparisons of this type of compliant optofluidic probe to a
standard metal cannula (see also Figure 4.2). The latter is hard, rigid, and displaces large
amounts of brain tissue (diameter ~500 µm), whereas the former is soft, flexible, and minimally
invasive (total thickness ~ 80 µm). The low bending stiffness (13-18 N/m, compared to > 5
MN/m for the 26 gauge cannula) of the optofluidic probes (Figure 4.3) facilitates adaptation to
the micromotions associated with movement, respiration, and blood flow (Gilletti and
Muthuswamy, 2006). This probe property minimizes mechanically induced damage or irritation
of the brain tissue in chronic applications (Lee et al., 2005). X-ray computed tomographic
images of mice implanted with these two types of fluidic delivery systems highlight the notable
differences in scale and impact on the tissue (Figures 4.1H and I).
Thermo-mechanical-fluidic Characteristics of the Optofluidic Devices
Figure 4.4A presents a schematic diagram of the overall system, with emphasis on the fluidcontrolling hardware. The schemes for fluid handling and pumping represent extensions of
recently reported drug delivery systems that use rigid, single-channel and single-reservoir
microfluidics and wired control interfaces (Spieth et al., 2012). Each of the four channels
connects to a separate reservoir whose base consists of an active layer (2:1 mixture of PDMS and
expandable microspheres, Expancel 031 DU 40, AkzoNobel) that initiates pumping through
expansion induced by Joule heating in an underlying element (serpentine traces of gold with
thickness of 185 nm). A dramatic increase in the volume of the active layer follows from
thermally induced, irreversible expansion of hollow polymer microspheres that encapsulate
hydrocarbon gas (Figure 4.4B). The supporting substrate (FR4) has a low thermal conductivity
(0.4 W/m'K), thereby minimizing the electrical power needed to reach the temperatures required
for this type of thermal actuation. The four reservoirs exist as molded features in a cyclic olefin
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polymer (COP), chosen for its low water vapor permeability (0.023g'mm/m2'day). Thin copper
membranes (thicknesses of 3 !m) seal the outlets of the reservoirs to prevent evaporation. This
design allows delivery of multiple drugs without the repeated insertion of a delivery probe.

A!

Flat top layer!

B!

500 µm!

C!

1 mm!

E!

500 µm!

F!

250 µm!

Molded !
channel layer!

D!

μ-ILED array!

μ-fluidic !
channels!

H!

G!
μ-fluidic channel!

μ-ILED!
5 mm!

I!

1 mm!

Liquid drug!

5 mm!
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Figure 4.1 Ultrathin, Soft Neural Probes with Wireless Capabilities in Programmed Drug
Delivery and Photostimulation (A) Schematic diagram of the assembly of a soft microfluidic
probe. Bonding thin, molded (bottom) and unmolded (top) layers of PDMS together yields a
system that includes four separately addressable microfluidic channels each with cross sections
of 10 & 10 µm2, and a total thickness of 50 µm and width of 500 µm, as illustrated in the inset at
the bottom right. (B) Optical micrograph of a microfluidic probe formed in this way. (Inset)
Magnified view of the channels. Scale bar, 100 µm. (C) Picture that illustrates the soft, compliant
mechanics of the device. (D) Schematic diagram of the integration of a soft microfluidic probe
with a flexible array of µ-ILEDs (each with lateral dimensions of 100x100 µm2, and thicknesses
of 6.54 µm) and metal interconnect traces on a film of PET (thickness of 6 µm). (E) Optical
micrograph of an integrated probe, which we refer to as an optofluidic system. (Inset) Colorized
SEM of a representative µ-ILED (contact electrodes, yellow; spreading layer, blue). Scale bar,
100 µm. (F) Tilted view of an optofluidic probe that shows the tip end. (Inset) SEM of the outlets
of the microfluidic channels. Scale bar, 50 µm. (G) Optofluidic neural probe during simultaneous
drug delivery and photostimulation. (Insets) Comparison of such a device (top) and a
conventional metal cannula (bottom; outer and inner diameters of ~500 and 260 µm,
respectively). Scale bars, 1 mm. (H & I) X-ray computed tomographic images of the mouse
models with (H) an optofluidic neural probe and (I) a metal cannula implanted into the brain.
Both devices are colorized green.
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A!

B!

Cannula!

Injector from pump!

C!
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Figure 4.2 Conventional cannulae to deliver drugs into the brain via an external pump.
Related to Figure 4.1. (A) Example of microinfusion pump system set up and connected to an
awake behaving mouse. Scale bar, 10 cm. (B) Injector and metal cannula (500 µm diameter
metal tube). Scale bar, 1 cm. (C) Connected injector/cannula (Note: 500 µm projection beyond
cannula termination). Scale bar, 1 mm. (D) Mouse with cannula implanted into dorsal striatum,
connected to microinfusion pump. Scale bar, 1 cm. (E) Top views of a metal cannula, an
optofluidic probe, and an optical fiber. Metal cannula: 500 µm in diameter; Optofluidic probe:
~80 µm in thickness; Optical fiber: 125 µm in diameter including a cladding. Scale bar, 1mm.
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Figure 4.3 Bending stiffness measurement of the optofluidic
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probe at physiological frequency range (respiration, heat beat,
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etc). Related to Figure 4.1. Dynamic mechanical analyzer (DMA

5
0
0.1
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10
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Q800) in the single cantilever mode was used to measure the bending
stiffness.

As illustrated in Figure 4.4C, activating a Joule heating element launches expansion of
the corresponding active layer (Figure 4.4B). The resulting pressure in the reservoir ruptures the
thin copper membrane and pumps the drug, with nearly 100% efficiency in volume delivery (0.5
!l in this case; Figure 4.4D), through the respective microfluidic channel. Quantitative
measurements and numerical modeling based on finite element analyses (FEA) capture the
thermal and mechanical aspects of operation. Because the modulus of the COP material (~ 2.6
GPa) is much higher than that of the expandable polymer (~ 3.0 MPa), deformations induced by
thermal actuation are almost exclusively accommodated by the latter, as shown by both
experimental and FEA results (Figure 4.4D and Figure 4.5, A-C). Quantitative studies (Figure
4.4D) indicate a negligible amount (< 8.5%) of infusion for heating of the active layer to
temperatures below ~75 oC, followed by a rapid increase above ~82 oC, finally reaching
complete infusion (> 99.5% of the volume of the reservoir) at ~87 oC. This nonlinear behavior
originates from the nonlinear thermal expansion properties (Figure 4.4B). FEA results for the
spatiotemporal temperature distribution of isolated Joule heating elements agree with IR images,
as shown in Figure 4.2E, thereby validating the use of computation in design optimization
(Figure 4.5D). The increase in temperature decays rapidly along both the thickness and in-plane
directions (Figure 4.4F and H), to allow efficient individual control of the reservoirs. Computed
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and measured temperatures at representative locations for times before, during and immediately
after actuation appear in Figure 4.4G. The average temperature of the drug in the reservoir
remains in a range (< 60 ºC) compatible with many neuroactive compounds (Callahan et al.,
2001; Joyce et al., 1984; Steger et al., 1996). Calculations based on a simplified fluid dynamics
model (see SI for details) indicate that the drug cools significantly as it flows down the
microfluidic channels before reaching the outlets and penetrating the targeted tissue (< 0.1 oC
higher than the temperature of the surroundings).
Wireless Optofluidic Devices Can Deliver Multiple Fluids and Photostimulation
Figure 4.6A (left) provides a schematic illustration of control hardware and associated
electronics, along with the key components that directly support the array of µ-ILEDs and the
soft microfluidic probe. A battery-powered infrared (IR) wireless module enables independent
control of fluid delivery and optical activation. The system uses serial communication between a
separate IR transmitter (950 nm wavelength) and the receiver, to provide programmable
activation of individual heaters in the array (heater 1, 2, 3, or 4) and the µ-ILEDs (in this case 5,
10, 20, or 40 Hz with 10 ms pulse width; Figure S4A). A thin, flexible printed circuit board
(PCB) serves as a substrate for a microcontroller (556-ATTINY84-20MU, Atmel), transistors,
and an IR detector with wide sensing angle (120˚; IR Sensor IC 38 kHz, Vishay
Semiconductors). Two small, rechargeable lithium ion batteries (GM300910H, PowerStream
Technology; Figure 4.7B) provide power. The entire collection of components (including the
optofluidic probe, microfluidic reservoirs and actuators, the wireless module, and two batteries)
is sufficiently lightweight (~ 1.8 g) to allow head mounting on adult mice and rats (Figure
4.7C). The wireless module and rechargeable batteries release from the optofluidics to allow
quick replacement, thus facilitating long-term operation in various behavioral experiments.
154

Cu membranes!

Reservoirs!

μ-fluidic !
channels!

Expandable !
layer!
Joule heaters!

Cu membrane
Drug
Heater on

1.6

Thermal expansion of expandable layer

Stage II:
Expansion

1.2
1.0
0.8
60

80
100
Temperature (ºC)!

Outlet

Inlet
Reservoir

Fluid channel
z
x
20!

Stage II!

Experiment

0.25 mm!

60

Heater

40

FEA

0.0!

20

20°C

70
80
90
Average temperature (ºC)!

Heater

H
120

100
80
60
40

0

105 (°C)!

120

110°C

20

Heater

E

87°C!

Temperature (ºC)!

x

Temperature (ºC)!

y

Stage I!

1.4

G 120

F!

Stage III:
Expancel
degradation

80

0
60

Drug

z

1.8

Stage I:
Thermal
dilatation
of PDMS

D 100

Infusion volume (%)!

C!

2.0

Relative thickness (t/t0)!

B!

A μ-ILEDs!

10
20
Time (s)!

30

100
80
60
40
20
0.0 0.5 1.0 1.5 2.0 2.5 3.0
Distance (mm)!

Figure 4.4 Thermo-Mechanical-Fluidic Characteristics of the Wireless Optofluidic System
(A) Exploded view schematic diagram that illustrates an array of µ-ILEDs mounted on top of a
soft microfluidic system that includes four separate microfluidic channels, each connected to a
set of fluid reservoirs that include copper membranes as hermetic seals, expandable composite
materials as mechanical transducers, and microscale Joule heating elements as actuators. (B)
Characteristics of a thermally expandable composite material. (Left) Thickness variation of this
material as a function of temperature. (Right) SEM images (scale bar, 100 µm) show the
expansion of microspheres upon application of heat at ~110 ˚C. (C) Actuation principle for drug
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delivery. Before actuation, drug remains in the reservoir (top). Upon activation of the Joule
heater, the expandable composite layer increases in volume to push drug through the connecting
microfluidic channel (bottom). (D) Dependence of the infused volume, as a percentage of the
total volume of the reservoir, on temperature of the composite material. The dashed line indicates
~100% infusion at 87 ºC. (Inset top) Cross sectional SEM image that shows complete filling of a
reservoir with composite material by thermal expansion, for a state of 100% infused volume.
(Inset bottom) Corresponding distribution of vertical displacements in the composite material
under the deformed configuration. (E) Comparison of temperature distributions for the system
with a bare heater in IR images (top) and FEA modeling results (bottom). The images show the
temperature distribution after activating the heater for 20 s. (F) Calculated temperature
distribution at the surface of the entire three-dimensional computational model (top), and that at
the cross-section defined by the red plane in the top (bottom). (G) Computed (blue) and
measured (red) temperature at the location of a thermal actuator, immediately before, during, and
after operation. The violet, green and yellow curves correspond to calculations at the reservoir,
the microfluidic inlet and outlet, respectively. (H) Temperature profile from the center of the
powered heater to the center of adjacent, unpowered heater, corresponding to the FEA model in
(E). The two red lines represent the boundaries of the two heaters.
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Figure 4.5. Results of thermo-mechanical modeling on the actuation process. Related to
Figure 4.4. (A) Schematic of the full 3D model of FEA. (B) Distribution of the out-of-plane
(i.e., the thickness direction) displacement in the structure, by applying a thermal strain of 22.4%
to the area covered by the heater (corresponding to heating the thermal expandable layer to an
average temperature of 87 oC). (C) The injected proportion of drug as a function of the thermal
strain in the expandable layer. (D) Power analyses for a safe and sufficient injection. The
minimum and maximum powers are plotted as functions of the heating time to complete the
injection.
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Figure 4.6A (right) demonstrate wireless operation of drug delivery and optical
stimulation with a compact, self-contained device in a 3D-printed enclosure. Upon wireless
triggering, the microcontroller activates a selected heater for drug delivery. The infusion rates
non-linearly increase up to ~ 5.2 !l/min, such that most of the fluid is delivered within 13
seconds after initiating actuation (Figure 4.6B). The time dynamics of the expansion process and
the geometries of the reservoirs and channels define these rates. Therefore, engineering the
geometries of reservoirs and the dimensions of the channels can modulate the flow rate for
different applications. Demonstration experiments using aqueous solutions of colored dyes and
phantom brain tissue (0.6 % agarose gel) verify these operational characteristics, as shown in
Figure 4.6C and D. Figure 4.6E shows results for total volumes of fluid delivered from a set of
reservoirs in a representative device.
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Figure 4.6 Wireless Optofluidic Devices Are Capable of Delivery of Multiple Fluids and
Optical Manipulation. (A) Complete wireless optofluidic system. (Left) Schematic illustration
of the electronics, power and wireless control system that plugs into the construct shown in
Figure 2A. (Right) Demonstration of wireless drug delivery and optical stimulation by operation
of the optofluidic system in a brain tissue phantom (0.6% agarose gel). (B) Flow rate in a
microfluidic channel (blue) and total infused volume (red) as a function of time before, during
and after actuation. (C) Time sequence of optical images that demonstrates delivery of liquid
(aqueous solution with orange dye) into brain phantom tissue (0.6 % agarose gel) through a
microfluidic channel: t1 = 0 s (onset of actuation), t2 = 3.1 s, t3 = 3.8 s, t4 = 15.2 s. (D) Images
that show capabilities in separate delivery of different liquids (aqueous solutions with red,
yellow, blue and green dyes) through four individual microfluidic channels. The image on the
right provides a magnified view. (E) Total infusion volumes from each of four reservoirs in
representative devices (average of three devices).
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Figure 4.7 Design of wireless control system. Related to Figure 4.6 (A) Overall design of
transmitter (remote controller) and receiver circuit. (B) Picture of optofluidic drug delivery
device system components including a case, an optofluidic device, wireless control circuit, and
lithium ion batteries. (C) Weight of an optofluidic system.
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Optofluidic Devices Are Suitable for Wireless Pharmacology and Optical Manipulation in
Awake, Behaving Animals
For application in vivo, the optofluidic drug delivery device can be chronically packaged with the
platform for wirelessly triggered operation that includes infrared remote control, battery power,
fluid reservoirs and pumps with associated control electronics, all contained in a small head stage
(Figure 4.8A, Figure 4.9A and B). To extend the lifetime of operation and reduce the impact on
smaller organisms, the packaged electronics for the optofluidic device can be acutely affixed to
an awake animal for acute device operation (Figure 4.8B). Mice with the fully encapsulated,
chronically implanted wireless optofluidic devices interfaced to the dorsal striatum perform the
rotarod test of sensorimotor control equally as well as cannula-implanted controls (Figure 4.8C
and Figure 4.9C). Furthermore when allowed to choose when and how to run on a wheel,
optofluidic-implanted mice run equally as often and as much as cannula-implanted controls
(Figure 4.8D and Figure 4.9D) and have equivalent baseline anxiety-like behavior in the open
field test (Figure 4.8E). These results indicate that even small mammals such as mice tolerate
the chronically implanted probes equally as well as mice with conventional cannulas targeting
the same brain structure. It is important to note that the cannulated mice in these experiments
were not connected to an external drug supply. Such tethering can restrict movement and impacts
performance on all of these tests, while the optofluidic device-implanted mice are fully
integrated with both the device and the fluid supply. In addition to comparable behavioral
responses, the mechanical compliance and smaller overall tissue displacement of the microfluidic
channels reduce lesioning and immunoreactive glial responses from deep brain implantation
(Figure 4.8F-J). Additionally, the optofluidic devices provide access to four channels of drug,
viral, or other fluid administration compared to a single channel for the cannula in a significantly
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Figure 4.8 Optofluidic Devices Are Suitable for Wireless Pharmacology in Awake,
Behaving Animals. (A & B) Images of a freely behaving (A) Sprague-Dawley rat and (B) a
C57Bl6 mouse mounted with wireless power systems that are capable of drug delivery and
photostimulation deep into brain tissue. All animals are healthy and freely moving, shown here
one week following surgery. Scale bars, 1 cm. (C-E) Wild-type (C57Bl6) mice tolerate the
microfluidic devices as well as traditional cannulas and do not exhibit any notable deficits in (C)
motor coordination, (D) spontaneous locomotor activity, or (E) anxiety-like behavior. (F)
Schematic and Mouse Brain Library atlas image of histological approach for inflammation and
lesion study. Dashed circle indicates approximate injection site. Scale bar, 1 mm. (G) Mean ±
SEM cross-sectional area of lesions from cannulas and optofluidic probes (Student’s T-Test,
**p<0.01, n=3/group). (H) Representative linescan of fluorescence intensity from cannula (gray)
and optofluidic probe (red) lesions. (I & J) Representative confocal fluorescence images of 30
!m horizontal striatal slices show immunohistochemical staining for Nissl bodies (blue),
astrocytes (GFAP, red) and activated microglia (Iba1, green) and overall lesion from a cannula
(I) and an optofluidic device. All histological and confocal settings were kept consistent across
groups. (J). In the rightmost panels, the shape and scale of the lesion from the cannula or
optofluidic device is overlaid on the image of the other device (dashed lines). Scale bars, 100
!m.
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Figure 4.9 Demonstration of chronically implanted, fully enclosed and wireless microfluidic
devices in various environments, related to Figure 4.8A-E. (A & B) Group-housed homecage
environment. (C) Rotarod test. (D) Spontaneous run on a running wheel.
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smaller cross-sectional area (Figure 4.8G) of the brain. These thin, flexible optofluidic neural
probes are better tolerated by the brain than rigid implants, consistent with previous reports of
ultrathin, flexible deep brain implants (see Chapter 2) (Canales et al., 2015; Capadona et al.,
2012; Kim et al., 2013b; Kozai and Kipke, 2009; Kozai et al., 2012).
Wireless Virally-mediated Recombination and Visualization of Fluid Delivery
As a demonstration of the optofluidic probes’ ability to delivery multiple, independent
fluids through a single implant in an awake, behaving animal we loaded two reservoirs with two
different

adeno-associated

viruses

to

allow

for

recombination-dependent

fluorescent

visualization of successful fluid ejection. First, we delivered a virus expressing Cre recombinase
(AAV5-PGK-Cre) into the dorsal striatum of a Cre-conditional tdTomato reporter mouse line
developed by the Allen Institute for Brain Science (Figure 4.10A) (Madisen et al., 2010). We
observed robust Cre-dependent expression of tdTomato in a distinct radius below the ventral tip
of the microfluidic channels, thereby indicating efficient remote-controlled, virally-induced in
vivo recombination (Figure 4.10A). When we counted the number of tdTomato+ cells emanating
from the tip of the implant we found the majority of the Cre-induced fluorescent reporter
expression to be within 500 !m of the injection site (Figure 4.10B). Next, in a separate group of
animals, we delivered the same AAV5-PGK-Cre as well as a Cre-dependent eYFP reporter virus
(AAV5-Ef1a-DIO-eYFP). In these animals we clearly observed co-expression of both tdTomato
and eYFP (Figure 4.10C-E) indicating successful, combinatorial viral-mediated recombination
in vivo. These are proof-of-principle experiments, but the same approach could be used to
wirelessly alter gene expression at multiple timepoints without the need for multiple, disruptive
surgeries or physical connection to viral infusion hardware. Together these results further
demonstrate the optofluidic neural probes can be used for in vivo remote-controlled, independent
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delivery of fluids within an isolated region through individual and distinct channels running
along a single implant.
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Figure 4.10 Wireless Virally-mediated Recombination Visualizes the Spread of Fluid
Delivery. (A) Schematic of viral delivery experiment depicting loading of two distinct viruses
into a single microfluidic device, fluorescence image depicts bolus of Cre-mediated
recombination (imaged as expressed tdTomato, red; Nissl, blue) near the tip of the implanted
microfluidic device. Right, enlarged maximum projection of 35 confocal fluorescence images
(tdTomato, red). Black scale bar, 1 mm; white scale bar, 25 !m. (B) Quantification of the spread
of AAV5-PGK-Cre viral recombination. Cells counted in serial coronal slices from point of
infusion (n=3 slices per brain from 3 brains). (C) Viral recombination scheme for the dual viral
approach taken in (D & E). (D) Representative maximum projection of 35 confocal fluorescence
images of 30 !m coronal striatal slices demonstrate efficient virally-induced gene expression
(Left-tdTomato, red; middle - eYFP, green, Right-overlay) following wireless delivery of
viruses. Chevron indicates example co-localization of tdTomato and eYFP. Scale bar, 25 !m. (E)
Quantification of co-localization of tdTomato (tdT) and eYFP (n=3 slices per brain from 3
brains).
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Untethered, Programmed Pharmacological Infusion Alters the Behavior of Freely Moving
Animals
The capability to load a single device with multiple fluids for independent, remotecontrolled delivery offers the user the advantage of either multiplexed therapeutic treatments or
easily controlled within-subject study designs. As a demonstration of the latter, we implanted
microfluidic devices unilaterally into the ventral tegmental area (VTA) of wild-type (C57Bl6)
mice. Previous reports have demonstrated a remarkably stereotyped rotation behavior to
unilateral !-opioid receptor (MOPR) activation in the VTA (Devine and Wise, 1994; Jenck et al.,
1988). As a proof-of-principle within-subject in vivo pharmacology experiment, two chambers of
each device were loaded with different pharmacological agents; one with the synthetic opioid
peptide and MOPR agonist, [D-Ala2, N-MePhe4, Gly-ol]-enkephalin (DAMGO, 200 pmol,
Tocris), and one with artificial cerebral spinal fluid (ACSF) as a vehicle control. In a counterbalanced design, we then wirelessly delivered either the DAMGO or vehicle into the VTA of
freely behaving animals over a distance of ~1 m away from the animal (Figure 4.11A and B).
Consistent with previous reports (Calenco-Choukroun et al., 1991; Devine and Wise, 1994;
Jenck et al., 1988; Latimer et al., 1987), when DAMGO was infused into the VTA the animals
showed a robust increase in overall locomotor activity (Figure 4.11C-E). In particular, the
unilateral administration causes stereotypical rotations contralateral to injection site that is
completely absent when the same animals receive the wireless ACSF infusion (Figure 4.11B, C
and E). This experiment demonstrates the utility of the optofluidic probes for self-contained,
within-subject experiments to wirelessly deliver multiple chemicals into the brain without any
physical contact with the animal for completely unconstrained freely moving behavior.
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Figure 4.11 Untethered Delivery of Opioids into the Ventral Tegmental Area Causes
Stereotypical, Repeated Rotation Behavior. (A) Schematic of the opioid peptide delivery
experiment depicting loading of an agonist (200 pmol DAMGO, Tocris) and its vehicle into
single microfluidic device. (B) Cartoon of wireless scheme for the DAMGO-induced rotation
experiment. (C) Representative traces of movement from the same animal over the course of two
minutes and one hour clearly show an increase in overall movement and rotations. (D-E) Withinsubject, counter-balanced experiments demonstrate robust wireless, DAMGO-induced changes
in ambulatory behavior. Intra-VTA DAMGO causes a significant increase in (D) overall
locomotion and (E) contraversive 360º rotations (n=7, Paired Student’s T-Test, **p<0.01).
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Concomitant Wireless Photostimulation with Pharmacological Antagonism Modulates a
Dopamine Receptor-1-sensitive Real-Time Place Preference
We next determined the in vivo optofluidic capabilities of these devices. Real-time place
preference has become a common tool for neuroscientists to assess the behavioral valence of
photostimulated neural circuits or cell bodies in a freely moving animal (Jennings et al., 2013;
Kim et al., 2013a; Siuda et al., 2015; Stamatakis and Stuber, 2012; Stamatakis et al., 2013; Tan
et al., 2012). In related behavioral models, phasic optogenetic activation of VTA dopaminergic
(VTA-DA) neurons is rewarding (see Chapter 2) (Kim et al., 2012, 2013b; Tsai et al., 2009;
Witten et al., 2011). However, we previously failed to observe that wireless phasic activation of
VTA-DA cell bodies was sufficient for a real-time place preference (see Chapter 2) (Kim et al.,
2013b). Because of the pronounced heterogeneity of VTA projections (Gunaydin et al., 2014;
Lammel et al., 2011, 2012, 2015; Stamatakis et al., 2013; Stuber et al., 2015), we sought to
selectively target VTA-DA projections into the shell of the nucleus accumbens (NAcSh). To do
this, we selectively targeted channelrhodopsin-2 fused with eYFP (AAV5-EF1a-ChR2(H134)eYFP) to VTA-DA neurons of TH-Cre mice and implanted an integrated optofluidic probe
adjacent to the NAcSh (Figure 4.12A and B; Figure 4.13A-C). In this experiment, we found
that photostimulation of the NAcSh-projecting VTA-DA fibers resulted in an increase in c-fos
expression, a widely used biochemical marker of neuronal activation, in both the accumbens and
the ventral tegmental area (presumably through antidromic activation) (Figure 4.13D and E). To
test whether any of the observed behavioral phenotypes were dopamine-dependent, we filled one
chamber of the optofluidic device with the selective dopamine receptor D1 (DRD1) antagonist
SCH23390 (400 ng, Tocris) (Billard et al., 1984; Gunaydin et al., 2014; Hyttel, 1983). We found
that phasic photostimulation (8 x 10 ms light pulses at 20 Hz every 5s) of VTA-NAcSh terminals
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was able to drive a robust real-time place preference (Figure 4.12C and D). Importantly, in a
counter-balanced design, this place preference was completely blocked by wireless
pharmacological delivery of SCH23390 prior to photostimulation in the real-time place
preference task, indicating that optogenetically-induced dopamine release into the NAcSh elicits
the real-time place preference via DRD1 activation. There was no effect of either the
photostimulation or the drug treatment on TH-Cre- control animals that did not express
ChR2(H134)-eYFP (Figure 4.12E and F) and no treatment group displayed a significant effect
on locomotor activity (Figure 4.12). These findings demonstrate that completely self-contained,
remote-controlled optofluidic neural probes can be easily incorporated into optogenetic studies to
introduce pharmacological agents into the immediate region of targeted photostimulation in a
programmed fashion that is time-locked and dependent on the behavior.
DISCUSSION
The wireless optofluidic neural probes presented here represent a compelling technology
for programmable drug delivery and optical manipulation of deep brain tissue in freely moving
animals. The resulting device platform has multifunctional capabilities in a single, soft implant
that provides powerful options for in vivo pharmacology and wireless optogenetics, many of
which would be impossible to reproduce with conventional metal cannulas and/or optical fibers.
A key advantage of these systems is the spatial specificity inherent in the multimodal
brain/device interface. Previous demonstrations of wireless drug delivery have focused on defuse
infusion of drug into the subcutaneous space of rats and, recently, humans (Farra et al., 2012;
Hoare et al., 2009, 2011; Timko et al., 2014). While these devices are capable of on-demand
fluid delivery, they are unable to couple to the types of microfluidic channels necessary for
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Figure 4.12 Wireless DRD1 Antagonism in the NAcSh Blocks Photostimulation-induced
Real-Time Preference of Freely Moving Animals. (A) Schematic of the optofluidic
experiment. AAV5-EF1a-DIO-ChR2-eYFP was injected into the VTA and six weeks later an
optofluidic probe loaded with SCH23390 (400 ng, Tocris) was implanted in the NAc of TH-Cre
animals. (B) Representative confocal fluorescence images depicting cell-type specific expression
of ChR2-eYFP in (right) dopaminergic, TH containing neurons of the VTA (TH, red; ChR2eYFP, green) and (left) their projections in the NAc (Nissl, blue; ChR2-eYFP, green). Triangular
arrow indicates the ventral tip of the microfluidic channels and the chevron indicates the ventral
tip of the optofluidic device. All scale bars for the figure are 100 µm. (C-G) Phasic
photostimulation (8 pulses at 20 Hz, 10 ms pulse width upon entry and every 5 s the animal
remains in the chamber) of NAc-projecting terminals from the VTA of TH-Cre animals drives a
real-time place preference. (C) Representative traces of movement during the real-time place
testing experiment of one TH-CreVTA:ChR2 animal show a SCH23390-sensitive preference for the
photostimulation-paired chamber. (D) All TH-CreVTA:ChR2 animals show a real-time place
preference that is significantly reduced following wireless intra-NAc delivery of SCH23390
(n=9, Paired Student’s T-Test, ***p<0.001). (E) In Cre- control animals, neither the
photostimulation or the SCH23390 treatment affects real-time preference behavior (n=8, Paired
Student’s T-Test, p=0.6234). (F) Grouped analysis confirms that the SCH23390-sensitive place
preference is selective for the TH-Cre+ animals (n=8-9/group, One-way ANOVA, Bonferroni
Post-Hoc, **p<0.01, ****p<0.0001). (G) There is no significant difference between any groups
for overall locomotor activity (n=8-9/group, One-way ANOVA).
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Figure 4.13 Further analysis of optofluidic real-time place preference experiment, related
to Figure 4.12 (A) Schematic of the optofluidic experiment. (B) Cartoon of wireless scheme for
the RTPP experiment. (C) Hit map of optofluidic placements for the experiments in Figure 7.
Blue lines represent the most ventral 1 mm of device in Cre+ animals, grey lines repersent the
most ventral 1 mm of device in Cre- animals. (D) Antidromic c-fos expression in the VTA
following 1 hour of photostimulation. Triangular arrow indicates example c-fos expression.
Scale bar, 10 !m. (E) Orthodromic c-fos expression in the NAcSh following 1 hour
photostimulation. Triangular arrow indicates example c-fos expression. Arrowhead indicates
ventral tip of optofluidic device. Scale bar, 100 !m.
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discrete, targeted fluid delivery into deep brain tissue. The wireless optofluidic probes reported
here overcome this challenge with a single device that causes a single, static lesion to brain
tissue, where fluids and photons arrive at precisely the same micro-region of the brain. This colocalization targets the same cells with both drugs and photostimulation. One interesting
possibility is in delivery of viral vectors for expression of exogenous receptors (light-sensitive
ion channels, receptors, pumps, etc. or DREADD receptors), ligands for these or endogenous
receptors, and photostimulation all to the same brain region and cell population. The compact,
self-contained construction eliminates the repeated micro-lesions associated with internal
cannulas and the angled lesions associated with exterior fiber optics dramatically reducing
overall trauma to the brain (Figure 4.8F and G). This minimally invasive operation facilitates a
within-subject experimental design, thereby reducing the number of animals one needs to
account for the behavioral variability that arises from any significant disruption of brain tissue.
The soft neural interfaces enabled by these ultrathin, compliant probes also create new
opportunities for chronic neuroscience research and preclinical investigation, as demonstrated
not only here but also in recent studies of other soft device technologies for use in the epidural
space (Minev et al., 2015). Importantly, the materials and designs presented here represent
significant advances over these and other neural interfaces, all of which rely on tethered
operation and lack capabilities in both wireless operation and photostimulation (Table
S1)(Canales et al., 2015; Minev et al., 2015; Spieth et al., 2012). An important perspective is that
the platforms reported here can easily be adapted for a wide range of other types of passive or
active electronics technologies, including electrical microstimulation.
For any configuration, the value of the technology to the community depends on the
extent to which it can be widely adopted. In this context, a relevant consideration is that the
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hardware for control and power management consists of readily available electronics hobbyist
components. Aside from a simple IR remote control, the animal carries a small IR receiver
system with little observable impact on its behavior (Figure 4.8). In fact, after the initial surgery
to implant and secure the device to the skull, the experimental subject never needs to come in
contact with a human again. Complete operation of these optofluidic neural probes, including
delivery of up to four distinct pharmacological agents, viruses, or other fluids, as well as
photostimulation can all be achieved wirelessly in any domain through which the IR signal can
pass.
Areas for further improvement include dynamic control of fluid flow. While the reported
devices provide for multiple delivery events, each operates with identical rates of infusion
(Figure 4.6B). Engineered variations in the dimensions of the reservoirs and channels represent
one means to define different flow conditions. Another limitation is in refilling devices. With the
current layouts, reuse of the microfluidics reservoirs and channels can be challenging. To
overcome these restrictions, implementing replaceable fluid-containing cartridges (analogous to
ink jet printer cartridges) might represent an attractive future design feature.
Even in existing embodiments, the device capabilities allow previously intractable
experiments such as altering gene expression in freely behaving animals while living in their
native home cage environments (Figure 4.9 and 4.10). The optofluidic neural probes can also
provide photostimulation and delivery of pharmacological agents in a closed-loop manner based
on the animals’ behavior (Figure 4.12). Integration with real-time video acquisition of socially
interacting animals (de Chaumont et al., 2012; Kunwar et al., 2015) would allow fully
automated, programmed fluid delivery that could be tuned entirely to the social interactions of
the animal. Beyond the possibilities in optogenetics, all which require genetic modification, an
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interesting application could be in optopharmacology. The use of photo-sensitive compounds
that act as photo-switches or ligands that bind to channels or receptors upon photo-conversion
(Kramer et al., 2013) could exploit the high spatiotemporal control of both fluid and light
delivery afforded by these optofluidic probes. Optopharmacological agents have been
enthusiastically received in neuroscience for in vitro applications (Banghart and Sabatini, 2012;
Callaway and Katz, 1993; Carter and Sabatini, 2004; Matsuzaki et al., 2001), but their use in vivo
has been limited. Although compelling findings exist addressing the external visual nervous
system and the surface of the cortex (Mourot et al., 2012; Noguchi et al., 2011; Polosukhina et
al., 2012; Tochitsky et al., 2014), optopharmacological application in the deep brain remains a
significant challenge. Optofluidic devices that provide access to the UV spectrum with advanced
µ-ILEDs could target these highly selective photosensitive tools to spatially isolated regions of
the central nervous system in non-genetically altered mammals.
Beyond basic research, the operation and architecture of the probes reported here will
allow for a smooth translation to non-human primate models as well as applications in clinical
medicine. Therapeutic solutions for a diverse set of pathologies (e.g. local neurooncotherapy,
pharmacologically-refined deep brain stimulation, delivery of agents to mitigate traumatic brain
injury etc.) will benefit from the untethered and fully-contained, programmable operation of
devices similar in design to these optofluidic neural probes. Such centrally targeted drug delivery
holds the promise of more tissue- and cell-type selective therapies that avoid perturbing offtarget organ systems. With these exciting future directions in mind, the results of our studies
establish strategies for minimally-invasive, ultrathin wireless optofluidic neural probes that can
serve as a starting point for new generations of fluid neural interfaces.
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MATERIALS AND METHODS
Fabrication of Ultrathin, Flexible Optofluidic Probes
Fabrication of flexible microfluidic probes started with creating microfluidic channel
patterns in a 25-µm-thick PDMS layer (Sylgard 184, Dow Corning) using a molding process. For
fabrication of a mold, photo-curable epoxy (SU-8 10, Microchem Inc.) was spin-coated (3000
rpm for 10 !m thickness) on a silicon wafer and UV-exposed (120 mJ/cm2) through a mask
pattern. Removing the unexposed region by developing, followed by thermal annealing (95°C
for 2 min) completed the mold for the fluidic channels. To facilitate release of patterned PDMS
from the mold, the mold was chemically treated with evaporated anti-stiction agent
(chlorotrimethylsilane, Sigma-Aldrich) for 20 min. PDMS was casted on the mold and pressed
with a glass slide (5 & 3.5 cm2) that was treated with Pt inhibitor solution (5% AEAPS (3-(2Aminoethylamino) Propylmethyldimethoxysilane, Sigma-Aldrich) and 95% methanol) for 45
min; this inhibitor treatment facilitated release of the thin PDMS layer from the glass slide by
deactivating Pt at the glass-PDMS interface, which is a catalyst for polymerization of PDMS.
The glass slide and the mold were clamped, and the PDMS between them was cured for 50 min
at 70°C. Then, the glass slide with the patterned thin PDMS layer was carefully detached from
the Si mold.
In the meantime, a flat, thin PDMS layer (20 !m thick) was prepared by spin-casting
PDMS (2000 rpm for 60 s) on a polycarbonate (PC) membrane and cured at 70°C for 1 hour.
The PC was chosen as a substrate for handling due to its surface property allowing easy release
of PDMS. Both this flat PDMS layer on the PC membrane and the patterned PDMS layer on the
glass slide were oxygen plasma–treated to activate their surfaces and bonded together to form
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microfluidic probes. After removing the PC membrane, the microfluidic probes were released
from the glass slide without damage due to the Pt inhibitor treatment of the glass surface.
The fabrication of the µ-ILED array on a thin PET layer (6 !m thick) was previously
presented (see Chapters 2 & 3) (Kim et al., 2013b; McCall et al., 2013) (See SI for fabrication
details). The !-ILED array was integrated onto the microfluidic probe using a double-sided
adhesive (25 !m thick; ARclear 8154, Adhesives Research), and the fabrication was completed.
The result was an ultra-thin (~80 !m thick), soft, and flexible optofluidic probe, suitable for
long-term implantation in the soft brain tissue.
Fabrication of Optofluidic Drug Delivery Devices With Thermal Actuators
Heater patterns were defined photolithographically on Cr/Au (5 nm/185 nm thick)
deposited FR-4 substrates (G10 glass epoxy sheet, ePlastics). The expandable layer (250 !m
thick) was prepared on top of heaters on the FR-4 substrate by spin-coating thermally expandable
polymer (2:1 mixture of PDMS (elastomer:curing agent = 10:1) and expandable microspheres
(Expancel 031 DU 40, AkzoNobel) and cured in a 70°C oven for 12 hours. Hemispherical
reservoirs, which were patterned in cyclic olefin polymer, were aligned on the heaters and
bonded using a double-sided adhesive (25 !m thick; ARclear® 8154, Adhesives Research).
Then, parylene C (6 !m thick) was deposited on the inner walls of the reservoirs to further
improve vapor impermeability as well as chemical resistance.
For drug loading, the reservoirs were first treated with oxygen plasma (March RIE) for
30 seconds to make the inner surface hydrophilic. A syringe with a blunt needle was used to
place the drug of interest into the reservoirs. To prevent fluid evaporation, the outlets of the

179

reservoirs were hermetically sealed with Cu membranes (3 !m thick) after drug loading. Then,
the inlets of an optofluidic probe were aligned and bonded with the outlets of the reservoirs.
Fabrication of µ-ILED Arrays on Flexible Microneedles
The fabrication of the µ-ILED was previously described (see Chapters 2 & 3) (Kim et al.,
2013; McCall et al., 2013). The GaN epi-layers, which were grown on a sapphire wafer (500 µm
thick with 2” diameter, Cermet Inc.), consisted of undoped GaN (3.8 µm), n-GaN (2 µm), spacer
(0.4 µm), multi-quantum well (0.14 µm), and p-GaN (0.2 µm). A sapphire surface were rinsed
with diluted HCl (33 %) to remove GaN oxide layer followed by sputter deposition (AJA ATC
2000) of current spreading layers of Ni/Au (15 nm/15 nm). Post-annealing at 500 oC for 5 min
formed an Ohmic contact between the metal and the GaN. After etching n-type regions with
inductively coupled plasma reactive ion etching (ICP RIE, Plasmatherm, SLR-770), n- and ppads of 15 nm/300 nm of Cr/Au were deposited by electron beam evaporation (Temescal, FC1800). To define the entire LEDs with 100&100 µm2, ICP RIE was used to remove GaN down to
the sapphire substrate, with negative photoresist (AZ 2070, Micorchem Inc) as an etching mask.
A passivation layer of SiNx (200 nm) was deposited by plasma enhanced chemical vapor
deposition (PECVD; STS, Mesc Multiple) followed by wafer bonding between a silicon wafer
with Cr/Pd/In layers (15 nm/150 nm/900 nm) and a sapphire substrate to make metallic alloy.
The LEDs were removed from a sapphire wafer by laser lift-off (KrF, intensity of ~0.9 J/cm2)
and additional heating up to 70 oC for melting of In metal on a hot plate. Wet etching with HCl
(5w%) removed the residual In layer, leaving porous structures of InPd alloy that acted as
anchors to hold the LEDs to the silicon wafer during following etching processes with Pd and Cr
metals. Entire LEDs were easily transferred onto PDMS slab which has micro-pillar (3 µm in
diameter, 1.2 µm in height, and 5 µm in space) via the van der Waals forces. Finally, wet etching
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of the residual Pd completed the fabrication of µ-ILEDs on PDMS, which were ready for transfer
printing.
To transfer the µ-ILEDs, a PDMS stamp with micro-post (100 & 100 µm2 and heights of
100 µm) was used to pick up the µ-ILED from a structured PDMS slab. The µ-ILED on the
micro-post was integrated onto a thin UV curable adhesive (Kim et al., 2014) coated 6 µm-thick
PET film which was micropatterned with a needle shape by using a mask aligner (Karl Suss,
MJB). After transferring the µ-ILEDs, the SiNx passivation layer was removed by reactive ion
etching (Plasmatherm 790). Photosensitive benzocyclobutene (6 µm thick) was spin-coated with
2000 rpm for 30 sec followed by UV exposure from bottom side through the transparent glass
substrate. UV light exposed all regions except the opaque n- and p- pads which are made of thick
metals. Developing away (Advanced Developer, DS2100) the unexposed region completed the
patterning process for via holes on to both pads. After fully curing in a glove box without
water/oxygen gases at 210 oC for 2 hr, metal interconnections was deposited with 15 nm/300 nm
of Cr/Au and patterned using photolithography and wet etching. Finally, the entire area except
contact pads for connection was encapsulated with 2 µm-thick SU-8 and hard-cured for
waterproof.
Preparation of Releasable Metal Microneedles for Injection
To prepare injection metal microneedles, thin metal foil of Stainless steel (50 µm
thickness) was purchased from Goodfellow Corporation. Needle shapes were designed with 500
µm width / 6 mm length from the tip to the mid-point and 1 mm width / 7 mm length from the
mid-point to the end. Metal foil was defined with laser mill which has focal point of 35 µm.
Detaching of cut needles from the residual foil and cleaning with IPA completed the preparation.
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For bonding of an optofluidic probe to the injection microneedle, a thin layer of purified
silk (7 wt%) or an adhesive from the water soluble PVA tape were used, to allow release after
implantation – it takes about 5 min for resolution of the adhesives inside saline solution.
Measurement of Device Temperature During Thermal Actuation
The temporal response of devices during thermal actuation was characterized by thermal
imaging with an infrared camera (A655sc, FLIR Systems, Inc.), which has measurement
accuracy at ±2% of the reading value.
Thermal Characterization of Thermally Expandable Polymer
To measure the volumetric expansion dependent on temperature, we increased the
temperature of the expandable polymer in an environmental chamber (Thermotron SM 1.0). The
temperature was increased by 10°C per hour from 20°C to 130°C for 11 hours. The thermal
expansion of the polymer was imaged with a camera (Logitech 720p Webcam C905), while the
temperature was simultaneously recorded with a K-Type thermocouple probe (OMEGA®)
connected to an analog channel of a NI DAQ board (myDAQ, National Instruments).
The thermocouple probe was attached to the polymer with heat paste to enhance the thermal
contact conductance. The images of the expanding polymer were analyzed by a custom code
with Image Processing Tool Box of Matlab (MathWorks).
Fluid Flow Rate Measurement
The flow rate was measured by tracking 2 µm green fluorescent microspheres (F-8827,
Thermo Fisher Scientific) diluted to distilled water by 100:1. Before injecting the tracer, the
microsphere solution was sonicated for 5 minutes to eliminate any aggregation. The video was
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captured by a digital high speed camera (Phantom v7.3, Vision Research) and an inverted optical
microscope (Leica) with a 20X objective (Leica) and wide-field fluorescence light source (XCite 120Q, Excelitas Technologies) at the frame rate of 20,000 frames per seconds. The video
was analyzed by Matlab (Mathworks) with an open source code for particle image velocimetry
(http://www.fast.u-psud.fr/pivmat/) to calculate the microsphere displacement between the each
frame. Then, the volumetric flow rate was calculated by multiplying the cross-section area with
the flow speed.
Delivered Fluid Volume Measurement
Delivered fluid volume was characterized by measuring device weight change per
actuation with a high-precision analytical balance (XS105, Mettler Toledo) and converting it to
volume.
Thermo-Mechanical-Fluidic Simulation
Three dimensional (3D) finite element analysis (FEA) was carried out using the software
ABAQUS to analyze the thermal conduction and mechanical deformation of the optofluidic drug
delivery devices. For a given power applied to the heater, the transient thermal analyses were
carried out first to calculate the spatial and temporal variations of temperature in the device. The
thermal expansion of expandable polymer could be then determined based on the nonlinear
thermal expansion curve (Figure 4.4B) and the increase of temperature obtained from thermal
analyses. In the subsequent simulation of mechanical deformations, the volume average of
thermal expansion was applied as a uniform thermal expansion strain, to the area of expandable
polymer underneath the operating heater for simplification. The injected volume of drug could
be then determined based on the deformed configuration of the entire device.
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In the thermal analyses, 8-node linear heat transfer elements were used, and the refined
meshes were adopted to ensure the accuracy. A volume heat source was applied within the
operating heater. The free surfaces of the device have natural convection with the surrounding
air. In the simulation of bare heater on the expandable polymer, the polymer was adhered to a
plastic case that was put on a large petri-dish, and therefore a constant temperature (equal to
room temperature) was applied to the bottom surface of plastic case. In the simulation of entire
operating device, the probe was inserted into a brain for interaction with neural tissues. In this
case, one side surface of device was in contact with the brain, and therefore should have a
constant temperature approximately equal to the body temperature. The material parameters
used in the simulations are summarized in Supplementary Table 1. The calculated temperature
distributions are shown in Figure 4.4E for the bare-heater system, which agrees reasonably well
with the corresponding experimental measurement.
In the mechanical analyses, 8-node 3D solid elements were used for all materials, with
refined meshes to ensure the accuracy. Since each reservoir is relatively far from each other,
only one reservoir was modeled in the mechanics analyses, as schematically shown in Figure
4.5A and B. The physical contact between the top surface of adhesive layer and the spherical
surface of reservior was taken into account during the thermal expansion.

The calculations

show that the deformation induced by thermal actuation is mainly accommodated by the
expandable layer, which is in agreement with the experiment results (Figure 4.4D). For a given
thermal expansion strain applied to the area of expandable polymer underneath the heater, the
injected proportion of drug was obtained in Figure 4.5C, which shows a saturation in the
injection for the thermal strain exceeding ~22%.
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Besides the thermal-mechanical simulations described above, a simplified computational
fluid dynamics model was adopted to estimate the cooling of heated drug in the channel, before
its reaction with neural tissues. Here, FLUID 142 element (in the software ANSYS) was used to
simulate the drug as a type of fluid flowed through the channel. For simplification, the straight
channel was assumed to be embedded in a cylindrical substrate that is sufficiently large. A
constant fluid temperature was adopted at the inlet of the channel, and the zero pressure
condition was set at the outlet. The free (i.e., outer) surface of the substrate have natural
convection with the surrounding air.

The fludic parameters include the density (1060 kg/m3),

the thermal conductivity (0.6 W/m/K), and the specific heat (4.184 kJ/kg/K). The calculations
show that the fluid temperature drops rapidly along the channel and the maximum temperature
increase at the outlet is less than 0.1 oC.
Table 4.2 The thermal and mechanical properties of various components in the
microfluidic drug device, where E denotes the modulus, " is the Poisson ratio, and # is the
density, cp is the specific heat and k is the thermal conductivity.

Component

" (kg/m3) cp (J/kg/K) k (W/m/K) E (MPa) #

Silicone adhesive

1050

1100

0.18

1

0.49

Expandable polymer

970

1460

0.24

3

0.48

COP

1020

1000

0.14

2600

0.35

Au heater

19280

129

318.00

78000

0.44
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Substrate (FR-4)

1200

1750

0.45

24000

0.13

Experimental subjects
Adult (25–35 g) male C57BL/6J and TH::IRES-Cre backcrossed to C57BL/6J mice were
group-housed, given access to food pellets and water ad libitum and maintained on a 12 h:12 h
light:dark cycle (lights on at 7:00 AM). All mice were held in a facility in the lab 1 week prior to
surgery, post-surgery and throughout the duration of the behavioral assays to minimize stress
from transportation and disruption from foot traffic. Adult (275-325g) male Lewis rats
(LEW/CRL) were purchased from Charles River and housed in a climate-controlled facility with
a 12:12-h light-dark cycle under standard conditions. All procedures were approved by the
Animal Care and Use Committee of Washington University and conformed to US National
Institutes of Health guidelines.
Viral Preparation
Plasmids

coding

pAAV-EF1a-DIO-EFYP

and

pAAV-EF1a-double

floxed-

hChR2(H134R)-EYFP-WPRE-HGHpA were obtained from Addgene (Addgene.org) originally
from the Deisseroth Laboratory at Stanford University. The DNA was amplified with a Maxiprep
kit (Promega) and packaged into AAV5 serotyped viruses by the WUSTL Hope Center Viral
Core. AAV5-PGK-Cre was acquired from the UNC Vector Core.

Table 4.3 Details on origin and titer of viral constructs used.
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Plasmid

Source

Packaged by

pAAV-EF1a-

Deisseroth

WUSTL

Hope AAV5

DIO-EFYP

Laboratory

Center

Viral

(Stanford)

Core

Deisseroth

WUSTL

Hope AAV5

Center

Viral

pAAV-EF1adouble

floxed- Laboratory

hChR2(H134R)-

(Stanford)

Serotype

Titer
5 x 10^12 vg/ml

2 x 10^13 vg/ml

Core

EYFP-WPREHGHpA
AAV5-PGK-Cre

UNC

Vector UNC

Core

Core

Vector AAV5

3.2

x

10^12

VM/mL

Stereotaxic Surgery
After the mice were acclimatized to the holding facility for seven to nine days, they were
anaesthetized in an induction chamber (4% Isolflurane) and placed in a stereotaxic frame (Kopf
Instruments, Model 1900) where they were maintained at 1-2% isoflurane. For the baseline
locomotor, anxiety, and inflammation assays, mice were implanted with the microfluidic device
into the dorsal striatum (stereotaxic coordinates from bregma (mm): anterior-posterior (AP):
+1.10, medial-lateral (ML): +/(1.50, dorsal-ventral (DV): (4.00). For the test of viral expression,
mice were implanted with the microfluidic device into the dorsal striatum (stereotaxic
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coordinates from bregma (mm): AP: +1.00, ML: +/(1.50, DV: (3.00). For the DAMGO-induced
rotation experiment, mice were implanted with the microfluidic device above the VTA
(stereotaxic coordinates from bregma (mm): AP:-3.10, ML: +/- 0.50, DV: -4.25). For the
optofluidics experiment, a craniotomy was performed and TH-Cre mice were injected with 1 !l
of AAV5-EF1a-ChR2(H134)-eYFP unilaterally into the VTA (stereotaxic coordinates from
bregma (mm): AP:-3.20, ML:+/(0.50, DV: (4.90). Five weeks later, mice were then implanted
with the optofluidic device adjacent to the NAcSh (stereotaxic coordinates from bregma: +1.30
AP, +/(0.20 ML, (4.80 mm DV). A standard electrode holder (KOPF 1770) was adapted to
implant the microfluidic and optofluidic devices. For biodissolvable samples, the device was
implanted at the desired target, ACSF was applied to the portion of the device that remained
outside of the skull to facilitate dissolution of the adhesive, and then the epoxy needle was
removed after a delay of 15 minutes. The implants were secured using two bone screws (CMA,
743102) and affixed with dental cement (Lang Dental). C57Bl6 mice were allowed to recover for
5 days prior to behavioral testing. Ai9 mice were allowed to recover three weeks following
surgery for viral expression. TH-Cre mice were allowed to recover one week following the final
surgery (for a total of six weeks to (permit optimal AAV expression and Cre recombinase
activity at VTA-NAc terminals). Post-surgery, all rats received subcutaneous injections of
buprenorphine hydrochloride (0.05 mg/kg, Reckitt Benckiser Healthcare Ltd., USA) for pain
management, and of ampicillin (50 mg/kg, Sage Pharmaceuticals, USA) to prevent infection at
the implantation site.

Immunohistochemistry
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Immunohistochemistry was performed as described (see Chapter 2) (Kim et al., 2013b)
Briefly, mice were anesthetized with pentobarbital and intracardially perfused with ice-cold 4%
paraformaldehyde in phosphate buffered saline (PBS). Brains were dissected, post-fixed for 24
hr at 4 ºC and cryoprotected with solution of 30% sucrose in 0.1M PB at 4ºC for at least 24 hr,
cut into 30 !m sections and processed for immunostaining. 30 !m brain sections were washed
three times in PBS and blocked in PBS containing 0.5% Triton X-100 and 5 % normal goat
serum. Sections were then incubated for ~16 hr at room temperature in rabbit anti c-fos antibody,
guinea pig anti-GFAP, rabbit anti-Iba1 and/or chicken anti-TH. Following incubation, sections
were washed three times in PBS and then incubated for 2 hr at room temperature in Alexa Fluor
488 goat anti-rabbit IgG, Alexa Fluor 594 goat anti-rabbit IgG, Alexa Fluor 633 goat antichicken, and/or goat anti-guinea pig Alexa Fluor 546, then washed three times in PBS, incubated
for 1 hr in Neurotrace 435/455 Blue Fluorescent Nissl stain (1:400), then washed three times in
PBS, and followed by three 1washes in PB and mounted on glass slides with HardSet
Vectashield (Vector Labs). All sections were imaged on both epifluorescent and confocal
microscopes. Gain and exposure time were constant throughout each experiment, and all image
groups were processed in parallel using Adobe Photoshop CS5 (Adobe Systems).

Table 4.4 Details on origin, species, and dilution of antibodies used.
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Antibody

Species

Dilution

Source

GFAP

Guinea Pig

1:500

Synaptic Systems

Iba1

Rabbit

1:300

Wako Chemicals

TH

Chicken

1:2000

Aves Labs

c-fos

Rabbit

1:1000

Santa Cruz

1:1000

Invitrogen

1:1000

Invitrogen

1:1000

Invitrogen

1:1000

Invitrogen

1:1000

Invitrogen

1:400

Life Technologies

Alexa Fluor 488 anti- Goat
rabbit IgG
Alexa Fluor 594 anti- Goat
rabbit IgG
Alexa Fluor 633 anti- Goat
chicken IgG
Alexa Fluor 546 anti- Goat
guinea pig IgG
Alexa Fluor 594 anti- Goat
chicken IgG
Neurotrace 435/455

N/A

Immuno-Glial Response in Implanted Tissues
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C57BL/6J mice (n=6) were implanted with microfluidic devices into the dorsal striatum
and allowed to recover for four weeks before perfusion. Immunohistochemistry was performed
as described.
c-fos Expression
TH-Cre animals expressing AAV5-EF1a-ChR2(H134)-eYFP unilaterally in the VTA and
implanted with optofluidic devices in the NAcSh were photostimulated at 10 Hz for 1 hour (see
Chapter 2) (Kim et al., 2013b), animals were perfused immediately following, and
immunohistochemistry was performed as above.
Rotarod Assay
An accelerating Rotarod (Ugo Basile, Comerio, Italy) was used as described previously
(Golden et al., 2013; Montana et al., 2009) to assess motor coordination C57Bl6 mice (cannulas
or microfluidic devices were implanted in the dorsal striatum as described, n= 5/group) received
two training sessions separated by 1 h. The first training session consisted of two trials of 120 s
spent walking on the Rotarod at a fixed speed of 4 rpm. The second training session consisted of
one trial of 120 s at 4 rpm. All mice completed the first training session without falling in five
attempts or less; all mice completed the second training session in two attempts or less without a
fall. One hour after the second training session, latency to fall as the Rotarod accelerated from 4
to 40 rpm over 5 min was assessed. Five consecutive acceleration trials were performed, with 10
min between each trial.
Spontaneous Running Assay
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C57Bl6 mice (cannulas or microfluidic devices were implanted in the dorsal striatum as
described, n=9-10/group) mice were habituated to locked low profile, wireless running wheels
(ENV-044, Med Associates) for one hour. Following this habituation the wheels were unlocked
and the animals were allowed to run freely for 2 hours. Revolutions of the wheel were counted as
the primary means of assessing spontaneous running.
Open Field Test
OFT testing was performed in a sound attenuated room maintained at 23ºC. Lighting was
measured and stabilized at 2000 lux, and performed in the afternoon between 13:00–1600 hrs.
The open field was a 50 x 50 cm square enclosure and was cleaned with 70% ethanol between
testing trials. For testing, C57Bl6 mice (cannulas or microfluidic devices were implanted in the
dorsal striatum as described, n=10/group) were placed in the center of the open field and allowed
to roam freely for 30 min. Movements were video recorded and analyzed using Ethovision. The
center was defined as a square comprised of 50% the total area of the OFT. Time in the center
expressed as percentages total time was the primary measure of anxiety-like behaviors.
Contraversive Rotation/Locomotor Testing Assay
C57Bl6 mice with microfluidic devices implanted above the VTA were placed in the
center of the same arena used for the OFT and allowed to roam freely for 1 hr. Wireless infusion
of vehicle or DAMGO was initiated and movements were video recorded and analyzed using
Ethovision. Rotations were defined as full 360º revolutions in the path of movement.
Real-Time Place Preference
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TH-CreVTA-NAc:ChR2 animals were placed in a custom-made unbiased, balanced twocompartment conditioning apparatus (52.5 x 25.5 x 25.5 cm) as described previously (Jennings et
al., 2013; Kim et al., 2013a; Stamatakis and Stuber, 2012; Stamatakis et al., 2013; Tan et al.,
2012). Mice were allowed to freely roam the entire apparatus for 20 min. Entry into one
compartment triggered photostimulation (8, 10 ms light pulses at 20 Hz every 5s) while the
animal remained in the light-paired chamber. Entry into the other chamber ended the
photostimulation. The following day SCH23390 (400 ng, Tocris) was administered 10 minutes
prior to the testing. Mice were counterbalanced so that ~50% received the SCH23390 on day 1,
there was no difference between animals that received the drug on day 1 or day 2. The side
paired with photostimulation was counterbalanced across mice and across sessions. Time spent
in each chamber and total distance traveled for the entire 20-minute trial was measured using
Ethovision 8.5 (Noldus Information Technologies, Leesburg, VA). The triggered wireless
photostimulation was elicited using a Noldus I/O Box coupled to an Arduino microcontroller that
controlled the output of the of IR remote control.
Data Analysis/Statistics
Data are expressed as means ± SEM. Data were normally distributed, and differences
between groups were determined using independent t-tests or one-way ANOVA followed by
post hoc Bonferroni comparisons if the main effect was significant at p < 0.05. Paired t-tests
were used in within subject design experiments. Statistical analyses were conducted using Prism
5.0 (GraphPad).
Genotyping of Mouse Lines
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DNA was isolated from tail tissue obtained from weanling mice (21-28 days of age), and
PCR screening was performed using the following primers: Cre recombinase (forward: 5’- GCA
TTA CCG GTC GAT GCA ACG AGT GAT GAG-3’ and reverse: 5’- GAG TGA ACG AAC
CTG GTC GAA ATC AGT GCG-3’) yielding a 400-bp PCR product in Cre positive animals.
Fatty acid-binding protein intestinal primers (forward: 5’- TGG ACA GGA CTG GAC CTC
TGC TTT CCT AGA-3’ and reverse: 5’- TAG AGC TTT GCC ACA TCA CAG GTC ATT
CAG-3’) were used as positive controls and yield a 200-bp PCR product.
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SUMMARY
The locus coeruleus noradrenergic (LC-NE) system is one of the first systems engaged
following a stressful event. While numerous groups have demonstrated that LC-NE neurons are
activated by many different stressors, the underlying neural circuitry and the role of this activity
in generating stress-induced anxiety has not been elucidated. Using a combination of in vivo
chemogenetics, optogenetics, and retrograde tracing we determine that increased tonic activity of
the LC-NE system is necessary and sufficient for stress-induced anxiety and aversion. Selective
inhibition of LC-NE neurons during stress prevents subsequent anxiety-like behavior.
Exogenously increasing tonic, but not phasic, activity of LC-NE neurons is alone sufficient for
anxiety-like and aversive behavior. Furthermore, endogenous corticotropin releasing hormone+
(CRH+) LC inputs from the amygdala increase tonic LC activity, inducing anxiety-like
behaviors. These studies position the LC-NE system as a critical mediator of acute stress-induced
anxiety and offer a potential intervention for preventing stress-related affective disorders.
INTRODUCTION
Anxiety is a complex set of behavioral and physiological responses that can be both
beneficial and detrimental to an individual. In stressful conditions, acute anxiety helps to
maintain the arousal and vigilance required to sustain attention, accomplish necessary tasks, and
avoid repeated exposures to dangerous conditions (Gross and Hen, 2004). Recent basic
neuroscience has elucidated circuits in the extended amygdala that are either natively anxiogenic
or anxiolytic, building a circuit-based pathology that may yield more selective therapeutic
approaches (Felix-Ortiz et al., 2013; Jennings et al., 2013; Kheirbek et al., 2013; Kim et al.,
2013a; Tye et al., 2011). However, the extended amygdala does not act alone in its control over
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anxiogenesis, as elegant recent work reveals parallel systems for anxiety in the
septohypothalamic circuitry related to persistent, stress-induced anxiety (Anthony et al., 2014;
Heydendael et al., 2014). Additionally, the great majority of these studies propose mechanisms
mediated by the fast-acting, small molecule neurotransmitters, GABA and glutamate. However,
clinically, we know that neuromodulators such as norepinephrine and various neuropeptides play
pivotal roles in long-term outcomes following stress exposure (Raskind et al., 2003, 2007, 2013).
Here we propose a separate neuromodulatory system underlying immediate, acute stress-induced
anxiety, which serves to alter risk aversion behavior immediately following a stressful event.
The locus coeruleus-noradrenergic system (LC-NE) is a small, tightly packed pontine
brain region that sends numerous projections to the forebrain and spinal cord. The LC-NE
system is involved in a broad number of physiological functions including arousal, memory,
cognition, pain processing, behavioral flexibility, and stress reactivity (Berridge and Waterhouse,
2003; Carter et al., 2010; Hickey et al., 2014; Snyder et al., 2012; Tervo et al., 2014; Valentino
and Van Bockstaele, 2008; Vazey and Aston-Jones, 2014).. Numerous environmental stressors,
including social and predator stress, activate the LC-NE system (Bingham et al., 2011; Cassens
et al., 1981; Curtis et al., 1997, 2012; Francis et al., 1999; Lechner et al., 1997; Reyes et al.,
2008; Valentino and Van Bockstaele, 2008; Valentino et al., 1991). Thus, the LC system is
thought to comprise a major component of the centrally mediated components of the classical
fight-or-flight response The response of the LC-NE systems to stress is particularly important in
the context of stress-induced human neuropsychiatric disorders such as posttraumatic stress
disorder (PTSD) where both basic and clinical research have revealed noradrenergic antagonism
to be a very promising therapeutic target (Olson et al., 2011; Raskind et al., 2003, 2007, 2013).
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Noradrenergic neurons within the LC-NE system exhibit three distinct activation profiles: low
tonic, high tonic, and phasic activity. It has been proposed that these neurons function differently
to determine behavioral flexibility to various environmental challenges. Low tonic LC discharge
(1-2 Hz) is thought to be consistent with an awake state (Aston-Jones and Bloom, 1981a; Bloom,
1981; Carter et al., 2010, 2012) whereas phasic burst activity results from distinct sensory stimuli
such as flashes of light, auditory tones, and brief touch (Aston-Jones and Bloom, 1981b; Foote
et al., 1980; Rasmussen et al., 1986). Stressful events and stimuli shift LC activity towards a high
tonic mode of firing (3-8 Hz) and stress-related neuropeptide release, such as corticotropinreleasing hormone (CRH) is thought to drive the high tonic state while simultaneously
decreasing phasic firing events (Curtis et al., 1997, 2001, 2012; Jedema and Grace, 2004; Page
and Abercrombie, 1999; Reyes et al., 2008; Snyder et al., 2012; Valentino and Foote, 1988). We
were particularly interested in examining the role of this high tonic activity of LC-NE neurons
during stress and defining the endogenous substrates that drive this increased LC-NE activity.
While phasic modulation of the LC is thought to be mediated by fast, small molecule
neurotransmission, neuropeptide transmission is thought to control tonic LC-NE activity.
Anatomical evidence suggests that neuropeptidergic inputs to the LC from the central nucleus of
the amygdala (CeA), including those containing CRH, may become activated in response to
stressors (Reyes et al., 2008; Valentino et al., 1992). Anatomical data support this notion using
tract tracing studies and electron microscopy to suggest that CRH-containing amygdalar
monosynaptic projections from the CeA terminate in the LC (Reyes et al., 2008). Given the
importance of CRH in stress-induced behavioral responses such as dysphoria, anxiety, and
aversion (Bruchas et al., 2009; Dunn et al., 2004; Francis et al., 1999; Gafford et al., 2012;
Heinrichs et al., 1994; Koob, 1999; Land et al., 2008), these projections are situated to
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significantly impact LC neuronal activity, yet the functional consequences of these inputs remain
unresolved.
Here we dissect the locus coeruleus circuitry in the context of stress-induced negative
affective behavior. In particular, we use chemogenetics and optogenetics to focus on the role of
neural activity of locus coeruleus noradrenergic (LC-NE) neurons in generating these behaviors.
We find that LC-NE neurons have increased activity during stress and that blocking this elevated
activity suppresses acute stress-induced anxiety. Furthermore, optogenetic activation and release
of endogenous amygdalar CRH into the LC promotes anxiety-like and aversive behavior. We
conclusively show that LC and its afferent circuitry are critical for encoding and producing
stress-induced anxiety.
Results
Selective inhibition of LC-NE neurons during stress suppresses subsequent anxiety
Numerous groups have reported that tonic activity of LC-NE neurons increases in
response to stress (Bingham et al., 2011; Cassens et al., 1981; Curtis et al., 1997, 2012; Francis et
al., 1999; Lechner et al., 1997; Reyes et al., 2008; Valentino and Van Bockstaele, 2008;
Valentino et al., 1991), but it has previously been untenable to selectively inhibit the activity of
only these NE neurons and assess their role in stress-induced behaviors. To examine the role of
LC-NE neurons in stress-induced anxiety-like behavior in mice, we implemented a restraint
stress paradigm (Chmielarz et al., 2013; Schaefer et al., 2000; Sim et al., 2013), which was
immediately followed by anxiety testing in the open field test (OFT) (Figure 5.1A). Following
30 minutes of restraint stress, wild-type (C57BL/6J) mice produce a robust stress-induced
anxiety phenotype and have increased immediate early gene (cfos) expression, consistent with
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increased activity of these neurons (Figure 5.1B-D, Figure 5.2A & B). To determine whether
this increase in activity is necessary for the resultant anxiety-like behavior, we selectively
targeted the inhibitory designer receptor exclusively activated by designer drug (Gai-coupled;
hM4Di DREADD (Armbruster et al., 2007) to LC-NE neurons by injecting a Cre-dependent
AAV into the LC of tyrosine hydroxylase-IRES-Cre mice (Th-Cre) (Figure 5.1E). When the
receptor is activated with its ligand, Clozapine-n-oxide (CNO; 10 mg/kg (Li et al., 2013; Mahler
et al., 2014; Penzo et al., 2015; Vazey and Aston-Jones, 2014)) prior to stress, there is a robust
and significant decrease in stress-induced c-fos+ LC-NE neurons indicating the selective hM4Di
DREADD approach is effective at reducing LC-NE neuronal activity (Figure 5.1F) during stress
exposure.
Next, we used the Cre-dependent, AAV-hM4Di DREADD approach to test whether
inhibition of LC-NE neurons during restraint stress can prevent subsequent stress-induced
anxiety in the OFT (Figure 5.1G). Stressed control animals that do not express the Credependent hM4di (Th-CreLC:hM4Di-) show a significant stress-induced anxiety-like behavior
compared to unstressed animals regardless of Cre-dependent hM4Di expression (Th-Cre LC:hM4Diand Th-Cre LC:hM4Di+) seen in both time spent in the center and entries into the center of the OFT
(Figure 5.1H & I). Stressed Th-Cre

LC:hM4Di+

animals, however, did not exhibit anxiety-like

behavioral responses and instead have behavior similar to and not statistically different from
both non-stressed Th-Cr LC:hM4Di+ and Th-Cre LC:hM4Di- mice that did not experience the stressor
(Figure 5.1H & I). Interestingly, hM4Di DREADD-mediated inhibition of LC-NE neurons prior
to stress did not alter stress induced fecal output suggesting that the inhibition of LC-NE neurons
suppresses acute stress-induced behavioral anxiety, but leaves other physiological responses
intact (Figure 5.1J) (Bruchas et al., 2009; Konturek et al., 2011; Larauche et al., 2009).
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Importantly, the hM4i DREADD manipulation has no effect on baseline anxiety levels (Figure
5.1H, I, L) and none of the manipulations affected gross locomotor activity in the OFT (Figure
5.1K). These findings suggest that stress-induced increases in LC-NE activity are required to
produce an acute stress-induced anxiety state.
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Figure 5.1 Selective inhibition of LC-NE neurons prevents stress-induced anxiety. (A)
Cartoon of experimental paradigm for restraint stress-induced anxiety. (B) Stressed animals
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Figure 7!

spend significantly less time exploring the center of the OFT than non-stressed controls (Data
represented as mean ± SEM, n=7-8/group: Student’s t-test, p<0.001). (C and D) Representative
immunohistochemistry and quantification show restraint stress increases c-fos immunoreactivity
in LC neurons (Red=c-fos, green=tyrosine hydroxylase, arrows indicate example co-localization,
scale bars= 100 µm; data represented as mean ± SEM, n=3 slices from 3 animals/group:
Student’s t-test, p<0.0001). See locomotor activity data in Fig. S1. (E) Cartoon depicting viral
strategy. (F and G) Representative immunohistochemistry and quantification show hM4Di
inhibition of LC neurons decreases c-fos immunoreactivity in LC neurons (Red=c-fos,
green=tyrosine hydroxylase, Scale bars= 100 µm; data represented as mean ± SEM, n=3 slices
from 3 animals/group: One-Way ANOVA, Bonferroni post-hoc, No stress/Cre- vs. No
stress/Cre+ **p<0.01, No stress/Cre- vs. Stress/Cre- ****p<0.0001, No stress/Cre- vs. Stress/Cre+
****p<0.0001, No stress/Cre+ vs. Stress/Cre- ****p<0.0001, No stress/Cre+ vs. Stress/Cre+, not
significant). (G) Cartoon of experimental paradigm for LC-NE inhibition during restraint stressinduced anxiety. (H and I) Inhibition of LC-NE neurons during stress blocks stress-induced
anxiety. Data represented as mean ± SEM, n=8-13/group: One-Way ANOVA, Newman-Keuls
post-hoc, No stress/Cre- vs. No stress/Cre+, not significant, No stress/Cre- vs. Stress/Cre**p<0.01, No stress/Cre- vs. Stress/Cre+, not significant, No stress/Cre+ vs. Stress/Cre- **p<0.01,
No stress/Cre+ vs. Stress/Cre+, not significant). (J) Inhibition of LC-NE neurons has no effect on
stress-induced bowel motility. Data represented as mean ± SEM, n= n=8-13/group: One-Way
ANOVA, Newman-Keuls post-hoc, No stress/Cre- vs. No stress/Cre+, not significant, No
stress/Cre- vs. Stress/Cre- *p<0.05, No stress/Cre- vs. Stress/Cre+ *p<0.05, No stress/Cre+ vs.
Stress/Cre-, not significant, No stress/Cre+ vs. Stress/Cre+, not significant). (K) Inhibition of LC-
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NE neurons has no effect on gross locomotor activity. Data represented as mean ± SEM. (L)
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Figure 5.2 Restraint stress does not alter total locomotor activity in the OFT. Related data
to Figure 5.1A-D (A) Restraint stress manipulation does not alter locomotor activity in the OFT.
Data represented as mean ± SEM, n=7-8/group. (B) Representative heat maps of activity during
OFT.
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Optogenetic entrainment of high tonic LC-NE activity
LC-NE neurons are reported to respond vigorously to stress with a robust increase in
tonic firing rate (Valentino and Van Bockstaele, 2008). While this physiological response has
been observed by many groups in variety of species the precise behavioral output of such an
increase has been previously inaccessible. We selectively targeted channelrhodopsin-2
(ChR2(H134)-eYFP) to LC-NE neurons of Th-Cre mice (Th-CreLC:ChR2) and observed restricted
eYFP labeling to the membranes of noradrenergic neurons of the LC (Figure 5.3A-C). Slice
recordings show that this targeting is sufficient to generate an inward photocurrent and
physiologically normal action potentials in response to 470 nm blue light (Figure 5.3D & E). To
determine whether this optogenetic strategy could be used to exogenously elevate the tonic firing
of LC-NE neurons in a sustained fashion, we performed slice physiology experiments which
demonstrated that LC-NE neurons can fire photostimulated-action potentials at 5 Hz for as long
as 30 minutes (Figure 5.3F). Furthermore, in in vivo extracellular recordings using a fiber opticcoupled multielectrode array (Sparta et al., 2011), we found that 5 Hz photostimulation produced
responses similar to that evoked by stress (Bingham et al., 2011; Curtis et al., 2012) (Figure
5.3G & H). Interestingly, putative LC neurons that did not appear to be directly photosensitive
(>10 ms spike latency) still show increased firing over time, perhaps due to well-known, tightly
coupled nature of neurons in this structure (Alvarez et al., 2002; Ballantyne et al., 2004) (Figure
5.3I). Furthermore, indirect response of these neurons to photostimulation is highly correlated
(r=0.89, p< 0.0001) to their baseline firing suggesting that some LC neurons are potentially more
intrinsically excited by broader LC activity (Figure 5.3J). These findings indicate that
optogenetic manipulation of LC-NE neurons can be used to sustain tonic firing of LC-NE that
mimics their response to stress.
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Figure 5.3 Optogenetic targeting to selectively increase tonic LC-NE activity. (A) Cartoon of
viral strategy for slice experiments. (B and C) Representative immunohistochemistry show
selective targeting of ChR2-eYFP to TH+ LC neurons (Red= tyrosine hydroxylase, green=ChR2eYFP, 4V = 4th ventricle, Scale bars= 100 and 50 µm, respectively). (D and E) Whole cell
current and voltage-clamp recordings of an LC-NE neuron expressing ChR2. D, scale bar is 200
pA x 100 ms and E, scale is 20 ms. (F) Slice recording of a single LC-NE neuron demonstrating
action potentials over 30 min in response to 5 Hz 470 nm light pulses. (G) Cartoon of viral and
multielectrode delivery for anesthetized, in vivo recordings. (H) Peristimulus time histogram
(PSTH) showing increased LC neuron firing during a 20 s optical stimulation at 5 Hz. (I) Firing
rate of n=16 cells before and during 5 Hz photostimulation (Paired Student’s t-test, p<0.01). (J)
Correlation of baseline activity to activity during photostimulation (r=0.8938, p<0.0001).
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Increased LC-NE tonic neuronal firing is acutely anxiogenic
Using the same optogenetic strategy as above, we examined whether selectively increasing LCNE tonic firing is sufficient to mimic acute stress-induced anxiety-like behaviors. We
photostimulated (5 Hz, 10 ms pulse width, 473 nm) LC-NE neurons during two well-established
assays of anxiety-like behavior, OFT and elevated zero maze (EZM) (Choleris et al., 2001;
Shepherd et al., 1994) (Figure 5.4A & B). In the OFT, photostimulated Th-CreLC:ChR2 mice spent
significantly less time exploring the center of the arena than did fluorophore expressing controls
(Th-CreLC:eYFP) (Figure 5.4C & D, Figure 5.5A & B). Importantly, 5 Hz photostimulation does
not affect total locomotor activity (Figure 5.4E, Figure 5.5C), suggesting 5Hz LC-NE tonic
activity selectively drives anxiety-like behavior. Furthermore, 5 Hz photostimulation in the EZM
also induced anxiety-like behavior in Th-CreLC:ChR2 animals compared to Th-CreLC:eYFP controls.
In the EZM, Th-CreLC:ChR2 spent less time in and entered the exposed areas of the EZM
significantly less than Th-CreLC-eYFP controls (Figure 5.4F-H). These experiments demonstrate
that increasing the tonic firing rate of LC-NE neurons in the absence of a physical stressor is
sufficient to produce robust anxiety-like behavior.
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Figure 5.4 High tonic LC-NE neuronal activity is sufficient to induce anxiety-like behavior.
(A) Cartoon of viral and fiber optic delivery strategy. (B) Calendar of behavioral studies. (C)
Representative heat maps of activity in the OFT. (D) 5 Hz photostimulation causes an anxietylike phenotype in OFT of Th-CreLC:ChR2 animals compared to Th-CreLC:eYFP controls (Data
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LC-NE tonic activity drives a frequency-dependent aversion
Following the observation that increased tonic activity of LC-NE neurons alone is
capable of driving anxiety-like behaviors; we next sought to determine whether this activity
produced place aversion in the animals. First we performed slice electrophysiology experiments
that demonstrated dynamic control of LC-NE firing at increasing frequencies while maintaining
spike fidelity (Figure 5.6A). We next sought to determine acute behavioral valence in ThCreLC:ChR2 and Th-CreLC:eYFP mice at a range of photostimulation frequencies. To assess the
positive or negative valence of the photostimulation we employed a real-time place-testing
(RTPT) assay that triggers photostimulation upon the animal’s entry into a chamber void of
salient contextual stimuli (Figure 5.6B). This assay assesses native behavioral preference to
photostimulation; regimes with a negative valence will cause an aversion from and those with a
positive valence will drive a preference for the chamber paired with photostimulation (see
Chapter 4) (Jennings et al., 2013; Kim et al., 2013a; Stamatakis and Stuber, 2012; Stamatakis et
al., 2013; Tan et al., 2012). Without photostimulation and at low tonic firing rates similar to alert,
awake LC activity (1 and 2 Hz) (Aston-Jones and Bloom, 1981a; Bloom, 1981; Carter et al.,
2010, 2012) there was no observable shift in chamber preference compared to baseline or ThCreLC:eYFP control animals (Figure 5.6C). However, when we increased the frequency of
photostimulation to induce a higher tonic firing rate of LC-NE neurons (5 and 10 Hz), we
observed a significant frequency-dependent shift away from the photostimulation-paired
chamber (Figure 5.6C). These data suggest that acutely increasing tonic firing of LC-NE
neurons elicits a negative valence that is capable of biasing behavior to avoid the increased
neuronal activity. Again, as we found in the anxiety-like behavioral assays, there was no change
in gross locomotor activity during any of the frequencies tested (Figure 5.6D & E, Figure 5.7A
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& B). To determine whether this negative valence was specifically due to increased tonic
activity, we implemented the same RTPT assay using two different phasic photostimulation
regimes (3 or 10 (10 ms) pulses at 10 Hz upon entry and every 30 s the mouse remains in the
chamber). In the phasic photostimulation paradigm, we did not observe any negative or positive
valence associated with phasic burst activity (Figure 5.6F, Figure 5.7C & D) in either regime.
This finding is in line with the evidence that suggests phasic responses of LC-NE neurons are
elicited by salient stimuli rather than stressful events (Aston-Jones and Bloom, 1981b; Bouret et
al., 2012; Sara and Bouret, 2012).
While the RTPT assay provides clear evidence that increased tonic, but not phasic,
activity of LC-NE neurons is acutely aversive, it does not provide information as to whether this
activity is encoded and can be later retrieved to inform future behavior. A natural response to a
stressful experience would be to avoid the context in which the stress occurred (Knoll and
Carlezon, 2010; Ungless et al., 2010). To test whether increased tonic activity of LC neurons
produces a learned change in behavior, we employed a Pavlovian conditioned place aversion
(CPA) assay (Bruchas et al., 2009; Al-Hasani et al., 2013; Land et al., 2008, 2009). In this assay,
Th-CreLC:ChR2 and Th-CreLC:eYFP animals are exposed to two distinct visual contexts that have no
initial bias. During two conditioning days, animals do not receive any optical stimulation in one
context and receive high tonic stimulation (5 Hz, 10 ms pulse widths) in the other context
(Figure 5.6G). When allowed to freely explore both chambers following conditioning, the ThCreLC:ChR2 animals spent significantly less time in the chamber that was paired with high tonic
photostimulation (Figure 5.6H). In contrast, Th-CreLC:eYFP controls did not show a change in
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Figure 5.6 LC-NE photostimulation drives both real-time and learned aversions. (A)
Current clamp whole cell recording with spike fidelity at 2, 3, 5 and 8 Hz. (B) Cartoon of viral
and fiber optic delivery strategy and calendar of behavioral studies. (C) Frequency response of
RTPT and (D) locomotor activity at 0, 1, 2, 5, and 10 Hz. Data represented as mean ± SEM, n=67/group: Two-Way ANOVA, Bonferroni post-hoc, 5 Hz ChR2 vs. 5 Hz eYFP *p<0.05, 10 Hz
ChR2 vs. 10 Hz eYFP

***p<0.001. (E) Representative traces of behavior at different

frequencies. (F) Phasic stimulation does not drive aversion, n=6/group. (G) Time line and
cartoon of 5 Hz CPA experiment. (H) Mean preference (s) ± SEM, post-test minus pre-test (n=79; Student’s t-test, p<0.05). (I) No locomotor effect in either pre- or post-test. (J) Representative
traces of behavior in the pre- and post-test. See also Figure 5.7.
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behavior from their initial exploration and neither group showed altered locomotor activity
(Figure 5.6I & J, Figure 5.7E). These results suggest that the negative valence and anxiety-like
behaviors previously observed during high tonic photostimulation of LC-NE neurons are capable
of being learned and influencing future behavior; and suggest that, the high tonic state of LC-NE
firing can inform behavior to avoid repeated exposure to conditions associated with stress-like
conditions.
Photostimulation of galanin-containing LC-NE neurons is also sufficient to elicit aversion
In addition to the catalytic enzymes necessary for catecholamine production, a majority
of LC-NE neurons are also known to produce the neuropeptide galanin and galanin
immunoreactivity is widely used as an LC neuronal marker (Holets et al., 1988; Le Maître et al.,
2013; Melander et al., 1986). Therefore, to further corroborate the results we observed using ThCre mice, we also used mice expressing Cre recombinase under the promoter for Galanin (GalCre) (Gong et al., 2003, 2007; Wu et al., 2014). To validate and confirm loci of Galanin
expression we first crossed these mice to a Cre-conditional tdTomato reporter line developed by
the Allen Institute for Brain Science (Ai9) (Madisen et al., 2010). As predicted, we see dense,
localized expression in the LC as well as the hypothalamus and brainstem (Figure 5.7A & B).
We also observed some tdTomato+ cells in regions that do not have mRNA for galanin in the
adult mouse (cortex, hippocampus, thalamus, and amygdalar structures) (Lein et al., 2007). In
each of these regions we identify transient mRNA expression throughout development (Figure
5.9) which would be sufficient to cause the recombination event needed to chronically express
the reporter. However, this Cre driver remains a viable tool for selective targeting of the LC
(Figure 5.7C), as seen when we selectively targeted ChR2(H134)-eYFP to LC-NE neurons of
Gal-Cre mice (Gal-CreLC:ChR2) there was restricted eYFP labeling to the membranes of
218

noradrenergic neurons of the LC (Figure 5.7D, Figure 5.10). We found that eFYP expression
was selective for LC-NE neurons (100% of eYFP expressing LC neurons were positive for the
NE marker, dopamine beta hydroxylase (DBH+)). However, we found that only 61.48% of LCNE neurons expressed ChR2(H134)-eYFP in this model – significantly fewer than those targeted
using the Th-Cre line (Figure 5.7E, Figure 5.10). To test whether tonic photostimulation of this
subpopulation of galanin-containing, LC-NE neurons also produces aversion, the Gal-CreLC:ChR2
animals were tested in RTPT with and without photostimulation at 5 Hz. In these experiments,
we found that increased tonic LC-NE stimulation in Gal-CreLC:ChR2 animals produced significant
avoidance behavior, consistent with the behavior we observed under the same conditions in the
Th-CreLC-ChR2 mice (Figure 5.7F & G). Using multiple, distinct in vivo LC-NE targeting
strategies, these experiments further corroborate our findings that high tonic stimulation of LCNE neurons drives an aversive behavioral response and further suggest that increased activity of
the entire population of LC neurons may not be necessary to elicit aversive behavior.
CRH+ neurons from the central amygdala send dense projections to the LC
Following multiple observations that exogenously increasing tonic firing of LC-NE
neurons is sufficient to drive anxiety-like and aversion behaviors in the absence of stress, we
sought to determine the endogenous substrate for such a change in firing. Previously, CRH has
been suggested as a potential mechanism for stress-induced increases in LC activity (Curtis et al.,
1997, 2001, 2012; Jedema and Grace, 2004; Page and Abercrombie, 1999; Reyes et al., 2008;
Snyder et al., 2012; Valentino and Foote, 1988). Consistent with these studies, we found that
systemic antagonism (Antalarmin HCl, 10 mg/kg, i.p.) of endogenous CRH action on CRHR1
receptors is sufficient to prevent stress-induced anxiety (Figure 5.11A-D) (Gafford et al., 2012;
Heinrichs et al., 1994). We next sought to determine whether the action of CRH locally within
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Figure 5.8 Galanin containing LC-NE neurons are sufficient to drive place aversion. (A and
B) Galanin labeling in Gal-Cre x Ai9-tdTomato compared to in situ images from the Allen
Institute for Brain Science in a sagittal section highlighting presence of galanin in the LC. All
images show tdTomato (red) and Nissl (blue) staining. See also Figure 5.9. (C) Cartoon of viral
and fiber optic delivery strategy for Gal-Cre experiment. (D) Image of ChR2-eYFP targeting to
DBH+ LC neurons. Scale bar=100 !m. (E) Quantification of Cre-dependent eYFP viral
expression in the LC of Th-Cre and Gal-Cre mouse lines. Data represented as mean ± SEM, n=3
slices from 3 animals/group: Student’s t-test, p<0.0001. See also Figure 5.10. (F) 5 Hz
stimulation ofLC-Gal neurons drives aversion (n=6, Paired Student’s t-test, p<0.01). (G)
Representative traces of behavior at different frequencies.
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Figure 5.8A & B. (A) Images show Cre-dependent reporter expression in adultAi9 X

Gal-Cre mice (left panel), in situ hybridization for Gal in adult WT

mice from the

Allen Institute (middle panel), and in situ hybridization for Gal in P14 WT mice from
the Allen Institute (right panel) for the (A) locus coeruleus,

(B) hippocampus, (C)

anteroventral thalamus, and (D) basolateral and basomedial amygdala. We did observe
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any regions that contain Cre-dependent reporter expression that were not positive for Gal
mRNA at some stage in development or in the adult animal.
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ChR2--eYFP

the LC is responsible for CRH-dependent anxiety-like behavior. To do so, we utilized two
retrograde tracing approaches to examine the potential sources of CRH input into the LC. First,
we injected the tracer Fluorogold into the LC of wild-type mice (Figure 5.11E\). Consistent with
previous studies, this non-selective retrograde tracing approach revealed known inputs into the
LC from the cortex, hypothalamus, and central amygdala - a known input and source of
extrahypothalamic CRH (Bouret et al., 2003; Dimitrov et al., 2013; Reyes et al., 2008, 2011)
(Figure 5.11F, Figure 5.12). We next used a dual injection strategy to anatomically isolate LCprojecting, CRH+ neurons. To do so, we used mice expressing Cre under the promoter for CRH
(Crh-Cre) mice (Taniguchi et al., 2011). We simultaneously injected a red-labeled retrograde
tracer, Cholera Toxin Subunit B (CTB-594) (Conte et al., 2009), to the LC and the green-labeled
AAV5-DIO-Ef1"-ChR2(H134)-eYFP to the CeA of these mice (Crh-CreCeA:ChR2; Figure
5.11G). From this approach we visualized Crh+ neurons in the CeA project to the LC by
observing significant colocalization of both fluorophores in single CeA neurons, indicating that
these neurons project to the LC (Figure 5.11H & I). Finally, to examine CRH+ terminal
innervation of the LC, we only injected the Cre-dependent reporter AAV5-DIO-Ef1"-eYFP in
the CeA of Crh-Cre mice (Figure 5.11J). We clearly observed projections from the CeA to the
LC in both transverse and coronal sections (Figure 5.11K-M). These anatomical studies identify
a discrete projection of Crh+ neurons from the CeA to the LC that could act to provide the
hypothesized CRH-induced increase in tonic LC activity.
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Figure 5.11 Identifying a CRH+ CeA input to the LC. (A) Calendar of pharmacological
experiment. (B) CRF-R1 antagonism blocks stress-induced anxiety-like behavior (C) with no
significant effect on locomotor activity (n=6-8/group, Student’s t-test, *p<0.05). (D)
Representative heat maps show behavior in the OFT, hotter colors indicate more time spent in a
position. (E) Cartoon depicting fluorgold tracing strategy. (F) Representative image shows
robust retrograde labeling of the CeA (Fluorgold pseudocolored red, Nissl=grey). See also F
Figure 5.12 (G) Cartoon depicting dual injection tracing strategy for CTB-594 and DIO-ChR2eYFP. (H) Representative image shows retrograde labeling in CeA of CTB-594 (red) and
anterograde labeling of CRH+ cells (green). Arrow indicates example co-localization. (I) ~25%
of each label co-labels with the other. (J) Cartoon depicting anterograde tracing strategy. (K) 71º
off of sagittal, transverse slice of Crh-Cre mouse expressing DIO-eYFP in the CeA. Image
shows intact projections from CeA to LC. Arrow indicates fiber optic placement. (L and M)
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Coronal images depict robust eYFP labeling in the CeA and LC of the same mouse. All scale
bars are 100 !m. + is in 4th ventricle.
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paraventricular nucleus of the hypothalamus (PVN), (D) auditory cortex (Aud Ctx),
and (E) frontal association (FrA) and prelimbic cortex (PrL Ctx) paraventricular nucleus
of the hypothalamus. In all images, fluorogold is psuedocolored red and Nissl is
in grey. All scale bars are 100 µm.
Photoactivation of CRH+ terminals in the LC causes increased tonic firing of LC neurons
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After identifying the CRH+ projection from the CeA to the LC, we sought to determine
the effects of stimulating these terminals locally within the LC. In Crh-CreCeA-LC:ChR2 mice, we
implanted multi-electrode arrays coupled to fiber optics into the LC and recorded LC activity
before, during, and after photostimulation (Figure 5.13A). The CeA has been reported to
spontaneously fire from 2-20 Hz (Ciocchi et al., 2010; Veinante and Freund-Mercier, 1998), so
we used a 10 Hz photostimulation paradigm to maintain a physiologically-relevant frequency at
the terminals. In recordings of 35 putative LC neurons from 5 different animals, we found a
heterogeneous population of responses including increased firing in a significant proportion of
cells (42.8% of observed putative LC units) (Figure 5.13B-F, Figure 5.14A). While the overall
sample of neurons significantly increased firing (Figure 5.13E & F), we did observe a subset
that decreased firing rate during photostimulation (Figure 5.13H). In cases where the firing rate
increased the mean latency to increase was 344.6 ms, suggesting a neuromodulatory influence of
the photostimulation (Figure 5.13F & G). Likewise, in cases where the firing rate decreased the
mean latency to decrease was 360.0 ms (Figure 5.13H & I). Similarly to what we observed with
direct LC-NE photostimulation (Figure 5.3J), we also observed that the increasing firing rates to
Crh-CreCeA-LC:ChR2 photostimulation, are correlated (r=.70, p< 0.0001) to the baseline state of
each neuron, again indicating that some LC neurons are innately more excitable by this
projection than others. (Figure 5.13J). Importantly, the observed increase in firing following this
selective photostimulation approach is consistent with other reports following either stress or
exogenous application of CRH (Curtis et al., 1997; Jedema and Grace, 2004; Page and
Abercrombie, 1999).
Stimulation of CRH+ CeA terminals in the LC is aversive and anxiogenic
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After identifying the CeA terminals to the LC as a projecting source of CRH+ LC inputs,
which are capable of increasing tonic activity, we next sought to test whether stimulation of these
terminals would drive similar behavioral profiles to direct LC-NE stimulation or stress alone. In
these experiments we used Crh-CreCeA-LC:ChR2 and Crh-CreCeA-LC:eYFP animals with fiber optic
implants over the LC (Figure 5.13K). Using the same stimulation procedure we used during in
vivo recordings (10 Hz, 10 ms pulse width), we first observed that in the CPA assay (Figure
5.13K) photostimulation of CeA-LC CRH+ terminals conditions a place aversion in Crh-CreCeALC:ChR2

compared to Crh-CreCeA-LC:eYFP controls (Figure 5.13L & M). We next determined

whether this stimulation was sufficient to induce anxiety-like behaviors in the EZM (Figure
5.13N). In Crh-CreCeA-LC:ChR2 animals, acute photostimulation produced significant anxiety-like
behavior compared to Crh-CreCeA-LC:eYFP controls (Figure 5.13O, Figure 5.14B & C). This
anxiety-like behavior is similar to both direct LC-NE stimulation (Figure 5.3) or stress (Figure
5.1A-D and Figure 5.11A-D). Importantly, when we locally antagonize CRHR1 directly into
the LC prior to photostimatulation ("-helical CRF 1 !g, intra-LC) this effect is completely
reversed, suggesting that CRH release from CeA-LC terminals is the substrate responsible for the
photostimulation-induced anxiety-like behavior (Figure 5.13O, Figure 5.14B & C).
Furthermore, systemic antagonism of CRHR1 (Antalarmin HCl, 10 mg/kg, i.p.) prior to
photostimulation of Crh-CreCeA-LC:ChR2 animals also prevents the induced anxiety-like behavior
(Figure 5.13P). Taken together, these results suggest that the CRH+ projection from the CeA to
the LC carries both an aversive and anxiogenic component mediated through CRH+ activation of
CRHR1 in the LC. This is the first functional identification that CeA CRH projections to the LC
can

induce

the

negative

affective
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behaviors

associated

with

stress.
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Figure 5.13 CRH+ CeA-LC terminals increase LC activity and drive anxiety through
CRFR1 activation. (A) Cartoon of viral and multi-electrode array delivery for anesthetized, in
vivo recordings. (B and C) Representative PSTHs of putative LC neurons responding to 20s of
10 Hz, 10 ms pulse width photostimulation (473 nm, ~10 mW). (D) Representative principal
component analysis plot showing the first two principal components with clear clustering of
units. (E) Total recorded sample shows significant increase in firing rate to 10 Hz
photostimulation (n=35, Paired Student’s t-test, p<0.01). (F) n=15 units increase firing rate by
>10% during 10 Hz photostimulation (Paired Student’s t-test, p<0.01). (G) Response latency
following onset of photostimulation for cells that increase firing. (H) n=15 units decrease firing
rate by >10% during 10 Hz photostimulation (Paired Student’s t-test, p<0.01). See also Fig. S7A.
(I) Response latency following onset of photostimulation for cells that increase firing. (J)
Correlation of baseline activity to activity during photostimulation (r=0.7029, p<0.0001). (K)
Cartoon of viral and fiber optic delivery strategy and calendar of CPA behavior. (L and M) CrhCreCeA-LC:ChR2 show a significant CPA compared to Crh-CreCeA-LC:eYFP controls. Representative
traces of behavior in the pre- and post-test and mean preference (s) ± SEM, post-test minus pretest (n=10-12/group; Student’s t-test, p<0.05). (N) Cartoon of viral, cannula, and fiber optic
delivery strategy and calendar of EZM behavior. (O) 10 Hz photostimulation causes an anxietylike phenotype in EZM of Crh-CreCeA-LC:ChR2 animals compared to Crh-CreCeA-LC:eYFP controls,
which is reversed by intra-LC "-helical-CRF ("HCRF) pretreatment (Data represented as mean
± SEM, n=7/group: One-Way ANOVA, Newman-Keuls, Crh-CreCeA-LC:eYFP vs. Crh-CreCeALC:ChR2

*p<0.05, CreCeA-LC:eYFP vs. Crh-CreCeA-LC:ChR2+AHCRF **p<0.01, CreCeA-LC:ChR2 vs. Crh-

CreCeA-LC:ChR2+AHCRF ***p<0.001). See also Fig. S7B&C. (P) Systemic CRHR1 antagonism
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reverses photostimulation-induced anxiety-like behavior (n=6-8/group, Student’s t-test,
p<0.001). (Q) Model and summary of results. See also Fig. S7D.

Figure 5.14 CRH+ CeA-LC terminals increase LC activity and drive anxiety through
CRFR1 activation. Related data to Figure 5.13. (A) n=5 units that did not increase or decrease
firing by >10% during 10 Hz photostimulation. (B) Representative heat maps of activity in the
EZM. (C) Cannula and fiber optic placements for the EZM experiments with Crh-CreCeA-LC
animals. Animals were excluded if the fiber tip ended >1 mm dorsal of the LC or caused
significant lesion to the LC or 4th ventricle. Additionally, cannulated mice were excluded if the
final injection placement appeared to be >0.5mm from the LC. (D) Hypothetical model of
downstream LC-NE influence on anxiety-like behaviors. Anterograde tracing of eYFP+ fibers
from Th-CreLC-eYFP mice reveals dense innervation in the CeA, BLA, and LS (red=Nissl, green –
DIO-eYFP, scale bars =100 µm).
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DISCUSSION
The LC-NE system has long been implicated as a key mediator of the central stress
response (Koob, 1999). Observational electrophysiological studies across many species have
identified that LC-NE neurons respond vigorously to stress and behavioral pharmacology has
revealed a potential role for endogenous CRH in the generation of this response (Bingham et al.,
2011; Cassens et al., 1981; Curtis et al., 1997, 2012; Francis et al., 1999; Lechner et al., 1997;
Jedema and Grace, 2004; Page and Abercrombie, 1999; Reyes et al., 2008; Snyder et al., 2012;
Valentino et al., 1991; Valentino and Foote, 1988; Valentino and Van Bockstaele, 2008). The
current study, however, is the first to selectively manipulate LC-NE neurons in the context of
stress and its resulting anxiety-like behaviors. Here, we report that the activity of LC-NE neurons
is necessary to elicit acute stress-induced anxiety. Furthermore, selectively increasing the firing
of LC-NE neurons is itself anxiogenic in the absence of stress. This same high tonic state has
negative valence that can inform future behavior through learned association. Finally,
optogenetic stimulation of CRH+ CeA terminals into the LC replicates both the cellular profile
and acute anxiogenic and aversive behavioral state of direct LC-NE high tonic stimulation
(Figure 5.13Q).
LC activity during stress is necessary for acute stress-induced anxiety
While the observation of the LC response to stress has implicated the LC-NE system in
negative affect associated with stress, it is only now, using a chemogenetic approach, that we can
conclude that this activity is required for stress-induced anxiety. Many studies have indicated
that noradrenergic tone is important for processing stressful stimuli, encoding fearful events,
deciphering threatening versus non-threatening signals (Aston-Jones et al., 1999; Snyder et al.,
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2012). The finding that activity of LC-NE neurons is necessary to transmit this information and
produce stress-induced anxiety-like behavior extends our understanding of this system’s role in
the stress and the canonical “fight or flight” response. Interestingly, inhibition of the LC-NE
system without stress did not affect baseline anxiety levels, suggesting that less LC activity is not
necessarily anxiolytic. Furthermore, inhibiting LC-NE neurons during stress did not prevent
other physiological readouts of stress, such as fecal output. It will be interesting to dissect
whether other stress-induced behaviors such as analgesia (Bannister et al., 2009; Butler and Finn,
2009; Hickey et al., 2014) and reinstatement to drug seeking (Al-Hasani et al., 2013; Shaham et
al., 2000) require intact LC-NE activity during stress.
The chemogenetic inhibition approach used here is temporally restricted due to the
kinetics of CNO activity, and the neuromodulatory function of the DREADD receptors.
Therefore it is difficult to precisely hypothesize when it would be crucial to inhibit LC-NE
activity to prevent a stress-induced anxiety event. However, this initial study provides a clearer
picture of how LC-NE activity during stress alters subsequent behavior. Additionally, it is quite
possible that only a subset of LC-NE neurons are required for stress-induced anxiety and
previous studies have indicated that the dorsal-ventral axis of the LC can have diverse actions
(Hickey et al., 2014). Future studies will be necessary to elucidate whether the microanatomy
and local neural circuits within the LC play an important role in stress-induced anxiety.
High tonic LC-NE neuronal activity can initiate anxiety-like behavior
Several recent studies have used optogenetics to generate binary control of acute anxiety
(see Chapter 2) (Felix-Ortiz et al., 2013; Heydendael et al., 2014; Jennings et al., 2013; Kheirbek
et al., 2013; Kim et al., 2013a, 2013b; Sidor et al., 2015; Tye et al., 2011). The circuits of the
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extended amygdala and some of their projections into the mesolimbic dopamine system have
demonstrated rapid onset and offset of anxiety that is likely mediated by small-molecule
neurotransmission. Here, we demonstrate anxiety-like behavior generated by increasing the tonic
activity of the neuromodulatory LC-NE system. While this activity generates anxiety on a short
timescale (seconds to minutes), it is unlikely that the immediate (subsecond timescale) result of
high tonic activity is anxiety. Rather, it is plausible that the LC serves to integrate information
from numerous forebrain and sensory inputs and, over time, the persistent high tonic state feeds
forward onto previously established anxiety circuits. This integration of information may serve
to adjust the gain on these downstream systems to ultimately drive anxiety, an idea consistent
with previous hypotheses on LC function (Koob, 1999). The extended amygdala is a potential
candidate region where feed-forward, gain modulation could exist as there are reciprocal
connections between the LC and multiple divisions of the amygdala (Bouret et al., 2003;
Buffalari and Grace, 2007; Samuels and Szabadi, 2008) (Figure 5.14D). Importantly, this
hypothetical model of LC modulation of anxiety circuitry is likely an endogenous mechanism
given than the removal of the LC-NE system prevents stress-induced anxiety.
Furthermore, the LC is the primary source of norepinephrine for the mammalian
forebrain (Berridge and Waterhouse, 2003; Sara, 2009). It is unlikely that increased
noradrenergic tone throughout the brain and spinal cord is what mediates the transition to
anxiety-like behavior. Rather, we suspect that particular efferent LC-NE projections likely
mediate particular behavioral outcomes. For example, the LC projects into the basolateral
amygdala and the lateral septum, both of which have been demonstrated to play a key role in the
regulation of stress and anxiety-like behaviors (Anthony et al., 2014; Felix-Ortiz et al., 2013; Tye
et al., 2011) (Figure 5.14D). This circuit-based theory of LC function is a helpful framework
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towards understanding other LC functions such as attention, arousal, and as presented here,
aversion.
High tonic LC-NE activity has a negative valence that can inform future behavior
The same optogenetic manipulation that incites anxiety also elicits aversive behaviors in
both real-time and conditioned assays. These findings demonstrate that exogenously increasing
LC tonic activity carries a significant negative valence. Mimicking the neuronal response to
stress in these cells produces behavior similar to exposure to stressful stimuli. While previous
studies have identified that the LC has increased immediate early gene expression during various
forms of aversion (Sandner et al., 1993), this is the initial attempt to examine, in real-time,
whether increased LC-NE activity is sufficient for these behaviors. In fact, we observe that high
tonic stimulation of LC-NE neurons is aversive in both real-time and a Pavlovian conditioning
paradigm. While this negative valence aligns with the previously discussed anxiogenic results, it
elucidates three key components of the system. First, in the real-time aversion assay, the
observed aversion behavior is frequency-dependent. In other words, low tonic stimulation that is
similar to baseline awake LC activity (1-2 Hz) (Aston-Jones and Bloom, 1981a; Bloom, 1981;
Carter et al., 2010, 2012) does not provide negative valence signals to the animal, but higher
tonic states, similar to those evoked by stress (5-10 Hz) (Bingham et al., 2011; Cassens et al.,
1981; Curtis et al., 1997, 2012; Francis et al., 1999; Lechner et al., 1997; Reyes et al., 2008;
Valentino and Van Bockstaele, 2008; Valentino et al., 1991), drive aversion. Furthermore, phasic
paradigms mimicking the intrinsic phasic bursting activity of LC neurons (Aston-Jones and
Bloom, 1981b; Bouret et al., 2003, 2012; Tervo et al., 2014; Valentino and Foote, 1988), and
similar to paradigms used to evoke real-time behavior in other catecholaminergic systems (see
Chapters 2 & 4) (Adamantidis et al., 2011; Chaudhury et al., 2013; Kim et al., 2013b; Lammel et
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al., 2012; Stamatakis and Stuber, 2012; Tsai et al., 2009; Tye et al., 2013; Witten et al., 2011), do
not carry the same aversive signals to the animal. Finally, it appears that higher tonic frequencies
potentially produce anxiety through negative affect. While it is generally thought that anxiety
and aversion are both negative affective states, the two behavioral outputs are neurobiologically
distinct in numerous systems (Kim et al., 2013a; Land et al., 2008) and can each exist without
the other. In the case of the LC system, however, the observed anxiety-like behavior does seem
to be driven by the aversive nature of the stimulation.
Galaninergic locus coeruleus neurons are sufficient to drive aversion
Previous studies have identified galanin as a common neuropeptide co-transmitter in the
LC (Holets et al., 1988; Le Maître et al., 2013; Melander et al., 1986). This selective colocalization allows for a second means of genetically targeting LC neurons. While the Gal-Cre
experiments support the findings targeting LC-NE neurons in Th-Cre mice, they also importantly
show that a smaller subset of LC neurons can still maintain the same behavior. This observation
suggests possible heterogeneity within the LC. It is now possible to directly compare Gal+ and
Gal- neurons using a Cre-OFF and Cre-ON system to express optogenetic or chemogenetic
constructs in clearly segregated populations of LC neurons (Fenno et al., 2014; Saunders et al.,
2012). Future work using these and other intersectional targeting strategies will help further
dissect the role of this important structure in behavior.
The Gal-Cre experiments also point to a gap in our knowledge of the downstream
substrate beyond LC-NE neurons. As previously discussed, it seems likely the LC operates with
circuit-selectivity to mediate various behaviors, however, postsynaptic cellular mechanisms
allow for orders of magnitude of more complexity. With at least nine different adrenergic
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receptors and three different galanin receptors, that have nearly all been indicated in anxiety-like
behaviors (Brunner et al., 2014; Dixit et al., 2014; Hanke et al., 2012; Kuteeva et al., 2008; Le
Maître et al., 2013; Mantsch et al., 2010; Raskind et al., 2007; Wohleb et al., 2011), the
combined circuit- and cellular-level dynamics of this system will provide significant challenges
for the next series of studies.
CRH+ CeA-LC terminals increase activity and drive anxiety through CRFR1 activation
Anatomical studies first identified the projection from the CeA to the LC (Van
Bockstaele et al., 1996, 1998) and recent work has helped understand the molecular profile of
these projections suggesting that CeA-LC projections are potentially glutamatergic and carry the
neuropeptides dynorphin and CRH (Kravets et al., 2015; Reyes et al., 2008, 2011). Here, we
identify that CRH+ neurons represent a clear subset of LC-projecting neurons that aligns with
electron microscopy data from the terminal populations in the LC (Kravets et al., 2015; Reyes et
al., 2008, 2011). Importantly, CRH+ CeA neurons have been shown to be a part of the protein
kinase C d- subpopulation (Haubensak et al., 2010) of CeA neurons that have recently been
shown to be distinct from those CeA neurons involved in conditioned fear and have a possible
role in driving food consumption (Cai et al., 2014; Haubensak et al., 2010). This CRH+
projection into the LC has been of particular interest for the possibility that this is a source of
extrahypothalamic CRH that increases tonic LC firing during stress. Here, we see the overall
population of recorded LC neurons does increase tonic firing following photostimulation of
CRH+ CeA-LC terminals. Unsurprisingly, however, this increase in activity was not ubiquitous.
The diversity of observed responses likely represents an anatomical differentiation of LC
neurons. It is quite possible that non-responding neurons do not receive innervation from the
CeA and the difference in increased or decreased responses could be explained by a varied
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expression of cell-surface receptors on the postsynaptic neurons. While the literature is clear that
monosynaptic connections exist in this circuit (Kravets et al., 2015; Reyes et al., 2008, 2011),
none of our recorded cells suggest any fast-acting neurotransmission. While this could be due to
the potential for selection bias inherent in in vivo recordings (only firing neurons can be
observed) or an artifact of slower acting neuropeptide/G-protein coupled receptor-mediated
transmission, we cannot rule out the possibility of a polysynaptic mechanism. Future work to
extensively investigate local GABAergic influence and other LC microcircuits will be necessary
(Aston-Jones et al., 2004).
Importantly, however, spatially-isolated photostimulation of these terminals in the LC
recapitulates the aversion and anxiety-like behaviors observed with both stress and direct LC
photostimulation. Furthermore, the anxiety-like behavior can be prevented by local antagonism
of CRHR1 in the LC. This finding suggests that photostimulation-induced release of CRH
mediates these behaviors through action in the LC. In addition, the same behavior can be blocked
by systemic antagonism of CRHR1. This systemic approach has previously been shown to be
anxiogenic in the absence of stress (Heinrichs et al., 1994), but here, still in the absence of stress,
the pharmacological manipulation is anxiolytic – reversing the photostimulation-induced anxiety.
Understanding the place of the LC in broader brain networks related to anxiety is crucial
to understanding anxiogenesis and determining potential points for therapeutic intervention.
While recent focus has been on fast-acting small-molecule transmission (glutamate/GABA) in
the generation of anxiety states, the role of stress and neuromodulatory fight-or-flight systems
has yet to be fully vetted. Understanding how the vast efferent projection network of the LC
facilitates this anxiogenesis will be an important next step. While Anthony and colleagues
(Anthony et al., 2014), clearly demonstrate the role of Crfr2+ neurons of the lateral septum (LS)
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in prolonged stress-induced anxiety, future work will be needed to investigate whether the
known LC inputs into the LS acutely modulate this system and produce prolonged
anxiety (Antonopoulos et al., 2004; Berridge et al., 1996; Bondi et al., 2007; Risold and
Swanson, 1997). Additionally, the LC also has many known projections to other anxiogenic
centers such as the amygdala including the basolateral amygdala and reciprocal projections back
to the CeA which merit similar future investigation (Bouret et al., 2003; Buffalari and Grace,
2007; Samuels and Szabadi, 2008)( Figure 5.14D). Nevertheless, we report here that stressinduced increases in LC activity are both necessary and sufficient for anxiety-like behavior,
collectively affirming the LC-NE system as a critical mediator of the acute behavioral stress
response. Taken together, this study provides fundamental framework for understanding the
mammalian brain circuitry responsible for the innate anxiety response.
MATERIALS AND METHODS
Experimental subjects
Adult (25–35 g) male C57BL/6J, TH-IRES-Cre, Crh-IRES-Cre, and Gal-Cre (all
backcrossed to C57BL/6J mice for ~10 generations) were group-housed, given access to food
pellets and water ad libitum and maintained on a 12 h:12 h light:dark cycle (lights on at 7:00
AM). All animals were held in a sound attenuated holding room facility in the lab 1 week prior
to surgery, post-surgery and throughout the duration of the behavioral assays to minimize stress
from transportation and disruption from foot traffic.

All mice were handled and, where

appropriate, connected to fiber optics and/or headstages two times a day for one week prior to
experimental testing. All procedures were approved by the Animal Care and Use Committee of
Washington University and conformed to US National Institutes of Health guidelines.
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Viral preparation
Plasmids

coding

pAAV-EF1"-DIO-EFYP

and

pAAV-EF1"-double

floxed-

hChR2(H134R)-EYFP-WPRE-HGHpA, were obtained from Addgene (Addgene.org) originally
from the Deisseroth Laboratory at Stanford University. The DNA was amplified with a Maxiprep
kit (Promega) and packaged into AAV5 serotyped viruses by the WUSTL Hope Center Viral
Core. The final viral concentration was 2-5 x 1012 genome vg/mL for the adeno-associated
viruses. AAV5-EF1"-DIO-HM4Di-mCherry was purchased directly from the UNC Vector Core.
Table 5.1 Viral vectors used.
Plasmid

Source

Packaged by

pAAV-EF1"-

Deisseroth

WUSTL

Hope AAV5

DIO-EFYP

Laboratory

Center

Viral

(Stanford)

Core

Deisseroth

WUSTL

Hope AAV5

Center

Viral

pAAV-EF1"double

floxed- Laboratory

hChR2(H134R)- (Stanford)

Serotype

Titer
5 x 10^12 vg/ml

2 x 10^13 vg/ml

Core

EYFP-WPREHGHpA
AAV5-EF1"-

Roth Laboratory UNC

DIO-HM4Di-

(UNC)

Vector AAV5

Core

mCherry
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3x10^12 VM/mL

Stereotaxic surgery
After the animals were acclimated to the holding facility for seven to nine days, they
were anaesthetized in an induction chamber (4% Isolflurane) and placed in a stereotaxic frame
(Kopf Instruments, Model 1900) where they were maintained at 1-2% isoflurane. A craniotomy
was performed and mice were injected with 500 nl of AAV5-DIO-HM4Di, AAV5-DIO-ChR2 or
AAV5-DIO-eYFP, Fluorogold, or CTB-594 unilaterally into the LC (stereotaxic coordinates
from bregma: -5.45 anterior-posterior (AP), +/(1.25 medial-lateral (ML), (4.00 mm dorsalventral (DV)), or the CeA (-1.25 AP, +/- 2.75 ML, -4.75 DV). Mice were then implanted with
metal cannula (PlasticsOne; coordinates adjusted from viral injection 0.00 AP, +/- 0.25 ML,
+1.00 DV) or fiber optic implants (coordinates adjusted from viral injection 0.00 AP, +/- 0.25
ML, +1.00 DV)(Carter et al., 2010). Custom adapters (WUSTL Instrument Machine Shop) for
the Kopf cannula holder (Model 1966) were used to implant the fiber optics(Sparta et al., 2011).
The implants were secured using two bone screws (CMA, 743102) and affixed with dental
cement (Lang Dental). Mice were allowed to recover for 3-6 weeks prior to behavioral testing;
this interval also permitted optimal AAV expression and Cre recombinase activity.
Immunohistochemistry
Immunohistochemistry was performed as described (see Chapter 2) (Al-Hasani et al.,
2013; Kim et al., 2013b). Briefly, mice were anesthetized with pentobarbital and transcardially
perfused with ice-cold 4% paraformaldehyde in phosphate buffer (PB). Brains were dissected,
post-fixed for 24 hr at 4 ºC and cryoprotected with solution of 30% sucrose in 0.1M PB at 4ºC
for at least 24 hr, cut into 30 !m sections and processed for immunostaining. 30 !m brain
sections were washed three times in PBS and blocked in PBS containing 0.5% Triton X-100 and
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5% normal goat serum. Sections were then incubated for ~16 hr at room temperature in rabbit
anti c-fos antibody (1:500, Santa Cruz), rabbit anti-DBH (1:2000, Millipore) and/or chicken antiTH (1:2000, Aves Labs). Following incubation, sections were washed three times in PBS and
then incubated for 2 hr at room temperature in Alexa Fluor 488 goat anti-mouse IgG (1:500,
Invitrogen), Alexa Fluor 594 goat anti-rabbit IgG (1:500, Invitrogen), and/or goat anti-chicken
Alexa Fluor 633(1:500, Invitrogen) were then washed three times in PBS and followed by three
10-min rinses in PB and mounted on glass slides with Hardset Vectashield (Vector Labs) for
microscopy. All sections were imaged on both epifluorescent and confocal microscopes. Gain
and exposure time were constant throughout each experiment, and all image groups were
processed in parallel using Adobe Photoshop CS5 (Adobe Systems). IHC was quantified as
previously described (see Chapter 2) (Al-Hasani et al., 2013; Kim et al., 2013b). Briefly,
channels were separated, an exclusive threshold was set, and positive staining for each channel
was counted in a blind-to-treatment fashion using Metamorph. The counts from each channel
were then overlaid and percent of co-labeled cells were reported.
Antibody

Species

Dilution

Source

TH

Chicken

1:2000

Aves Labs

c-fos

Rabbit

1:500

Santa Cruz

DBH

Rabbit

1:2000

Millipore

1:500

Invitrogen

Alexa

Fluor

488 Goat

anti-mouse IgG
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Alexa

Fluor

594 Goat

1:500

Invitrogen

633 Goat

1:500

Invitrogen

594 Goat

1:500

Invitrogen

anti-rabbit IgG
Alexa

Fluor

anti-chicken IgG
Alexa

Fluor

anti-chicken IgG
Table 5.2 Antibodies used.
Anatomical tracing
For retrograde tracing experiments (Fluorogold and CTB-594), the tracer was injected
and the animal was allowed to recover for six days before perfusion. For anterograde viral
tracing, the virus was injected and the animal was allowed to recover for six weeks before
perfusion.
Stress-induced anxiety paradigm
Mice assigned to stress groups were restrained in 50 ml disposable conical tubes that
were adapted for this purpose by drilling holes to permit air circulation and for the tail to be
extended. For acute stress-induced anxiety-like behavior, mice were immobilized in the tube
once for 30 minutes. Immediately following stress, animals were transferred to the open field
(see below). Fecal boli were collected from both the tube and the open field. For the hM4Di
experiments, mice were injected with CNO (10 mg/kg, i.p., 30 min prior to exposure to the
restraint tube) (Armbruster et al., 2007; Li et al., 2013; Mahler et al., 2014; Penzo et al., 2015;
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Vazey and Aston-Jones, 2014). For the CRF antagonism experiment, mice were injected with
Antalarmin HCl (10 mg/kg, i.p., 30 min prior to exposure to the restraint tube).
Open Field Test (OFT)
OFT testing was performed in a square enclosure (50 x 50 cm) within a sound attenuated
room maintained at 23ºC. Lighting was measured and stabilized at ~25 lux. For stress-induced
experiments, we followed the above paradigm immediately prior to a 20 minute test. For
optogenetic experiments, we connected Th-CreLC:ChR2 or Th-CreLC:eYFP mice to fiber optic cables
and placed them in the center of the open field and allowed them to roam freely for 21 min.
Photostimulation alternated between off and on states in 3 min time segments, beginning with 3
min of no stimulation. For the photostimulated time segments, animals received 5 Hz (10 ms
width) photostimulation (~10 mW light power). The open field was cleaned with 70% ethanol
between each trial. Movements were video recorded and analyzed using Ethovision 8.5 (Noldus
Information Technologies, Leesburg, VA). The center was defined as a square comprised of 50%
the total area of the OFT. Time in the center was the primary measure of anxiety-like behaviors.
Slice preparation and solutions (experiments by performed by Chris Ford, PhD)
Following anesthesia, horizontal midbrain slices containing the LC (240 !m) were cut in
ice-cold sucrose cutting solution that contained (mM): 75 NaCl, 2.5 KCl, 6 MgCl2, 0.1 CaCl2,
1.2 NaH2PO4, 25 NaHC03, 2.5 D-glucose, 50 sucrose; bubbled with 95% O2/5% CO2. Slices
were incubated post-cutting at 35°C in oxygenated 95% O2/5% CO2 ACSF solution that
contained (mM): 126 NaCl, 2.5 KCl, 1.2 MgCl2, 2.5 CaCl2, 1.2 NaH2PO4, 21.4 NaHCO3, 11.1
D-glucose for 45 minutes before recording. During incubation, 10 !M MK-801 was included to
reduce excitotoxicity and increase slice viability. Following incubation, slices were placed in a
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recording chamber and constantly perfused with warm ACSF (34 ± 2°C) containing 100 !M
picrotoxin, 10 !M DNQX and 1 !M idazoxan at 2 ml/min. Neurons were visualized with a
BXWI51 microscope (Olympus) with infrared custom-built gradient contrast optics.
Slice electrophysiology (experiments by performed by Chris Ford, PhD)
Whole-cell current-clamp recordings were made as described (Courtney and Ford, 2014;
Ford et al., 2009) using an Axopatch 200B amplifier (Molecular Devices). Patch pipettes (1.5-2
M$) were pulled from borosilicate glass (World Precision Instruments). The intracellular pipette
solution contained 115 (mM): 115 K-methylsulphate, 20 NaCl, 1.5 MgCl2, 10 HEPES(K), 10
BAPTA-tetrapotassium, 1mg/ml ATP, 0.1 mg/ml GTP, and 1.5 mg/ml phosphocreatine (pH 7.4,
275 mOsm). Data were acquired using an ITC-18 interface (Instrutech) and Axograph X
(Axograph Scientific) at 10 KHz and filtered to 2KHz for voltage-clamp recordings. Widefield
activation of ChR2 was activated with collimated light from a LED (470 nm) through the 40x
water immersion objective.
In vivo electrophysiology
For light modulated responses, an array of 16 (35-µm tungsten wires, 150-µm spacing
between wires, 150-µm spacing between rows, Innovative Physiology) was epoxied to a fiber
optic and lowered into the LC of a lightly (<1% isoflurane) anesthetized, Th-CreLC:ChR2 (Figure
5.3) or Crh-CreCeA-LC:ChR2 animals (Figure 5.13). Two skull screws were arbitrarily placed
anterior to bregma on either side of the midline and used to ground the electrode array. In either
approach, voltage readings from each electrode were bandpass-filtered with activity between 250
and 8,000 Hz analyzed as spikes. LC cells were selected based on their stereotaxic position,
baseline activity, and response to a toe pinch. The signal was amplified and digitally converted
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using commercially available hardware and software (Omniplex and PlexControl, Plexon).
Spikes were sorted using principal component analysis and/or evaluation of t-distribution with
expectation maximization (Offline sorter, Plexon). Sorted units were analyzed using
NeuroExplorer 3.0 and timestamps were exported for further analysis in Microsoft Excel and
Matlab 7.12.
Elevated Zero Maze (EZM)
EZM testing was performed in a sound attenuated room maintained at 23ºC at 200 lux
(see Chapter 2) (Bruchas et al., 2009; Kim et al., 2013b), and trials were performed in the
afternoon between 13:00–16:00 hr. The EZM (Harvard Apparatus, Holliston, MA) had the
following dimensions: 200 cm in circumference comprised of four 50 cm sections: two opened
and two closed. The maze was elevated 50 cm above the floor, with a path width of 4 cm and a
0.5 cm lip on each open section. The maze was cleaned with 70% ethanol between trials. Prior to
testing, Th-CreLC:ChR2, Th-CreLC:eYFP, Crh-CreCeA-LC:ChR2, or Crh-CreCeA-LC:eYFP were connected
to the fiber optic and placed at the threshold of a closed section facing the open section and
allowed to roam freely for 7 min. Th-Cre animals received 5 Hz (10 ms width) and Crh-Cre
animals received 10 Hz (10 ms width) photostimulation (~10 mW light power). For the CRFR1
antagonism experiments, mice were injected into the LC with "-helical CRF (1 !g, intra-LC, one
hour prior to behavior, Tocris) or Antalarmin HCl (10 mg/kg, i.p., 30 min prior to behavior,
Sigma). Movements were video recorded and analyzed using Ethovision 8.5 (Noldus
Information Technologies, Leesburg, VA). Open section time and entries into the open section
following a one-minute habituation were the primary measures of anxiety-like behaviors.
Conditioned Place Aversion
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Th-CreLC:ChR2, Th-CreLC:eYFP, Crh-CreCeA-LC:ChR2, or Crh-CreCeA-LC:eYFP animals were
trained in an unbiased, balanced three-compartment conditioning apparatus as described
(Bruchas et al., 2009; Al-Hasani et al., 2013; Land et al., 2008, 2009). Briefly, mice were pretested by placing individual animals in the small central compartment and allowing them to
explore the entire apparatus for 30 min. Time spent in each compartment was recorded with a
video camera (ZR90; Canon) and analyzed using Ethovision 8.5 (Noldus). Mice were randomly
assigned to photostimulation and no-photostimulation compartments and received no
photostimulation in the morning and photostimulation (Th-CreLC:ChR2: 5 Hz, 10 ms pulses; CrhCreCeA-LC:ChR2: 10 Hz, 10 ms pulses) in the afternoon at least 4 h after the morning training on
two consecutive days. CPA was assessed on day 4 by allowing the mice to roam freely in all
three compartments and recording the time spent in each. Scores were calculated by subtracting
the time spent in the photostimulation-paired compartment post-test minus the pre-test.
Real-time Place Testing
Th-CreLC:ChR2, Th-CreLC:eYFP, Gal- CreLC:ChR2, Crh-CreCeA-LC:ChR2, or Crh-CreCeA-LC:eYFP
animals were placed in a custom-made unbiased, balanced two-compartment conditioning
apparatus (52.5 x 25.5 x 25.5 cm) as described previously (see Chapter 4) (Jennings et al., 2013;
Kim et al., 2013a; Stamatakis and Stuber, 2012; Stamatakis et al., 2013; Tan et al., 2012). Mice
were allowed to freely roam the entire apparatus for 20 min. Entry into one compartment
triggered photostimulation of various frequencies (0, 1, 2, 5, 10 Hz, etc.) while the animal
remained in the light-paired chamber. Entry into the other chamber ended the photostimulation.
The side paired with photostimulation was counterbalanced across mice and across session. Time
spent in each chamber and total distance traveled for the entire 20-minute trial was measured
using Ethovision 8.5 (Noldus Information Technologies, Leesburg, VA).
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Data Analysis/Statistics
All data expressed as mean ± SEM. Data were normally distributed, and differences
between groups were determined using independent t-tests or one-way ANOVA, or two-way
ANOVAs followed by post hoc Bonferroni comparisons if the main effect was significant at
p<0.05. Statistical analyses were conducted using Prism 5.0 (GraphPad).
Genotyping of mouse lines
DNA was isolated from tail tissue obtained from weanling mice (21-28 days of age), and
PCR screening was performed using the following primers: Cre recombinase (forward: 5’- GCA
TTA CCG GTC GAT GCA ACG AGT GAT GAG-3’ and reverse: 5’- GAG TGA ACG AAC
CTG GTC GAA ATC AGT GCG-3’) yielding a 400-bp PCR product in Cre positive animals.
Fatty acid-binding protein intestinal primers (forward: 5’- TGG ACA GGA CTG GAC CTC
TGC TTT CCT AGA-3’ and reverse: 5’- TAG AGC TTT GCC ACA TCA CAG GTC ATT
CAG-3’) were used as positive controls and yield a 200-bp PCR product.
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Chapter 6

Determining the downstream receptor and projection
targets that mediate locus coeruleus-induced negative
affective behaviors

This chapter contains components of a manuscript currently in preparation:
J.G. McCall*, E.R. Siuda*, Z.A. McElligot, S.L. Anderson, G.D. Stuber, M.R. Bruchas.
Activation of locus coeruleus projections to the basolateral amygdala induce anxiety and
condition aversion (in preparation).
Author contributions for the above citation:
*co-first author J.G.M, E.R.S., and M.R.B. designed all of the experiments and wrote the
paper. J.G.M. performed all of the experiments except for the fast scan cyclic voltammetry
(FSCV). E.R.S. and S.L.A. performed the immunohistochemistry. J.G.M and E.R.S. performed
the in vivo electrophysiology experiments together and E.R.S analyzed the in vivo
electrophysiology data. E.R.S. analyzed the behavior for Figures 6.6 & 6.7. Z.A. McElligot
performed and analyzed the FSCV. G.D.S. supervised the FSCV. M.R.B. oversaw all of the
work and helped write the paper. A similar, though distinct, chapter is contained in the
dissertation of E.R.S. E.R.S. made the layouts for Figures 6.2-6.7.
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SUMMARY
Increased tonic activity of locus coeruleus noradrenergic (LC-NE) neurons induces
anxiety-like and aversive behavior. While some information is known about the afferent circuitry
that endogenously drives this neural activity and behavior, the downstream receptors and
anatomical projection targets that mediate these behaviors remain unresolved. Here we use a
combination of in vivo optogenetics, behavioral pharmacology, single-unit electrophysiology and
fast scan cyclic voltammetry to determine the neural substrates downstream of LC-NE activity.
We show that !-adrenergic receptors mediate the anxiety-like phenotype of increased tonic LCNE activity, while "1-adrenergic receptors mediate the real-time place aversion. Additionally,
we demonstrate that norepinephrine release in the basolateral amygdala (BLA) alters BLA
activity and increases anxiety-like and conditioned aversive behaviors, but not real-time place
preference. These studies begin to illustrate how the complex efferent system of the LC-NE
system selectively mediates different behaviors through distinct receptor and projection-selective
mechanisms.
INTRODUCTION
After determining that increased tonic activity of LC-NE neurons drives negative
affective behaviors in Chapter 5, we next sought to determine the downstream components of
this system towards driving anxiety. Though Chapter 5 investigated the circuitry upstream of
the LC, we were careful to make our conclusions based on LC-NE cell activity rather than on
downstream effectors (e.g. receptors, anatomical targets). With at least nine different adrenergic
receptors and three different galanin receptors, that have nearly all been indicated in anxiety-like
behaviors (Brunner et al., 2014; Dixit et al., 2014; Hanke et al., 2012; Kuteeva et al., 2008; Le
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Maître et al., 2013; Mantsch et al., 2010; Raskind et al., 2007; Wohleb et al., 2011) and a
widespread projection network through the brain and spinal cord (Berridge and Waterhouse,
2003; Sara, 2009), the downstream targets for these behaviors could quickly become
complicated. The LC sends dense neuronal projections to the amygdala and extended amygdala,
which are thought to be responsible for the widely known role of norepinephrine (NE) in
affective behaviors (Berridge and Waterhouse, 2003; Davis, 1992; Valentino and Aston-Jones,
2010). In particular, noradrenergic cell firing in the LC has been shown to increase in the context
of stressful stimuli (Abercrombie and Jacobs, 1987a, 1987b; Aston-Jones et al., 1999; Mana and
Grace, 1997). While the anatomical projections from the LC and their cell types have been
studied for several years, the precise mechanisms by which the LC generates its influence over
basolateral amygdala (BLA) function remain undefined. In particular, how the LC-BLA
projection integrates affective behavioral responses via specific receptor systems and cell activity
is unknown.
To determine what downstream receptor systems might be involved in the anxiety-like
and aversive behavior induced by high tonic LC-NE activity, we replicated experiments from
Chapter 5 (Figure 5.4 and 5.6) with systemic antagonism of either !-adrenergic receptors or
"1-adrenergic receptors. These pilot experiments unexpectedly reveal that the observed anxietylike and real-time aversion behaviors are mediated through different receptor systems. To
determine the role of noradrenergic influence on BLA function and negative affective behavior
we utilized optogenetic control of LC-NE inputs into the BLA. Here we directly tested whether
NE release from LC terminals into the BLA can drive anxiety-like and aversive behavioral
responses. We demonstrate that photostimulation of LC projections to the amygdala releases NE
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to cause localized excitability. This increased noradrenergic tone is sufficient to produce anxietylike and conditioned aversive behaviors.
RESULTS
The anxiety-like component of increased LC-NE tonic neuronal firing is mediated through
!-adrenergic receptor activation
Using the same optogenetic strategy described in Chapter 5 (Figure 5.4), we tested
whether systemic antagonism could block the anxiogenic behavioral response induced by
selectively increasing LC-NE tonic firing. 30 minutes prior to behavioral testing, we pre-treated
animals with either the non-selective !-adrenergic receptor antagonist Propranolol HCl (10
mg/kg, i.p., Tocris) (Al-Hasani et al., 2013), the "1-adrenergic antagonist Prazosin HCl (1
mg/kg, Sigma) (Bortolozzi and Artigas, 2003), or a vehicle control. We next photostimulated (5
Hz, 10 ms pulse width, 473 nm) LC-NE neurons during access to elevated zero maze (EZM)
(Choleris et al., 2001; Shepherd et al., 1994) (Figure 6.1A & B). As we saw in Chapter 5, 5 Hz
photostimulation in the EZM induced anxiety-like behavior in Th-Cre+ animals expressing ChR2
in the LC compared to Th-Cre- control animals that do not express ChR2 (Figure 6.1C). Th-Cre+
animals that were pre-treated with Propranolol were not significantly different from controls,
indicating that !-adrenergic antagonism blocked the effect of LC-NE photostimulation (Figure
6.1C). Importantly, this was not the case in the animals treated with Prazosin (Figure 6.1C). The
blockade of "1-adrenergic receptors trended towards a more anxiogenic baseline state in the
controls and a potentiation of the photostimulation-induced effect in the Cre+ animals, but this
trend was not significant. These experiments demonstrate that the anxiogenic state that is driven
by increasing tonic firing of LC-NE neurons is meditated by !-adrenergic receptor activation.
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Figure 6.1 The anxiety-like and real-time place aversion behaviors induced by high tonic
LC-NE activity are mediated by separate receptor systems. (A) Cartoon of viral and fiber
optic delivery strategy. (B) Calendar of behavioral studies. (C) 5 Hz photostimulation causes an
anxiety-like phenotype in EZM of Th-Cre+ animals expressing ChR2 in the LC compared to ThCre- control animals that do not express ChR2. This effect is reversed by Propranolol pretreatment, but not by Prazosin (Data represented as mean ± SEM, n=6-11/group; One-Way
ANOVA, Bonferonni post-hoc, **p<0.01, *p<0.05, ns=no significance). (D) 5 Hz
photostimulation causes a real-time place aversion in RTPT of Th-Cre+ animals expressing ChR2
in the LC compared to Th-Cre- control animals that do not express ChR2. This effect is not
reversed by Propranolol pre-treatment, but is by Prazosin (Data represented as mean ± SEM,
n=6-10/group; One-Way ANOVA, Bonferonni post-hoc, ****p<0.0001, **p<0.01, ns=no
significance).
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The negative valence elicited by high tonic LC-NE activity is mediated by "1-adrenergic
receptors
We next sought to determine whether this same systemic antagonism of !-adrenergic
receptors could prevent the acute negative behavioral valence seen in the real-time place testing
(RTPT) assay from Chapter 5 (Figure 5.6). This assay assesses native behavioral preference to
photostimulation (see Chapters 4 & 5) (Jennings et al., 2013; Kim et al., 2013a; Stamatakis and
Stuber, 2012; Stamatakis et al., 2013; Tan et al., 2012). We previously demonstrated that 5 Hz
photostimiluation of LC-NE neurons in this assay causes an aversion from the chamber paired
with photostimulation (Figure 5.6). Similarly, when we replicated this experiment with vehicle
controls, we see the same behavioral phenotype as before – Th-Cre+, ChR2-expressing animals
have an aversion from the photostimulation-paired chamber compared to controls (Figure 6.1D).
Surprisingly pre-treatment with Propranolol did not block this effect (Figure 6.1D). Even more
unexpected, however, we found that pre-treatment with Prazosin did block the real-time place
aversion (Figure 6.1D). These data suggest that the negative affective behaviors elicited by
elevating LC tonic activity are separable behavior phenomenon. At the least the anxiety-like and
real-time aversive components of these behaviors are mediate by different downstream receptor
systems (anxiety-like behavior through !-adrenergic receptors and real-time aversion through
"1-adrenergic receptors). Whether there is also a circuit-based mechanism for this segregation
remains to be seen.
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After gaining some insight into the receptors through which increased tonic LC-NE
activity induces behavioral responses, we next sought to test whether these same behaviors can

264

be generated by releasing NE at localized LC projection in the BLA. Using the same Th-Cre
mice as above to genetically isolate LC-NE neurons, we injected Cre-dependent virus expressing
channelrhodopsin-2 (AAV5-EF1"-DIO-ChR2-eYFP) into the LC and allowed six weeks for
ChR2 expression to reach terminals within the BLA (LC-BLATh-Cre; Figures 6.2 A-D and 6.3
A,B).
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To determine if photostimulation of LC-BLATHcre projections resulted in NE
release at terminals, we first performed fast-scan cyclic voltammetry (FSCV) in acute
brain slices of LC-BLATHcre animals. A carbon fiber microelectrode was positioned in the
amygdala and slices were stimulated with a 473 nm LED for 30x, 5-ms pulses at 10 Hz
(Figure

2.3

A).

Oxidative

and

reductive

currents

were

observed

following

photostimulation displaying characteristic catecholamine cyclic voltammograms and
uptake similar to NE (t1/2 = 2.0 ± 0.2 s, Figure 2.3 B). Following 20 minutes of consistent
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baseline NE oxidative current, 1 !M reserpine (an inhibitor of vesicular monoamine
transporters) was perfused on the slices to deplete catecholamine from the terminals
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Photostimulation of LC-BLA terminals releases NE
In Chapter 5, we demonstrated optogenetic control of LC-NE neurons (Figure 5.3).
However, these studies did not examine where the observed spiking activity caused release of
neurotransmitters, particularly NE. To test whether photostimulation of LC-BLATh-Cre projections
resulted in NE release at terminals, we collaborated with the Stuber lab at the University of
North Carolina (UNC). After injecting LC-BLATh-Cre mice with AAV5-EF1"-DIO-ChR2-eYFP,
we sent the animals to UNC for Zoe McElligot to acutely slice for fast-scan cyclic voltammetry
(FSCV). A carbon fiber microelectrode was positioned in the amygdala and slices were
stimulated with a 473 nm LED for 30x, 5-ms pulses at 10 Hz (Figure 6.4A). Oxidative and
reductive currents were observed following photostimulation displaying characteristic
catecholamine cyclic voltammograms and uptake similar to NE (t1/2 = 2.0 ± 0.2 s, Figure 6.4B).
Following 20 minutes of consistent baseline NE oxidative current, 1 µM reserpine (an inhibitor
of vesicular monoamine transporters) was perfused on the slices to deplete catecholamine from
the terminals projecting from the LC (Dahlström et al., 1965). Reserpine treatment significantly
depleted evoked terminal NE (31.6 +\- 1.0 % of baseline, Figures 6.4C & D) confirming
optically-evoked NE release in this isolated LC-BLATh-Cre projection. This study demonstrates
that long-range BLA projections from the LC can be photostimulated to induce NE release.
Photostimulation of LC-BLA terminals modulates
BLA neurons have well reported responses to exogenous application of NE (Buffalari and
Grace, 2007). We next sought to determine if the optically-evoked endogenous NE release would
mimic the responses of BLA neurons to exogenous NE. To do so, we examined BLA single-unit
activity in LC-BLATh-Cre mice using 16-channel microelectrode arrays coupled to a fiber optic
implant (optrode arrays) (Sparta et al., 2011). These optrode arrays were used to isolate and
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Figure 2.3. Photostimulation of locus coeruleus terminals in the BLA releases
norepinephrine. (A) Fast scan cyclic voltammetry schematic. (B-D) Oxidative and
reductive currents (with representative voltammograms) in response to photostimulation
Figure
6.4 Photostimulation
of locus
coeruleus interminals
in current
the BLA
releases
are attenuated
by reserpine (1 !M).
(H) Attenuation
NE oxidative
in response
to reserpine (1 !M; **p < 0.01; paired Student’s t-tests to baseline; n = 3 pairs; mean ±
norepinephrine.
(A) Fast scan
cyclic
voltammetry
Oxidative
and reductive
S.E.M). CONTRIBUTION:
Data
collected
and schematic.
analyzed (B-C)
by Zoe
A. McElligott,
PhD
(UNC Chapel Hill).
currents (with representative voltammograms below) in response to photostimulation are

attenuated by reserpine (1 µM). (D) Attenuation in NE oxidative current in response to reserpine
local BLA ChR2 activation, and downstream modulation of the BLA in LC-BLATHcre mice
(1 µM; **p < 0.01; paired Student’s t-tests to baseline; n = 3 pairs; mean ± S.E.M).
in vivo, we used 16-channel microelectrode arrays coupled to a fiber optic implant
(optrode arrays) (Sparta et al., 2012) to isolate and record BLA single-unit activity
resulting from photostimulation of LC-BLATHcre projections (473 nm, 5 Hz, 10 ms pulse
width) (Figure 2.3A).
In these experiments photostimulation of LC-BLATHcre terminals caused a
significant increase in firing frequency in 58% of units recorded in the BLA, while some
18
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Figure 2.4. Photostimulation of LC terminals in the BLA alters neuronal
excitability. (A) Schematic illustrating single unit extracellular recording paradigm of
BLA neurons presynaptically activated by ChR2 expressing locus coeruleus terminals.
(B) Distribution of differential firing rates present in photostimulated BLA neurons. (C)
Photostimulation (5 Hz) of LC terminals in the BLA shows neurons that either increase
(excitatory; blue; n = 12; **p < 0.01, paired Student’s t-test), decrease (inhibitory; grey; n
= 5; *p < 0.05, paired Student’s t-test), or show no change (black; n = 3) in firing rate.
Representative histograms (1 sec bin) of isolated single units showing increase (D),
decrease (E), or no change (F), in neuronal firing in response to photostimulation (473
nm, 5 Hz, 3 min). (G) Representative histogram (1 sec bin) of isolated single-unit shows
269to constant photostimulation (473, constant
an increase in neuronal firing in response
light, 20 sec, 5 mW). (H) Neuronal firing rate increases in response to 20 sec (473 nm,
constant light) photostimulation and returns to baseline values in the absence of light (**
p < 0.01, ***p < 0.001, One-Way Repeated Measures ANOVA followed by Bonferroni

Figure 6.5. Photostimulation of LC terminals in the BLA alters neuronal excitability. (A)
Schematic illustrating single-unit extracellular recording paradigm of BLA neurons
presynaptically modulated by ChR2-expressing LC-BLA terminals. (B) Distribution of
differential firing rates present in BLA neurons following LC-BLA terminal photostimlation. (C)
Photostimulation (5 Hz) of LC terminals in the BLA shows neurons that either increase
(excitatory; blue; n = 12; **p < 0.01, paired Student’s t-test), decrease (inhibitory; grey; n = 5;
*p < 0.05, paired Student’s t-test), or show no change (black; n = 3) in firing rate. Representative
histograms (1 sec bin) of isolated single-units showing increase (D), decrease (E), or no change
(F), in neuronal firing in response to photostimulation (473 nm, 5 Hz, 3 min). (G) Representative
histogram (1 sec bin) of isolated single-unit shows an increase in neuronal firing in response to
constant photostimulation (473, constant light, 20 sec, 5 mW). (H) Neuronal firing rate increases
in response to 20 sec (473 nm, constant light) photostimulation and returns to baseline values in
the absence of light (** p < 0.01, ***p < 0.001, One-Way Repeated Measures ANOVA followed
by Bonferroni post hoc comparison test).
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record BLA single-unit activity before, during, and after photostimulation of LC-BLATh-Cre
projections (473 nm, 5 Hz, 10 ms pulse width) (Figure 6.5A). In these experiments
photostimulation of LC-BLATh-Cre terminals caused a significant increase in firing frequency in
58% of units recorded in the BLA, while some cells showed inhibitory responses (26%), and
some showed no response (16%) (Figures 6.5B-F). Responses are also shown from isolated
units receiving constant light stimulation (Figures 6.5G,H). Together, these heterogeneous firing
properties are consistent with previous studies using iontophoresis of norepinephrine to the
region, and further highlight the complex pharmacological activity of NE in this structure
(Buffalari and Grace, 2007; Ferry et al., 1997; Huang et al., 1996). These results demonstrate
that photostimulation of LC terminals in the BLA causes varied responses in BLA firing rate,
with a majority of observed units increasing in response the terminal photostimulation.
Optogenetic targeting of LC-NE projections to the BLA promotes anxiety-like behavior
After identifying the LC terminals to the BLA as a projecting source of NE, which is
capable of increasing BLA activity, we next sought to test whether stimulation of these terminals
would drive similar behavioral profiles to direct LC-NE stimulation. Fiber optics were implanted
at LC-NE terminal sites in the BLA of LC-BLATh-Cre mice (Figures 6.6A and 6.3A & B).
Photostimulation of LC-BLATh-Cre terminals using the parameters that induce anxiety-like
behavior at LC-NE cell bodies in Chapter 5 (5 Hz) resulted in a significant decrease in time
spent in the open area of the elevated zero maze (EZM) (Figures 6.6B & C) with no significant
change in general locomotor activity (Figures 6.6D-F). This experiment shows stimulation of a
subset of LC-NE fibers, only those projecting to the BLA, is sufficient to induce anxiety-like
behavior.
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Figure 6.6. Photostimulation of LC terminals in the BLA induces anxiety-like behavior. (A)
Figure 2.5. Photostimulation of LC terminals in the BLA induces anxiety-like
behavior.
(A)and
Viralfiber
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optic
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Viral
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optic and
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LC-BLA
mice. (B) Colorized heat maps of
mice. (B) Colorized heat maps of elevated zero maze activity (EZM) of control and
ChR2 animals. (C) Cumulative open arm time course of photostimulated ChR2 (blue, n
elevated zero maze activity (EZM) of control and ChR2 animals. (C) Cumulative open arm time
= 8) and control animals (black; n = 7) (5 Hz, 10 ms pulses; * p < 0.05, ** p < 0.01, via
multiple Student’s t-tests; mean ± SEM). Control (black; n = 6) and ChR2 (blue; n = 8)
course of photostimulated ChR2 (blue, n = 8) and control animals (black; n = 7) (5 Hz, 10 ms
expressing animals: travel similar distances (D), have similar velocities (E), and make
similar number of entries (F) into open arms of EZM. CONTRIBUTION: Data collected
pulses; * p < 0.05, ** p < 0.01, via multiple Student’s t-tests; mean ± SEM). Control (black; n =
and analyzed by Jordan McCall.
6) and ChR2 (blue; n = 8) expressing animals: travel similar distances (D), have similar
velocities (E), and make similar number of entries (F)THcre
into open arms of EZM.
Furthermore, photoactivation of LC-BLA
terminals (5 Hz, 10 ms) caused
significant conditioned place aversion (CPA, -165 ± 45 s) to the chamber paired with
photostimulation in ChR2-eYFP expressing LC-BLATHcre mice following two days of
conditioning (Figures 2.6 A-C), but not in control mice and without altering locomotor
activity (Figure 2.6 D). However, real-time place aversion (RTPA) to photostimulation of
LC-BLATHcre terminals, was not aversive at either 5 Hz (Figures 2.6 E,F) or 60 Hz
21
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LC-BLATh-Cre terminal stimulation is sufficient to condition place aversion, but does not
drive a real-time place aversion
Following the observation that stimulation of LC-BLA fibers alone is capable of driving
anxiety-like behaviors, we next tested whether this same stimulation produces a learned change
in behavior. Similarly to Chapter 5, (Figure 5.6) we employed a Pavlovian conditioned place
aversion (CPA) assay (Bruchas et al., 2009; Al-Hasani et al., 2013; Land et al., 2008, 2009).
When allowed to freely explore both chambers following two conditioning days of
photostimulation of LC-BLATh-Cre terminals (5 Hz, 10 ms), the animals expressing ChR2-eYFP
spent significantly less time in the chamber that was paired with photostimulation compared to
eYFP-expressing controls (Figure 6.7A-C). Neither group of mice had significant changes in
locomotor activity before, during, or after conditioning (Figure 6.7D). These results suggest that
the negative affect produced by LC-BLATh-Cre photostimulation is capable of being learned and
biasing behavior away from contexts in which the experience took place. This finding is also
consistent with prior work showing a role for noradrenergic influence in fear-related memory
formation (Debiec and Ledoux, 2004).
These experiments, however, do not assess whether or not the stimulation itself has a
negative valence. Surprisingly, when LC-BLATh-Cre animals are tested in the RTPT paradigm
there was no aversion at either 5 Hz (Figures 6.7E & F) or 60 Hz photostimulation (Figures
6.7G & H). This finding is particularly interesting in light of the systemic pharmacology
experiments (Figure 6.1) and suggests that perhaps the negative valence of LC-NE stimulation is
produced via another circuit. It is also possible that the neuromodulatory effects on this circuit
potentially require a learning component compared to acute activation of similar
neurotransmitter pathways (GABA/Glutamate) (Haubensak et al., 2010; Kim et al., 2013a).
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Taken together these data suggest that LC-BLA projections release NE into the BLA,
which can cause increased neuronal excitability and facilitate condition aversive and anxiety-like
behavioral responses. It is possible that the neuronal activity responses and behavior are
mediated by !-adrernergic receptors and unlikely to be mediated by "1-adrenergic receptors.
These data provide a critical framework for understanding the downstream influence of the LCNE system in the BLA as it relates to anxiety-like and aversive behavioral states.
DISCUSSION
Though LC-NE neurons contain numerous co-transmitters (Berridge and Waterhouse,
2003), NE is considered the primary effector released from these neurons. Here we show that NE
activates multiple receptors for the generation of unique negative affective behaviors. The
observation that these behaviors segregate by receptor system foreshadows an elegant, but
complicated future in dissecting the role of the LC-NE system in behavior.
The BLA is an important component in the neural circuitry of negative affective behavior
(Davidson, 2002; Davis, 1992). Activation of BLA cell bodies and their projections to the ventral
hippocampus mediate anxiety-like behavior (Felix-Ortiz et al., 2013; Tye et al., 2011). The BLA
receives noradrenergic input from the LC (Asan, 1998; Fallon et al., 1978) and NE increases in
the BLA following stress events (Galvez et al., 1996; Hatfield et al., 1999). Here we use FSCV
to show that Th+ positive neurons from the LC release NE in the amygdala. Previous studies
have demonstrated that noradrenergic cell firing in the LC increases tonic drive (5-8Hz)
following stressful stimuli (see Chapter 5) (Abercrombie and Jacobs, 1987a, 1987b; AstonJones et al., 1999; Mana and Grace, 1997). We also demonstrate that selective activation of
terminals from these neurons (5Hz) increases the excitatory drive of BLA neurons in vivo.
Additionally, we show that stimulation of LC terminals in the BLA causes robust increases in
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anxiety-like and conditioned aversive behavior suggesting a strong role of NE in mediating these
behaviors. However, given that the LC terminals likely release more than NE, the postsynaptic
neuronal responses and their subsequent behavioral outputs may potentially be mediated through
a different mechanism of action. While there is some concern that photostimulation of LCBLATh-Cre causes backpropagating action potential to LC-NE cell bodies, the observation that this
stimulation does not replicate all of the behavioral phenotypes seen in Chapter 5 (i.e. no RTPT)
suggests there is at least some degree of circuit isolation in these studies. Future work should
strive to account for such a possibility either by genetically isolating the projection (Fenno et al.,
2014) or pharmacologically inactivating backpropagation (Stuber et al., 2011).
To further solidify the role of NE in mediating anxiogenic behavior, future studies should
combine photostimulation of LC-BLATh-Cre with local infusion of adrenergic antagonists in the
BLA. However, these data could prove difficult to interpret as antagonists would not target
specific cell types and could “spill over” from the predominately glutamatergic BLA to the
neighboring GABAergic CeA (Carlsen, 1988; McDonald, 1982; Smith and Paré, 1994). These
experiments represent an ideal application of optofluidic neural probes (Chapter 4), where
spatial restriction of both pharmacological agents and photostimulation will be required. While
isolation of the specific contributions of different receptor subtypes to NE- mediated anxiety-like
behavior and aversion could be challenging via classical pharmacological methods, other modern
techniques, such as DREADD and optically-sensitive GPCRs, show potential in dissecting these
contributions.
Taken together, our results demonstrate that LC-NE downstream influence on negative
affective behaviors is an elegant and complex system likely involving many different
postsynaptic receptor systems and anatomical projection targets. These findings have broad
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implications for our understanding of the mechanisms of stress-induced and anxiety disorders
and suggest that further study of these noradrenergic circuits and signaling pathways should
greatly advance our current understanding of these pathologies.

MATERIALS & METHODS
Animals
Adult (25–35 g) male C57BL/6J and TH::IRES-Cre backcrossed to C57BL/6J mice were
group-housed, given access to food and water ad libitum and maintained on a 12 h:12 h
light:dark cycle. All animals were held in a facility in the lab 1 week prior to surgery, postsurgery and throughout the duration of the behavioral assays to minimize stress from
transportation and disruption from foot traffic. All procedures were approved by the Animal Care
and Use Committee of Washington University and conformed to US National Institutes of
Health guidelines.
Viral preparation
Plasmids encoding pAAV-EF1"-DIO-eYFP [final titer 5 x 1012 vg/ml], pAAV-EF1"double floxed-hChR2(H134R)-eYFP-WPRE-HGHpA [final titer 2 x 1013 vg/ml], were obtained
from Addgene (Addgene.org) originally from the Deisseroth Laboratory at Stanford University.
The DNA was amplified with a Maxiprep kit (Promega) and packaged into AAV5 serotyped
viruses by the WUSTL Hope Center Viral Core.
Stereotaxic surgery
Mice were anaesthetized in an induction chamber (5% isoflurane) and placed in a
stereotaxic frame (Kopf Instruments, Model 1900) where they were maintained at 1-2%
isoflurane throughout the procedure. A craniotomy was performed and mice were injected as
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follows. For locus coeruleus terminal studies, 1 µl of AAV5- DIO-ChR2 or AAV5-DIO-eYFP
was injected unilaterally into the locus coeruleus at stereotaxic coordinates from bregma: -5.45
mm anterior-posterior (AP), ± 1.25 mm medial-lateral (ML), -3.65 mm dorsal-ventral (DV).
Mice were then implanted with chronic fiber optic implants with coordinates adjusted from viral
injection to 0.00 mm 30(AP), ± 0.25 mm (ML), and +1.00 mm (DV). The fiber optic implants
were secured using two bone screws (CMA, 743102) and affixed with TitanBond (Horizon
Dental Products) and dental cement (Lang Dental) (McCall et al., 2013). Mice were allowed to
recover for at least 3-6 weeks prior to behavioral testing; this interval also permitted optimal
AAV expression and Cre recombinase activity.
General Behavior Notes
Behavioral assays were performed in a sound attenuated room maintained at 23°C.
Lighting was measured and stabilized at ~ 4 lux for anxiety tests and ~200 lux for place testing.
All behavioral apparatuses were cleaned with 70% ethanol in between animals. In each assay,
animals received constant photostimulation throughout the entire trial. AAV5-DIO-ChR2 and
AAV5-DIO-eYFP animals received 5 ms pulses of 10 Hz photostimulation (473 nm).
Movements were video recorded and analyzed using Ethovision Software.
Elevated Zero Maze (EZM)
The EZM (Harvard Apparatus) was made of grey plastic, 200 cm in circumference,
comprised of four 50 cm sections (two opened and two closed). The maze was elevated 50 cm
above the floor and had a path width of 4 cm with a 0.5 cm lip on each open section. Animals
were connected to cables coupled to a function generator, positioned head first into a closed arm,
and allowed to roam freely for 6 min. Mean open arm time was the primary measure of anxietylike behavior.

278

Conditioned Place Aversion (CPA)
Mice were trained in an unbiased, balanced three compartment conditioning apparatus as
previously described (Al-Hasani et al., 2013; Kim et al., 2013b). Briefly, mice were pre-tested by
placing individual animals in the small central compartment and allowing them to explore the
entire 31apparatus for 30 min. Time spent in each compartment was recorded with a video
camera (ZR90; Canon) and analyzed using Ethovision 8.5 (Noldus). Mice were randomly
assigned to light and no-light compartments and received no light in the morning and light (5 Hz
for LC-BLA) in the afternoon at least 4 h after the morning training on two consecutive days.
CPA was assessed on day 4 by allowing the mice to roam freely in all three compartments and
recording the time spent in each. Scores were calculated by subtracting the time spent in the light
stimulus-paired compartment post-test minus the pre-test.
Real Time Place Testing (RTPT)
Mice were placed into a custom-made unbiased, balanced two-compartment conditioning
apparatus (52.5 x 25.5 x 25.5 cm) as previously described (Stamatakis and Stuber, 2012) and
allowed to freely roam the entire apparatus for 20 min. Entry into one compartment triggered
constant photostimulation (5 Hz for LC-BLA; ~10 mW light power) while the animal remained
in the light-paired chamber. Entry into the other chamber ended the photostimulation. The side
paired with photostimulation was counterbalanced across mice. Time spent in each chamber and
total distance traveled for the entire 20 min trial was measured using Ethovision 8.5 (Noldus).
Data are expressed as mean +/- S.E.M percent time spent in photostimulation-paired chamber.
Voltammetry
Slice voltammetry experiments were performed as previously described (Stamatakis et al.,
2013). Briefly, mice were anesthetized (Euthasol) and perfused with ice-cold sucrose aCSF (in
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mM: 225 sucrose, 119 NaCl, 1.0 NaH2PO4, 4.9 MgCl2, 0.1 CaCl2, 26.2 NaHCo3, 1.25
glucose). Following rapid decapitation, slices were prepared 32 on a vibratome (VT-1000, Leica
Microsystems) and allowed to rest for at least 30 min in oxygenated aCSF (in mM: 119 NaCl,
2.5 KCl, 1.0 NaH2PO4, 1.3 MgCl2, 2.5 CaCl2, 26.2 NaHCO3, and 11 glucose) at 35oC prior to
placement in the recording chamber where slices were perfused with oxygenated aCSF at 37oC
at a rate of 2 ml/min. Carbon fiber microelectrodes (CFME, 75 µm in length) were lowered into
300 µM coronal slices and placed where the densest ChR2-eYFP expression was observed
(CeA/BLA border) of THLC::ChR2 mice. To detect NE, the CFME was ramped from -0.4 V to
1.3 V versus a Ag/AgCl reference electrode (in the bath) at a rate of 400 V/s at 10 Hz. Slices
were stimulated with 30 pulses of a blue LED (Thorlabs, 473 nm, 5 ms pulse width, 1 mW) via a
40X objective at 10 Hz every 5 minutes to release NA. Electrochemical data was collected and
analyzed via custom software (Tar Heel CV, HD CV, Labview). Following collection,
background subtracted cyclic voltammograms (CVs) were transformed with a Fast Fourier
Transformation (Bucher et al., 2013). CVs had characteristic oxidation and reduction peaks
coinciding with catecholamine detection (ox: 600-700 mV red: -200-300 mV). Oxidative
currents were analyzed at the peak of the oxidative potential for individual experiments.
Clearance half-life (t1/2) was measured in Clampfit 10.2 (Molecular devices) as previously
described (McElligott et al., 2013).
In vivo electrophysiology
Spontaneous single unit activity was recorded as previously described (Kim et al., 2013b;
Sparta et al., 2011). Briefly, mice were lightly anesthetized (1% isoflurane), placed in a
stereotactic frame and two skull screws were placed on either side of the midline to ground the
electrode array. The recording apparatus consisted of a 16-channel (35-µm tungsten wires, 150-

280

µm spacing between wires, 150-33 µm spacing between rows, Innovative Physiology) electrode
array. This array was epoxied to a fiber optic and lowered into the BLA (stereotaxic coordinates
from bregma: -1.3 mm (AP), ± 2.9 mm (ML) and -4.9 mm (DV). Extracellular recordings were
taken from LC-BLATh-Cre mice

and its corresponding viral control mice. Spontaneous and

photostimulated neuronal activity was recorded from each electrode, bandpass-filtered with
activity between 250 and 8,000 Hz, and analyzed as spikes. Voltage signals were amplified and
digitally converted using OmniPlex and PlexControl (Plexon). For LC-BLATh-Cre recordings, 3
min of baseline recordings were made followed by 3 min of 5 Hz photostimulation (10 ms
pulses, 10 mW) and then another 3 min post- stimulation (off, on, off). Principle component
analysis and/or evaluation of t-distribution with expectation maximization was used to sort
spikes using Offline Sorter (Plexon).
Statistics/Data Analysis
All data are expressed as mean ± SEM. Statistical significance was taken as *p < 0.05, **p
< 0.01, ***p < 0.001, as determined by the Student’s t-test (paired and unpaired): One-Way
Analysis of Variance (ANOVA) or One-Way Repeated Measures ANOVA, followed by
Dunnett’s or Bonferroni post hoc tests as appropriate. Statistical analyses were performed in
GraphPad Prism 5.0.
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Chapter 7

Further discussion and future directions
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PART 1: The development and application of cellular-scale optoelectronic devices for
wireless manipulation of intact mammalian neural circuitry
To date, the primary implementation of the technologies presented in Part 1 has been in
“proof-of-principle” experiments. Initially, Tae-il Kim and I devised a means to combine many
different functional electronic modalities into a single, ultrathin device (Chapter 2, Figure 2.1).
These ultrathin (~20 µm), flexible devices allow for electrophysiological, optical, and thermal
observation of brain tissue as well as wireless photostimulation. We devised a means to implant
this thin interface into the brain using a removable insertion needle that temporarily binds to the
flexible device with a biodissolvable adhesive (Figure 2.1D). By utilizing the well-established
reward-related circuitry of the ventral tegmental area dopamine (VTA-DA) system, we were able
to demonstrate that these devices can safely and effectively integrate with awake, behaving
animals as small as a C57Bl/6 mouse (Figure 2.1G). Furthermore, we for the first time, directly
addressed the role of tonic VTA-DA activity in anxiety-like behavior (Figure 2.28).
In an effort to facilitate the widespread distribution of this new technology Tae-il,
Gunchul Shin, and I prepared a detailed protocol explaining every step of the fabrication and use
these first generation devices (Chapter 3). Though this protocol is specific to these devices, the
principles of both the materials science and the neuroscience approaches presented are portable
to other endeavors such as the fabrication of other flexible optoelectronic technologies (Figure
3.1-3.3) and/or the general stereotaxic surgery (Figure 3.5).
Though the devices detailed in Chapters 2 & 3 enable previously impossible
experimental power for wireless photostimulation, they are limited greatly in their scope for
other wireless perturbations such as local pharmacological manipulations in the deep brain.
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Local pharmacology is a powerful tool in dissecting both neural circuits and endogenous
receptor/ligand systems (Parker et al., 2010; Stachniak et al., 2014). However, to date, localized
fluid delivery has relied exclusively on tethered approaches. Together, Jaewoong Jeong and I
achieved wireless fluid delivery that can be paired with photostimulation (Chapter 4). These
optofluidic neural probes can deliver up to four different fluids (Figure 4.1 & 4.6) and we have
shown utility in viral gene transfer (Figure 4.10), local pharmacology (Figure 4.11), and paired
optogenetic and pharmacological manipulation (Figure 4.12). Here we again returned to the
well-established VTA-DA system to demonstrate the latter combinatorial approach. Following
the extensive progress that had recently been made in the VTA-DA field (Gunaydin et al., 2014;
Kim et al., 2012, 2013; Lammel et al., 2011, 2012, 2015; Stamatakis et al., 2013; Stuber et al.,
2015; Tsai et al., 2009; Witten et al., 2011), we isolated a distinct projection to photostimulate
and antagonize dopamine D1 receptors (DRD1) (Figure 4.12). The isolation of this projection
greatly increased the selectivity of our approach in Chapter 2 (Figure 2.11) and revealed a role
for this particular projection in the real-time place preference assay (Figure 4.12).
All of the devices presented in Part 1 represent first forays into new technology.
Following the initial proof-of-principle experiments presented here, there are myriad of ways to
expand application of the technology.
Enhanced spatial targeting using independently-controlled !-ILEDs
A major motivation and primary strength of the !-ILED approach to photostimulation is
the ability to spatially restrict the path of light (Figure 2.23) (Kim et al., 2013). At the time that
we began work on these devices the most celebrated approach to directing the light path was
feeding a fiber optic cable through a beveled cannula (Tye et al., 2011). Contemporaneous
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development of optical waveguide-based probes (Zorzos et al., 2010, 2012) achieved marked
success in spatial targeting of light, but failed to implement these impressive devices into
experiments with behaving animals. While these waveguides provide impressive optical abilities,
their rigid design and cumbersome optical coupling have limited their use in the field. !-ILED
devices, however, should be capable of spatial targeting beyond what we have so far presented.
The initial devices used an array of four !-ILEDs all under the same control. Gunchul Shin has
since developed !-ILED devices that have two !-ILEDs separated by 1 mm that can be
independently controlled. These “bidirectional” devices provide a first concept towards enhanced
spatial targeting with !-ILEDs and we have demonstrated their utility dissecting the
microanatomy of the nucleus accumbens. Ream Al-Hasani and I have recently identified a
functional anatomical segregation within dynorphin-expressing neurons of the nucleus
accumbens (Appendix 1). Here we show that activation of dynorphin neurons in the dorsal shell
of the nucleus accumbens (NAcSh) drives a preference behavior and activation of dynorphin
neurons in the ventral NAcSH drives an aversion behavior. Using Gunchul’s devices we were
able to demonstrate that this behavioral diversity can be elicited in the same animal by shifting
the spatial targeting of photostimulation between dorsal to ventral (Figure A1.3 and A1.4).
While the dynorphin experiments show the promise of spatial selectivity using !-ILEDs,
there likely remain greater spatial targeting achievements. One can imagine flexible devices that
insert between the hippocampus and cortex of mouse brain or along sulci in higher mammals that
would allow spatially segregated targeting of different regions. Other possible schemes could
involve flexible net-like devices that could overlay the cortex (Viventi et al., 2010, 2011),
providing numerous independently-addressable !-ILEDs. One such exciting application that
exploits the spatial properties of independently-addressable !-ILEDs is using optogenetics for
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cochlear stimulation. Preliminary studies have already shown that such an approach is feasible
with !-ILEDs (Hernandez et al., 2014), but soft, flexible devices with independently-addressable
!-ILEDs that could wrap along the cochlea similar to traditional cochlear implants could help
refine the sensitivity of such prosthetics (Clark, 2015). Such devices could greatly aid study of
larger network dynamics with the fine control of optogenetics. Furthermore, the independentlyaddressable !-ILEDs could also access different wavelengths to either provide combined
stimulation/inhibition or to activate discrete opsins targeted to distinct cell-types along a similar
projection (Chuong et al., 2014; Klapoetke et al., 2014; Lin et al., 2013).
Miniaturization of the harvesting antenna
The initial power harvesting antennas that we presented were relatively large (~2 g) and
most of this weight resulted from a reliance on a standard, commercially available rigid printed
circuit board. By printing the same circuitry on flexible Kapton film we were able to reduce the
weight of the harvester to ~700 mg. These lightweight devices, however, still require external
mounting and would interfere with more ethologically-relevant behaviors such as social
interaction. Following our work from Chapter 2 (Kim et al., 2013), Sung il Park in the Rogers
group has worked diligently to reduce the size of the power harvester needed to power the
µ#ILEDs. The ultimate goal of this work is to achieve a miniaturized power harvester capable of
being embedded completely under the scalp of an animal. Sung il achieved an order of
magnitude reduction in weight by increasing the operating frequency of the harvesters (Park,
2013). The original harvesters operated at ~900 MHz and an increase to 1.5 GHz, resulted in
substantially smaller harvesters (Figure 7.1A & B). These devices were operational and proved
sufficient for Ed Siuda and myself to demonstrate that wireless activation of Gs-signaling in
CAMKII"+ neurons the BLA is sufficient for anxiety-like behavior in the light-dark box assay
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(Figure 7.1C-F). Importantly, this assay involves the animal entering an enclosed environment
and would be incompatible with tethered fiber optic system. After this initial reduction in size,
Sung il once again increased the operating frequency to allow for further miniaturization of the
harvesters. Now with harvesters optimized near 2.4 GHz, the devices are an order of magnitude
lighter ~60 mg and can easily be implanted under the scalp (Figure 7.1G). Proof of principle
experiments

Figure 7.1: Ongoing work to reduce the size of the RF energy harvester. (A) Circuit diagram
of an energy harvester operating at 1.5 Ghz. It consists of antenna, impedance matching circuits,
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Cockcroft-Walton multiplier, and micro-LEDs. (B) Radiofrequency power harvester with µLEDs. µ-LEDs are detachable from the harvester as shown in the inset. Scale bars = 5 mm. (C)
Viral injection site, unilateral !-ILED implant and brief overview of wireless transmission
system. (D) Representative traces of individual control (black) and individual opto-!2AR (blue)
animal in light dark box behavioral assay. (E) Wireless photostimulation of mice expressing
opto-!2AR (blue; n = 7) in the BLA enter the dark box faster than viral controls (black; n = 11)
(* p < 0.05; log-rank (Mantel-Cox) Test) (inset * p < 0.05; Students’ unpaired t-test). (F) Opto!2AR animals (blue) spend more time in the dark box than viral controls (black) (*p < 0.05;
multiple Student’s unpaired t-tests). All data expressed as mean ± SEM. All light pulses are 473
nm, 1 W/cm2. (G) Demonstration of subcutaneous implantation of 2.4 GHz RF harvesters. (A &
B) Data generated by Sung il Park, Rogers Group, University of Illinois at Urbana-Champaign
(C-F) Data generated and analyzed by Edward R. Siuda, Jordan G. McCall, and Martin J.
Schmidt. (G) Data generated by Jordan G. McCall.

293

using these devices are underway, but these miniaturized harvesters may prove difficult to
implement with freely behaving animals due to the limitations of RF power harvesting.
Limitations of radiofrequency power scavenging
The wireless capabilities of the devices presented in Chapters 2 & 3 (Kim et al., 2013;
McCall et al., 2013) are all based on the concept of radiofrequency power harvesting from
intentionally broadcasted sources. This powering scheme is advantageous because it allows the
user to wirelessly operate the devices while foregoing both an onboard battery and a processor of
some kind to determine the parameters of photostimulation (the latter is avoided by manipulating
the broadcasted RF signal). However, the intentionally broadcasted RF signal is linearly
polarized. This polarization limits the angle at which the broadcasted signal can be efficiently
harvested for power of the µ#ILEDs. Practically speaking, this property can greatly limit the
ability to deliver effective wireless photostimulation. As discussed briefly in Chapter 3 (McCall
et al., 2013), the use of multiple broadcast antennas arranged purposefully can overcome some of
these polarity issues. However, the increase in operating frequency that allows for
miniaturization of the harvester makes these devices inherently more prone to polarity issues.
These issues can be problematic. Despite the use of multiple broadcasting antennas, there can
often be numerous “dead zones” or areas where there is insufficient RF radiation to power the
devices in a behavioral arena. This likely did not affect our behavioral results in (Figure 7.1C-F)
as we were using an optically-sensitive GPCR with a activation time that outlasts the period of
photostimulation (Airan et al., 2009), but users wishing to use a faster acting channel or pump
(Mattis et al., 2012) may face hurdles. This limitation is likely a greater concern in the 2.4 GHz
subcutaneous versions of the harvesters.
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Despite the limitations introduced by the higher operating frequency, the goal of
miniaturization is a worthy target. One possible solution is to use the implanted nature of these
devices to harness the tissue of the animal as a greater harvesting platform (Peyman et al., 2001;
Poon et al., 2010). Such an approach would allow smaller harvesters that are not nearly as
effected by the head direction of the animal (as the whole body of the animal could be used to
help capture RF energy). Another approach would be to supplement the small-scale harvesters
with a small battery that engages when power is lost. This would eliminate dead zones, but the
battery and its interface to the harvester may prove too large to have the device remain
subcutaneous. It is also possible that such a strategy would need a miniaturized microcontroller
to ensure proper control of the photostimulation. Finally, and perhaps most promising, is the
prospect of moving away from high frequency RF scavenging altogether. Lower frequency RF
(~13 MHz) such as that used for Near Field Communication (NFC) can similarly be used for
energy transfer from an initiator antenna to power a passive target, in this case an µ#ILED array
(S.n et al., 2012). A similar approach was recently demonstrated using a resonant cavity to
broadcast circularly polarized RF signals to nearby RF harvesting coils for wireless
photostimulation in mice (Ho et al., 2015). In that particular case, the resonant cavity inherently
restricts the operating distance and types of behavior accessible to this technology. The NFC
initiator-based approach also sacrifices the distance at which the devices can be wirelessly
powered (high frequency RF can operate µ#ILEDs at ~2 m, low frequency is likely close to 10
cm). However, the NFC initiator can be many different shapes and could presumably be formfitted to any behavioral environment. Assuming three-dimensional access to the environment in
which the subject was freely moving, it should be possible to maintain efficient photostimulation
without limitations of polarity or “dead spot” areas in the field using an NFC initiator approach.
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Furthermore, NFC should easily accommodate underwater scenarios that are difficult with high
frequency RF or battery-based systems (Zoksimovski et al.) and the technology is already being
used for bidirectional information exchange which would easily enable physiological monitoring
systems such as electroencephalography (Bertrand, 2015).
Increasing the functionality and accessibility of optofluidic neural probes
The optofluidic neural probes presented in Chapter 4 foreshadow a number of parallel
advances in wireless neural interface technologies including therapeutic approaches accessing
the peripheral nervous system (Minev et al., 2015), the expansion of in vivo photoconversion of
caged ligands (Kramer et al., 2013; Polosukhina et al., 2012; Tochitsky et al., 2014), and
improved wireless photostimulation schemes based on battery-powered microprocessors (Iwai et
al., 2011; Lee et al., 2015). The designs we present in Chapter 4 can be modified to address
each one of these exciting new directions. Local delivery of drugs into the spinal cord and
peripheral nervous system could provide opportunities for better pain management and/or aid in
regeneration of damaged nerves (Minev et al., 2015; Richards and McMahon, 2013; Scheib and
Höke, 2013). Such delivery may be more readily achieved using these thin, flexible microfluidic
channels. Likewise, the integration of the optofluidic neural probes with UV spectrum (~405 nm)
!-ILEDs that Gunchul Shin has recently developed will hopefully expand the applicability of
these devices to wild-type animals and increase the chance of therapeutic translation using caged
compounds (Banghart and Sabatini, 2012; Kramer et al., 2013). Finally, it is worth noting that
the wireless scheme presented in Chapter 4 is unique from those presented in Chapters 2 & 3.
Using a battery-powered microprocessor insures equivalent efficiency of the !-ILEDs regardless
of the position or orientation of the animal in space, thus providing another solution to the
polarity issues discussed above. While these battery-powered designs are larger (~1.8 g) than the
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current generation of RF harvesters, size reduction for devices intended exclusively for
photostimulation are immediately possible. The power requirements for the µ#ILED is
substantially less than that of the Joule heaters needed for fluid delivery, so such a device would
only need a single battery. Furthermore, control of the pulse paradigm for photostimulation could
be removed from the on-board microcontroller and instead controlled remotely by pulsing the IR
signal. In other words, if the microcontroller was reduced to serve as an I/O gate to the µ#ILEDs
then the IR signal could be pulsed to any desired parameters. Such modifications could likely
make a wireless photostimulation device weighing less than 500 mg that would not suffer any
orientation limitations.
Unlike the ultrathin, flexible multimodal µ#ILED devices presented in Chapters 2 & 3
(Kim et al., 2013; McCall et al., 2013), the optofluidic neural probes presented in Chapter 4 are
fabricated from readily available and/or 3D-printable materials in a standard lab environment.
However, accessibility to these devices is limited to how the fluid chambers are filled (see
Chapter 4 Materials & Methods). The current design only allows each set of four chambers to
be filled a single time. Ideally, access to the fluidic channels would be limitless. In tethered
approaches, fluid supply is never an issue and certainly not the limiting step towards adopting the
technique. Development of a cartridge system that could reversibly connect to the microfluidic
channels is one possibility for overcoming this hurdle. In this case, fluid could be filled into
limitless disposable cartridges and once the fluid is dispensed from all chambers in the cartridge,
the entire cartridge is replaced. The primary challenge with this idea will be the creation of fluid
interconnects that remain patent between cartridges, but such a goal should be achievable.
Even though each device and technology platform introduced in Part 1 has room for
improvement and modification, each device design is ready to address new biological questions.
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In large part, these tools were developed to help us answer previously intractable questions
concerning the locus coeruleus noradrenergic system. Though application of these technologies
to locus coeruleus circuitry has begun (Figure 2.23, Figure 7.1C-F), much more work will be
needed to better understand how this system regulates such a broad range of behaviors. In Part
2, we began a relatively gross modern dissection of LC-NE circuitry in negative affect. With the
help of the technology from Part 1, we can uncover more of the fundamental nature of LC-NE
mediated behaviors.
PART 2: Dissecting the role of locus coeruleus circuitry in negative affective behaviors
The locus coeruleus noradrenergic (LC-NE) system has been known to be involved in
central stress response for many decades (Koob, 1999). While numerous groups have observed
that the LC-NE electrophysiological activity increases in response to stressors (Bingham et al.,
2011; Cassens et al., 1981; Curtis et al., 1997, 2012; Francis et al., 1999; Lechner et al., 1997;
Jedema and Grace, 2004; Page and Abercrombie, 1999; Reyes et al., 2008; Snyder et al., 2012;
Valentino et al., 1991; Valentino and Foote, 1988; Valentino and Van Bockstaele, 2008), the
underlying circuitry and cellular dynamics of this response have not previously been fully
elucidated. Recent advances in cell-type selective control of neural circuitry, namely
optogenetics and chemogenetics, provide an ideal toolbox for furthering our understanding of
this small, pontine brain structure. Indeed, one of the earliest in vivo optogenetics studies
targeted the LC-NE cell bodies to understand this structure’s role in arousal (Carter et al., 2010).
The bidirectional control of arousal through LC-NE cell bodies by Carter et al., 2010
demonstrated the powerful command this small brainstem structure can have on gross behavioral
states. This early observation, though striking, left much unexplored territory for the LC which is
known have roles in stress responses (Koob, 1999), attention (Sara, 2009; Sara and Bouret,
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2012), and descending pain modulation (Jones, 1991) among other behavioral outputs (Berridge
and Waterhouse, 2003; Sara, 2009). In order to better understand how the LC-NE system
mediates these and other behaviors, more detailed studies were necessary to dissect the
underlying circuitry. The studies presented in Chapters 5 & 6 are the first to selectively
manipulate LC-NE neurons in the context of stress and the resulting anxiety-like behaviors and
are the first to explore afferent and efferent projections from this structure with regard towards
negative affective behavior.
In Chapter 5, we report that the activity of LC-NE neurons is necessary to elicit acute
stress-induced anxiety (Figure 5.1). Furthermore, selectively increasing the firing of LC-NE
neurons is itself anxiogenic in the absence of stress (Figure 5.4). This same high tonic state has
negative valence that can be learned to influence future behavior (Figure 5.6). Interestingly, this
negative valence can be generated by a subset of LC-NE neurons that express the neuropeptide
Galanin (Figure 5.8). In an effort to understand the endogenous afferent circuitry that mediates
these effects we traced CRH+ inputs from the central amygdala (CeA) to the LC (Figure 5.11).
Optogenetic stimulation of CRH+ CeA terminals into the LC replicates both the cellular activity
profile and acute anxiogenic and aversive behavioral state of direct LC-NE high tonic
stimulation (Figure 5.13).
Following these experiments, we sought to determine what downstream brain regions and
receptor systems could be targets to drive the negative affective behaviors mediated by the LC.
In Chapter 6, I observed that the anxiogenic and aversive components of LC activation may be
mediated through two different adrenergic receptor systems (Figure 6.1). In an effort to
understand where these effects are mediated, Ed Siuda and I identified an anxiogenic and
aversive efferent projection from the LC to the basolateral amygdala (BLA) (Figure 6.6 and
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6.7). Increased tonic stimulation of this projection releases norepinephrine (NE) into the BLA
(Figure 6.4) and alters BLA single unit activity similarly to exogenously applied NE (Figure
6.5) (Buffalari and Grace, 2007). In the behaving animal, stimulation of these LC-BLA terminals
drives similar anxiety-like behavior and conditions an aversion similar to direct LC-NE cell body
stimulation (Figure 6.6, Figure 7.2A). Together these findings suggest a critical amygdalarcoerulear network in the mediation of stress-induced anxiety (Figure 7.2 B). Understanding
these circuits in the context of natural behaviors will require further study, but there is
undoubtedly a wealth of knowledge to be gained by further circuit dissection of the LC-NE
system.
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Figure 7.2 Possible models for LC-NE mediated stress-induced negative affective
behaviors. (A) Chapter 6 indicates that LC-BLA projections likely mediate acute stress-induced
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persistent stress-induced anxiety, the LC sends projections to this region which could play a role
in sustained stress-induced anxiety.
Considerations when using Cre-driver lines for cell-type selective targeting
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Much of the data presented in this dissertation was gathered using various Cre-driver
lines (e.g. Th-Cre, CRH-Cre, Gal-Cre, Dyn-Cre, etc.). While these mouse lines can enable celltype selective expression of constructs using Cre-dependent viral vectors, it is important to
consider the limitations of these animals. Recent work highlighted various Cre-driver lines
commonly used to target VTA-DA neurons may target slightly different populations within and
near this brain region (Lammel et al., 2015). While there is significant controversy concerning
this work (Stuber et al., 2015), it is important to appreciate that no Cre-driver system is likely
perfect. In our hands with the Gal-Cre mouse, using a Cre-dependent reporter mouse, we
observed Cre-dependent activity in brain regions that should be absent of Galanin in the adult
(Figure 5.9). After a thorough investigation using the Allen Brain Atlas of the Developing
Mouse Brain, we determined that the ectopic reporter expression was due to recombination from
transient Galanin (and therefore Cre) expression during development. After histological
evaluation in the adult mouse, we believe that this appearance of “leaky” Cre expression is likely
an artifact brought on through development. Such developmental changes of Cre expression have
been observed before (Bruchas et al., 2011) and the extent to which they can bias results will
depend on each mouse line and each experiment. Importantly, following histological
examination in all of the mouse lines we used in Part 1 and Part 2, we do no believe there is
cause for concern in interpreting our data.

Single-unit electrophysiology qualifications and future alternatives
The single-unit electrophysiological studies of LC neurons presented in Chapters 5 & 6
were all performed in isofluorane-anesthetized animals. While the LC is still active under light
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(<~1%) isofluorane anesthesia, its activity is significantly reduced and can be dampened
completely with higher levels of isofluorane (Gompf et al., 2009). Conversely, significant LC
activation can reverse the effects of isofluorane anesthesia (Vazey and Aston-Jones, 2014).
Significant effort was taken to perform these experiments at the lowest possible level of
anesthetic that still maintains an anesthetized state of the animal (~0.7%). That being said, the
basal activity of LC neurons and the likelihood of observing an LC neuron were both likely
decreased in all of the recording experiments. This side effect of the experimental preparation
introduces an inherent selection bias as one can only record from neurons that are observably
active. Though attempts were made to record from the LC of awake, behaving animals the
signal-to-noise ratio was not ideal to isolate single LC neurons. An important future step in
understanding LC-NE function will be to observe the activity of these neurons during naturalistic
behaviors (e.g. during the stress experience and/or the expression of anxiety-like behaviors. One
possible approach would be to visualize the LC-NE neurons using a genetically targeted
fluorescent Ca2+ indicator paired with a deep brain implanted gradient-index (GRIN) lens and
miniature fluorescent microscope (Hamel et al., 2015; Jennings et al., 2015; Ziv et al., 2013).
While the temporal resolution of in vivo Ca2+ imaging is much slower than single-unit
electrophysiology, there should be valuable information gained from the visualization of these
neurons in awake, behaving animals. Even at a reduced temporal resolution, gross alterations in
LC-NE activity should be observable with in vivo Ca2+ imaging. Such observational studies
would greatly inform how the LC processes stressful events and induces negative affective
behavior.
The implementation of deep brain microendoscopy can be challenging, however, due to
the invasive nature of the implanted GRIN lens. Fiber photometry represents a less invasive
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opportunity to resolve population activity with genetically targeted fluorescent Ca2+ indicators
(Cui et al., 2013, 2014). While this approach likely does not yield much greater information that
multiunit activity would at cell bodies, the technique can be used to observe Ca2+ activity in
terminal fields (Gunaydin et al., 2014). This feature of the technology would be very powerful in
understanding the dynamics of long-range projections into and out of the LC. Furthermore, it is
possible that the flexible photodetector presented in Chapters 2 & 3 could be adapted for similar
purposes (Figure 2.1, Figure 3.3).
Temporal limitations and the implications for persistent and chronic stress-induced anxiety
While these studies are the first of their kind to dissect LC function with cell-type- and
projection-selective targeting, there remain many limitations in the interpretation of the data. The
necessity of the LC-NE system in stress-induced anxiety was shown by cell-type selective
chemogenetic inhibition of LC-NE neurons (Figure 5.1). This approach is somewhat temporally
ambiguous due to the onset kinetics of CNO and the Gi-coupled DREADD receptor. We chose
this tool purposefully as it should enable inhibition of LC activity for an extended period of time
(~1 hour). However, because LC activity was likely dampened during both the stressor and the
test of stress-induced anxiety-like behavior, it is difficult to know the contribution of increased
LC activity to either. Inhibitory optogenetic constructs are much more temporally precise,
however achieving equivalent inhibition via illumination across a large area can be problematic.
Not only are there concerns of tissue heating (Yizhar et al., 2011), but the first generation
optogenetic constructs can lead to altered cell activity after the inhibition has ceased (Raimondo
et al., 2012).
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Similar to the temporal concerns of the inhibition experiments, all of our studies in
Chapters 5 & 6 relate only the acute phase of stress-induced anxiety. While we suggest that LC
activity may work in a feed-forward loop through the amygdala to promote an anxiety-like state
it is unclear at this time if LC-NE activity alone can sustain such a loop. Experiments that acutely
increase LC tonic activity prior to anxiety testing (rather than during) and those addressing
chronic LC activation (see below) can help address these outstanding questions. Recent evidence
has shown that persistent stress-induced anxiety is mediated through CRFR2+ cells in the lateral
septum (Anthony et al., 2014). It is possible that the LC mediates acute anxiety-like behavior
through a projection to the BLA (Figure 7.2A), while modulating more long-term stress-induced
anxiety through inputs into the lateral septum (Figure 5.14, Figure 7.2C).
Do diverging projections explain diverging behaviors?
A central question underlying LC-NE research is how a small structure with such
ubiquitous innervation of the forebrain can selectively contribute to a wide array of physiological
and behavioral functions as it does? Our work here (Chapters 5 & 6) begins to illustrate a
circuit-based mechanism for this diversity. First, in Chapter 5 we demonstrate that only a subset
of neurons are required to sufficiently drive a real-time place aversion (Figure 5.8) and that
sparse innervation from the CeA is sufficient for both learned aversion and anxiety-like behavior
(Figure 5.13). Next, in Chapter 6 we show that anxiety-like and real-time place aversion are
mediated by two separate downstream adrenergic receptor systems (Figure 6.1) and that the
anxiety-like behavior is likely mediated through !-adrenergic receptors activated by LC
projections to the BLA (Figures 6.1, 6.4, 7.1, 7.2A). This divisibility of behavioral output
suggests that subsets of LC neurons with different efferent projection targets can drive distinct
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LC-mediated behaviors. It will be important to extend these findings to other behaviors,
particularly other stress-induced behaviors as described below.
The next generation of functional circuit dissection should access finer selectivity than
the research presented here. Combinatorial approaches that utilize intersectional genetics as well
as projection-selective viral gene transfer will greatly enhance our ability to decipher complex
circuitry in vivo (Fenno et al., 2014; Madisen et al., 2015; Saunders et al., 2012; Stamatakis et
al., 2013). We previously suggested that a similar approach be taken using the Gal-Cre mice to
selectively target LC-NE neurons that do not express Galanin (i.e. using the Cre-OFF system
(Saunders et al., 2012), but such an approach could be used in combination with retrograde viral
targeting to yield, projection- and perhaps synapse-selective cell-type selective control of
neuronal subtypes (Goshen et al., 2011; Krashes et al., 2014; Ogawa et al., 2014; Watabe-Uchida
et al., 2012).
Exploring LC-NE activity in other stress-related behaviors
Stress-induced anxiety and aversion represents only a subset of known behavioral
responses to stress (Bruchas et al., 2011; Butler and Finn, 2009; Weninger et al., 1999). Several
stress-induced behaviors are known to be influenced or mediated by NE, including stressinduced relapse to drug seeking (Weinshenker and Schroeder, 2007) and stress-induced analgesia
(Butler and Finn, 2009). Exploring the possibility of these behaviors being mediated by LC
efferent projections is a compelling next step.
Stress-induced relapse
While it is possible the NE involved in other stress-induced behaviors could come from
the other A1/A2 noradrenergic neurons of the brainstem (Erb et al., 2000; Shaham et al., 2000),
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preliminary data indicates that tonic activation of the LC-NE system is sufficient for
reinstatement of a cocaine place preference (Appendix 2, Figure A2.1). While these data need
to be extended and replicated, the findings represent an interesting observation that goes against
the accepted dogma in the addiction field (Weinshenker and Schroeder, 2007). The LC-NE
system has not been considered a mediator of stress-induced relapse since an early
pharmacological study asserted that the mechanism was independent of LC activity (Shaham et
al., 2000). While this study and others (Delfs et al., 2000) clearly demonstrated the involvement
of A1/A2 noradrenergic neurons in these behaviors, the data are not sufficient to rule out a role
for the LC-NE system. Furthermore, our lab has recently shown that the LC does have an
important role in kappa opioid-induced reinstatement to cocaine place preference (Al-Hasani et
al., 2013). Future studies will be necessary to determine if the reinstatement behavior induced by
tonic activation of LC-NE cell bodies is truly mirroring stress-induced reinstatement. However,
the tools now exist for elegant dissection of this behavior to demonstrate both the necessary and
sufficient components of the system paralleling the approach used in Chapter 5.
Beyond using selective modulation of LC-NE cell bodies in drug seeking behavior, it will
also be important to investigate the underlying circuit mechanisms of such behavior. For
example, the efferent projections from the LC that mediate reinstatement behavior may not be
the same as those that mediate anxiety-like or aversion behaviors. While it is possible that the
negative affective behaviors induced by tonic activation of the LC fibers in the BLA can drive
reinstatement behavior (Bruchas et al., 2009, 2011; Land et al., 2009), it is also possible that the
LC-NE system can mitigate reinstatement from direct activation of the VTA-DA system (MejíasAponte et al., 2009; Velásquez-Martinez et al., 2012) (Figure 7.3A). Furthermore, the afferent
circuitry that activates the LC-NE system during such behavior could be independent of the
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Figure 7.3 Possible models for the role of LC-NE in other stress-induced behaviors. (A)
Stress-induced reinstatement of drug seeking could possible be mediated in part by LC
projection into the VTA that activates "1-adrenergic receptors or by activating the anxietyrelated circuits in Figure 7.2. (B) Stress-induced analgesia may be mediated by descending
projections into the spinal cord via "1-adrenergic andor "2-adrenergic receptors.
Stress-induced analgesia
The LC-NE system has a well-established role in the descending modulation of pain
(Jones, 1991; Liu et al., 2008; Millan, 2002; Ossipov et al., 2010; Tsuruoka et al., 2010).
Furthermore, NE and its receptor systems are known mediators of stress-induced analgesia
(Buerkle and Yaksh, 1998; Butler and Finn, 2009; Howe et al., 1983). The link between these
two observations, however, has yet to be clearly made. Recently both our group (Appendix 2,
Figure A2.2) and another (Hickey et al., 2014) have demonstrated that increased tonic LC-NE
activity can drive antinociception in both mice and rats, respectively. This selective increased
activity mimics stress-induced anxiety (Figure 5.4), but whether the same can be said for stressinduced analgesia remains to be seen. Selective inhibition of LC-NE neurons during stress will
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be important to determine whether there is physiological relevance to the findings in Figure
A2.2 and Hickey et al., 2014.
The study of descending modulation of pain by the LC-NE system is clear example of a
case where integration between Part 1 and Part 2 of this dissertation would be fruitful (Figure
7.3B). As previously discussed, integration of the optofluidic neural probes (Chapter 4) with the
spinal cord is a promising future direction. In the case of descending LC-NE projections, the
ability to optically stimulate LC-NE terminals within the spinal cord would provide direct
evidence that the analgesic effect of LC-NE stimulation is via descending projections rather than
through central modulation in the amygdala or elsewhere. Furthermore, local pharmacology in
the spinal cord could help to resolve the receptor systems mediating any observed effects.
Beyond local modulation in the spinal cord, Hickey et al., 2014 presented evidence of a dorsalventral shift between pronociception and antinociception in the LC. Using independentlyaddressable !-ILEDs such as those used in Appendix 1, could help decipher the contribution and
significance of this anatomical functional segregation within the LC proper.
Stress-induced arousal disorders
The LC-NE system is intimately involved in the regulation of arousal states (Aston-Jones
and Bloom, 1981; Carter et al., 2010, 2012; Foote et al., 1980; Sara and Bouret, 2012). While the
awake state seems to be mediated by the presence of any tonic activity (Aston-Jones and Bloom,
1981; Bloom, 1981; Carter et al., 2010), we now know that increased tonic activity mimics the
behavioral phenotypes of stress (Figures 5.4, 5.6, 5.8, 5.13, 6.1, 6.6). The connection between
stress, anxiety, arousal and the LC-NE system is likely a continuum: the more LC-NE activity,
the more arousal, the more anxiety-like behavior. While we believe that LC activation likely
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adjusts the gain on downstream anxiety systems (e.g. BLA activity), we have not examined the
long-term consequences of exogenously increasing LC activity. Chapters 5 & 6 only test acute
anxiety-like and aversive states. It is possible that chronic, long-term activation of LC-NE cell
bodies would produce a state of hyperarousal a known symptom of post-traumatic stress disorder
(Krystal and Neumeister, 2009). Once again, utilizing some of the technology presented in Part 1
can now more directly test such a hypothesis. Wireless !-ILED devices that utilize RF power
harvesting are suitable for long-term photostimulation in a homecage environment. Thus, one
could directly test the behavioral effects of chronic LC stimulation. Wireless optogenetics,
however, are not necessary for such a design. It would also be possible to mimic chronic
activation of the LC by targeting the Gq-coupled DREADD receptor to LC-NE neurons and
deliver CNO via an osmotic pump. While the time-frame of this design would be limited by the
CNO exposure, it would certainly allow for long-term activation of LC-NE neurons.
Closing thoughts
While both Part 1 and Part 2 of this dissertation provide new tools for interrogating
neural function and insight into the role of LC-NE system in stress-induced behaviors, each Part
is only a very early step in these processes. Flexible, wireless neural probes ultimately have the
potential clinical translation. Perhaps not with optogenetics in mind, but less invasive and less
cumbersome medical devices are promising future applications of these kinds of technology.
With a clearer understanding of the function of the LC-NE system in stress-induced behaviors, it
is even possible that such technologies could be used to ameliorate psychiatric disorders, relieve
pain, or prevent the deleterious effects of chronic stress and axnxiety.
MATERIALS & METHODS
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Stereotaxic surgery
Mice were anaesthetized in an induction chamber (5% isoflurane) and placed in a
stereotaxic frame (Kopf Instruments, Model 1900) where they were maintained at 1-2%
isoflurane throughout the procedure. Following craniotomy mice were injected bilaterally with
1.2 !l of either lenti-EF1"-GFP or lenti-CaMKII"-opto!2AR-mCherry in the basolateral
amygdala at stereotaxic coordinates from bregma: -1.3 mm (AP), ± 2.9 mm (ML) and -4.9 mm
(DV). For wireless !-ILED BLA studies, animals were injected unilaterally, not bilaterally. Mice
were then implanted with chronic fiber optic implants or !-ILED wireless devices with
coordinates adjusted from viral injection to 0.00 mm (AP), ± 0.00 mm (ML), and +1.00 mm
(DV). For bio-dissolvable samples, the device was implanted at the desired target, ACSF was
applied to the portion of the device that remained outside of the skull to facilitate dissolution of
the adhesive, and then the epoxy needle was removed after a delay of 15 min (Kim et al., 2013;
McCall et al., 2013). The fiber optic implants and wireless !-ILED devices were secured using
two bone screws (CMA, 743102) and affixed with TitanBond (Horizon Dental Products) and
dental cement (Lang Dental) (McCall et al., 2013). Mice were allowed to recover for at least 3-6
weeks prior to behavioral testing; this interval also permitted optimal viral expression.
Wireless powering and RF powering scavenger for wireless optogenetics
Wireless powering of the !-ILED devices was adapted as previously described (Kim et
al., 2013; McCall et al., 2013). The wireless power transmitter includes an RF signal generator
(Agilent N5181A), a power supply (Agilent U8031A), a RF power amplifier (Empower RF
Systems 1119-BBM3K5KHM), an RF signal splitter (RF Lambda RFLT2W0727GN), and two
panel antennas (ARC Wireless ARC-PA2419B01). The RF signal generator is internally
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modulated to delivery sufficient power to light the !-iLEDs at the given stimulation protocol (10
Hz, 50 ms pulse widths). The RF power amplifier that is powered by the power supply enlarges
the modulated RF signal from the RF signal generator. The RF power is then transmitted from
the panel antenna to the headstage power harvesters. The RF signal generator has a power
output from -10 to 0 dBm at 1.5 GHz, optimized daily to ensure equivalent light power
throughout the space of the LDB assay. Mice with chronically implanted µ-ILED devices were
acutely connected to the headstage power harvesters immediately prior to any wireless
photostimulation.
Behavior – Light/Dark Box (LDB)
Behavioral assays were performed in a special sound attenuated room maintained at
23°C. Lighting was measured and stabilized at ~ 4 lux for anxiety tests and ~200 lux for place
testing. All behavioral apparatuses were cleaned with 70% ethanol in between animals. In each
assay, animals received constant photostimulation throughout the entire trial. For all behavioral
experiments, lenti-EF1"-GFP and lenti-CaMKII"-opto!2AR-mCherry received 5 sec of constant
photostimulation (473 nm) followed by 5 sec of no light throughout the entire trial. Movements
were video recorded and analyzed using Ethovision Software. The LDB was a 50 x 50 cm square
plexiglass enclosure with a 16.5 cm x 49 cm dark insert. For testing, animals were connected to
wireless harvester and placed into the corner of the open enclosure and allowed to roam freely
for 10 min.
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Distinct subpopulations of nucleus accumbens
dynorphin neurons drive aversion or reward
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SUMMARY
Both the nucleus accumbens (NAc) and the dynorphinergic system are widely implicated
in motivated behaviors. Prior studies have shown that activation of the dynorphin-kappa opioid
receptor (KOR) system can lead to aversive, dysphoria-like behavior. However, the endogenous
sources of dynorphin in these circuits remain unknown. We investigated whether dynorphinergic
neuronal firing in the NAc is sufficient to induce aversive behaviors. We found that
photostimulation of dynorphinergic cells in the dorsal NAc shell induces robust place preference
and is positively reinforcing in an operant paradigm, whereas activation of dynorphin neurons in
the ventral NAc shell elicits robust conditioned and real-time aversive behavior via KOR
activation. These results show a previously unknown, discrete NAc subregion of dynorphincontaining cells in the ventral shell that selectively drive aversive behavior. Understanding the
regional specificity by which NAc dynorphinerigic cells regulate aversion provides valuable
insight into the motivated behaviors dysregulated in stress and psychiatric disease.
INTRODUCTION
It is now widely thought that many mood disorders are associated with major disruption
of the brain’s reward circuitry (Nestler and Carlezon, 2006). The nucleus accumbens (NAc) is a
key region within this circuitry with major projections from the ventral tegmental area (VTA),
medial prefrontal cortex (mPFC), basolateral amygdala (BLA) and the hippocampus (Russo and
Nestler, 2013). Recent studies have identified the striatum as crucial for integrating behavioral
responses to both positive and negative reinforcement (Castro and Berridge, 2014; Everitt and
Robbins, 2005; Kravitz et al., 2012). Furthermore, it is thought that negative emotional states are
what mediate and perpetuate the phases of depression as well as increase susceptibility to drug
abuse. NAc neuronal activity is consistently reduced in major depression in humans (Drevets et
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al., 1992; Mayberg et al., 2000) and is thought to reflect loss of reward function that drives
common symptoms such as anhedonia (Russo and Nestler, 2013). In order to better understand
these processes, it is important to dissect how neuromodulator systems within specific
subregions of the brain function to influence negative emotional states, represented by changes in
motivated behavior.
The kappa opioid receptor (KOR) system has recently been identified as one such
prominent neuromodulator system for regulating motivated behavior and is highly implicated in
stress-induced dysphoria and vulnerability to drug abuse. Its peptide dynorphin (Dyn), which is
cleaved from the precursor prodynorphin, endogenously activates KORs (Chavkin et al., 1982).
Dyn is known to mediate negative emotional states, with KOR agonists inducing place aversions,
depression-like behavior, and dysphoria in human and animal models (Mucha et al., 1985;
Pfeiffer et al., 1986; Shippenberg et al., 2007). Notably, direct infusion of KOR agonists into the
NAc mediates conditioned place aversion (Bals-Kubik et al., 1989), and local antagonism of
KOR in this region prevents depression-like behavioral responses (Land et al., 2009; Shirayama
et al., 2004). Furthermore, Dyn-containing axon terminals and cell bodies are located in the NAc
(Van Bockstaele et al., 1995). Additionally, a number of studies have shown recruitment of the
Dyn/KOR system in the NAc following compulsive drug taking (Daunais et al., 1993; Fagergren
et al., 2003; Hurd et al., 1992; Lindholm et al., 2000; Schlussman et al., 2005; Solecki et al.,
2009). It is thought that monoamine output within the NAc is tightly regulated via presynaptic
KORs on serotonergic and dopaminergic cells in the region, ultimately acting to suppress release
of dopamine and serotonin. However, the mechanisms and role of Dyn-containing circuits in the
regulation of KOR-mediated negative affective behaviors remain unresolved (Bruchas et al.,
2010, 2011).
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Here we directly ascertained the sufficiency of local Dyn release within the NAc shell to
drive aversive behavior. We hypothesized that photostimulation of Dyn-containing cells in the
NAc shell will drive an aversion behavior in a real-time place testing paradigm using a new form
of birdirectional wireless !-ILED optogenetic technology, a conditioned place testing paradigm
and an operant self-stimulation paradigm. We report a distinct subpopulation of ventral NAc
Dyn-containing cells that when activated produce robust aversive behavioral responses, whereas
stimulation of a nearby dorsal NAc site engages positively reinforced motivated behaviors.
RESULTS
Activation of dynorphinergic cells in the NAc shell drives both aversion and reward
To determine key sites of Dyn influence throughout the brain we generated a DyntdTomato-reporter mouse by crossing preprodynorphin-IRES-Cre (Dyn-IRES-Cre) mice to Allen
Institute for Brain Science tdTomato flox-stop reporter line (Ai9) (Madisen et al., 2010) (Figure
A1.1A, Figure A1.2). This new mouse line (Dyn-CretdTomato) is useful for Cre-dependent
expression/excision in selected Dyn-circuits and provides a representative map of Dyn
expressing cells, Dyn axon projections, and terminal fields. We first characterized Dyn
expression across the full brain of these mice, comparing our Dyn-CretdTomato expression side-byside with in situ hybridization data (Figure A1.1B) to confirm soma specific labeling in well
known Dyn enriched regions. Using Dyn-CretdTomato mice we visualized an abundance of Dyncontaining cells within the NAc, in direct line with current literature (Figure A1.1C). In
addition, we found robust Dyn-induced tdTomato expression in the hippocampus, bed nucleus of
the stria
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Figure A1.1: Photostimulation of dynorphinergic cells in the NAc shell drives and aversion
and reward. A. Dyn labeling in Dyn-IRES-cre x Ai9-tdTomato compared to in situ images from
the B. Allen Institute for Brain Science in a sagittal section highlighting presence of Dyn in the
striatum, the hippocampus, BNST, amygdala, hippocampus and substantia nigra. All images
show tdTomato (red) and Nissl (blue) staining. C. Coronal section highlighting dynorphinergic
cell labeling in the NAc as compared to the Allen Institute for Brain Science. D. Cartoon
depicting virus and fiber optic placement. E. Whole cell slice recording showing that
dynorphinergic cells in the NAc shell fire optically stimulated action potentials from 5-40 Hz. F.
Cartoon of real time place testing set up and a frequency response curve showing two distinct
groups ‘preferers’ and ‘averters’ spend significantly more time in the stimulated and nonstimulated side, respectively, following 10, 20 and 40 Hz stimulation (Data represented as mean
± SEM, n=6: Two-Way ANOVA, interaction effect between groups and frequency, p<0.0001) in
a real-time place testing paradigm G. At 10 Hz preferers and averters show a significant
preference or aversion compared to one another and controls (Data represented as mean ± SEM,
n=5-8: One-Way ANOVA, Bonferroni post-hoc, control vs preferers ****p<0.0001, control vs
averters **p<0.01, preferers vs averters ####p<0.0001). H. At 20 Hz preferers and averters show
a significant preference or aversion compared to one another and controls (Data represented as
mean ± SEM, n=6: One-Way ANOVA, Bonferroni post-hoc, control vs preferers ****p<0.0001,
control vs averters ***p<0.001, preferers vs averters ####p<0.0001). I. Scatter plot for preferers
and averters at following 10Hz photostimulation, with representative IHC showing that preferers
show dorsal ChR2 expression whereas averters show ventral ChR2 expression (n=7-10).
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Figure A1.2 Additional Dyn labeling in Dyn-IRES-cre x Ai9-tdTomato throughout the
brain. A. Bregma 1.94, coronal section including the cortex and NAc. B. Bregma -2.18, coronal
section including the hippocampus and tracts through the cerebral peduncle. C. Bregma -3.08,
coronal section including the substantia nigra and the VTA. D. Bregma -5.34, coronal section
including the parabrachial nucleus and the colliculus E. Dynorphinergic labeling in the dopamine
rich areas of the ventral tegmental area and the substantia nigra. F. Dynorphinergic labeling in
the locus coeruleus and G. the dorsal raphe. Images are representative of three separate brains
imaged in their entirety.
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terminalis, basolateral amygdala, central nucleus of the amygdala, throughout the cortex, caudate
putamen, globus pallidus, the dopamine rich areas of the ventral tegmental area and the substania
nigra, dorsal raphe and locus coeruleus (Figure A1.1A, Figure A1.2A-G).
To dissect the role of NAc Dyn-containing cells, we utilized in vivo optogenetics to
selectively target these neurons and assess their ability to be photostimulated (Figure A1.1D).
However, due to the novelty of this Dyn-Cre mouse line we first determined whether
photostimulation of Dyn-containing cells could elicit action potentials at multiple frequencies in
slice. We injected AAV5-DIO-ChR2-eYFP into the NAc of Dyn-Cre mice and performed
whole-cell electrophysiology. We found robust intact spike fidelity at frequencies of 5 Hz, 10Hz
and 20Hz (1 ms pulse width), which was not maintained at 40 Hz (Figure A1.1E).
Prior reports have suggested that the Dyn/KOR system mediates negative emotional
states through increased Dyn expression in the NAc, contributing to the dysphoria associated
with depression and drug dependence. However, the endogenous source of Dyn in these
responses has not been previously shown (Britton et al., 1982; Bruchas et al., 2010; Knoll et al.,
2011; Lindholm et al., 2000; Mucha et al., 1985; Pfeiffer et al., 1986; Rylkova et al., 2009;
Schlosburg et al., 2013; Shippenberg et al., 2007). Given the location of Dyn-containing cells in
the NAc, we first hypothesized that photostimulation of NAc-Dyn neurons will produce aversive
behaviors. To test this hypothesis we injected AAV5-DIO-ChR2-eYFP,chronically implanted a
fiber optic into the NAc shell of Dyn-Cre positive and Dyn-Cre negative mice and used a realtime place-testing paradigm (RTPT) (Figure A1.1F). During this 20 min behavioral test,
photostimulation occurs in real-time only upon entry into the counterbalanced designated
chamber (Carter et al., 2010; Stamatakis and Stuber, 2012; Tan et al., 2012). Behavioral data are
then calculated as time spent in the photostimulation- paired chamber, expressed as a percentage
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of total time. In this experiment we also assessed the efficacy of photostimulated cell firing in
vivo in producing real-time behavioral responses, as compared to the in vitro whole-cell
recordings. In accordance with our hypothesis, we show that photostimulation of Dyn-containing
cells in the NAc shell over the same range of frequencies, 5Hz, 10Hz and 20Hz produces a
significant real-time aversion behavior, that plateaued at 40Hz, correlating with the in vitro
whole-cell recordings (Figure A1.1E). However a subgroup of mice showed a robust preference
behavior when compared to controls. We therefore defined these two groups as real time
‘averters’ or ‘preferers’. Our data show a significant interaction between the preferers, averters,
controls and the frequency of photostimulation (Figure A1.1F). In addition, in vivo 10Hz and
20Hz stimulation produced a significant real-time place-preference and aversion in the preferers
as well as the averters, respectively, compared either to control or to one another (Figure A1.1 G
and H). To investigate what may drive these opposing behavioral states between preferers and
averters we carefully examined the anatomical distribution of viral expression within the NAc
shell of each individual mouse and group. Interestingly, we identified that mice which exhibited
a preference behavior, showed isolated dorsal viral expression in the NAc shell whereas mice
which exhibited an aversion behavior showed a more ventral pattern of viral expression (Figure
A1.1I). These results suggest that photostimulation of Dyn-containing cells in discrete
subregions within the NAc shell can drive opposing behaviors with distinct positive or negative
valence. These data indicate that photostimulation of Dyn-containing cells in the dorsal NAc
drives a real-time place preference whereas photostimulation of Dyn-containing cells in the
ventral NAc drives a real-time place aversion.
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Spatially discrete targeting of NAc dyn-containing cells engages both preference and
aversion in the same animal
To further investigate the subregional distinction in behavior within the NAc shell and to
enable precise, discrete spatial targeting we used a novel modified form of our recently
developed wireless µ-ILED devices (Kim et al., 2013; McCall et al., 2013). We reconfigured the
original wireless !-ILED devices to produce a device that allows isolated and directionally
controlled light to specific NAc subregions. In this case we positioned one !-ILED to target the
dorsal NAc and the other the ventral NAc shell (Figure A1.3A, Figure A1.4), separated by a
distance of 1 mm. These devices are wirelessly controlled using an RF power source, which can
either stimulate each !-ILED independently or both together simultaneously (Figure A1.3B,
Figure A1.4). These devices provide discrete spatial targeting and importantly allow us to
photostimulate each region to drive opposing behaviors within the same individual mouse.
Following viral injections of AAV5-DIO-ChR2-eYFP into the NAc shell of Dyn-Cre positive
and Dyn-Cre negative mice, with expression spanning both dorsal and ventral co-ordinates,
devices were implanted into mice and used in the real-time place preference paradigm (Figure
A1.3C). Here we show that within the same mouse we can selectively photostimulate the ventral
NAc, to produce a real time aversion or we can photostimulate the dorsal NAc to drive a real
time preference (Figure A1.3D, E & F). In addition, photostimulation of Dyn-containing cells in
either the dorsal or the ventral NAc shell does not induce any significant changes in locomotor
activity compared to controls (Fig 2F). In addition, we wanted to investigate if targeting these
distinct regions in the NAc induced anxiety behavior, since recent reports have implicated the
KOR/Dyn system in anxiety-like behavioral responses (Bruchas et al., 2009; Knoll et al., 2011).

329

!

<J")+P56
E(H0.;.56

<J"E2,5221
EE!@7#B:7M*<%75NJ)7#A2"M65"

$"

"

#"

!"

$"

<J"4.L210
Generator

!"

#"

Directional
+-ILED

Fiber Optic

%&&"'("

#

#"

%&&"'("

%"(("

">G""

"%>""

%?"

%@""

B(H012,"I5F.D5".2,+"
3ED"

<=)="
%&"(.2"

<=)="
%&"(.2"

<=)="
%&"(.2"

#1A"">""

!"
J.K56"+H,.D-"

'7.89#"
B2C5D,""EE!@"
F.6/-".2,+"3ED"

'7.89#-"
:;;"""

#+6-10""

!52,610"

80
60
40
20
0

#+6-10

'

100

!52,610

5000

**
80

=+,10"1D,.F.,A"QD(S

&

100

=.(5".2"-,.(/01,.+2"-.I5"QRS

3+"4,.(/01,.+2" )*+,+-,.(/01,.+2"

%

=.(5".2"-,.(/01,.+2"-.I5"QRS

O

$

60
40
20
0

$1-5 #+6-10 !52,610

4000
3000
2000
1000
0

$1-5 #+6-10 !52,610

Figure A1.3 Discrete spatial targeting drives preference and aversion in the same animal.
A. Directionally-controlled light spread of !-iLED devices has advantages over fiber optics for
isolating subregions of NAc as demonstrated in the fluorescein images. B. Images of an ultrathin
(~10-50 !m), flexible integrated system. Light can be isolated to either dorsal or ventral NAc C.
Behavioral calendar outlining the design of the experimental procedure. D. Examples of realtime mouse behavioral traces following no stimulation, ventral or dorsal wireless
photostimulation. E. An aversion and preference real-time behavior following stimulation of the
ventral and dorsal NAc shell within each individual mouse (Data represented as mean ± SEM,
n=5: Student’s t-test, p=0.05). F. Stimulation with dorsal LED drives a real-time place
preference but stimulation with ventral LED drives an aversion, which are significantly different
from one another (Data represented as mean ± SEM, n=6: One-Way ANOVA, Bonferroni posthoc **p<0.01) G. No significant difference in locomotor activity measured during a 20 min trial
between all groups (Data represented as mean ± SEM, n=6).
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Together, these data support the hypothesis that activation of Dyn-containing cells in the
ventral NAc shell drives an aversion behavior. These novel devices also demonstrate that within
the same animal we can cause a preference behavior by stimulating Dyn-containing cells in the
dorsal NAc shell. Bidirectional µ-ILED control adds confidence to the current findings and
suggests that stimulation of the subsets of neurons within the NAc dynorphinergic system is
capable of dynamic engagement of either positive or negative behavioral valence. Furthermore,
because these devices are ultrathin, minimally invasive, (Kim et al., 2013) and target both dorsal
and ventral NAc, there is limited likelihood that dorsal lesions from our earlier fiber optic
implantation (Figure A1.1) influence the observed behavioral responses.
Aversion following photostimulation of Dyn-containing neurons in the ventral NAc shell
requires KOR activity
Current research indicates a role for NAc KORs in aversive negative affective behaviors
involved in stress, dysphoria and drug abuse (Bals-Kubik et al., 1989; Land et al., 2009; Mucha
et al., 1985; Shippenberg et al., 2007; Solecki et al., 2009). Therefore, we hypothesized that
activation of kappa opioid receptors following the photostimulated-release of Dyn in the ventral
NAc is one of the key underlying mechanisms for the observed aversion behavior.
From this point onward we modified our virus volume and co-ordinates to specifically
target either the dorsal or ventral NAc shell. We also injected Cre-negative control mice in either
the dorsal and ventral NAc and saw no effect of photostimulation in either group. Based on the
results from our whole cell slice recordings and in vivo frequency response data we
photostimulated at 10 Hz with a 10 ms pulse width to elicit action potential firing, evoke release
of Dyn, remain physiologically-relevant and to maintain spike fidelity. We first assessed how
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photostimulation of Dyn-containing cells in the ventral NAc shell drives an aversion in a
conditioned place preference paradigm.

This behavioral model is a form of pavlovian

conditioning used to measure the motivational or aversive effects of an associated experience.
The key component of this model is the learning aspect, which was absent in our RTPT
paradigm (Figure A1.1). We showed that in a y-maze conditioning paradigm (Figure A1.5A)
we are able to condition mice to the photostimulation of Dyn-containing cells in the ventral Nac
to drive an aversion behavior, which is consistent with our earlier findings. In addition,
conditioned photostimulation of dorsal Nac shell was able to drive a significant preference
behavior when compared to controls and to each other (Figure A1.5B, C & D).
To test the hypothesis that the aversion behavior is driven by the release of Dyn from
cells within the ventral NAc shell acting on KOR we locally infused the long acting KOR
antagonist NorBNI (2.5µg/1µl) (Bruchas et al., 2007; Al-Hasani et al., 2013; Melief et al., 2010)
into the ventral NAc shell, 14 days after site specific viral (AAV5-DIO-ChR2-eYFP) injection in
to the ventral NAc (Figure A1.5A). Importantly, injection of NorBNI into the ventral NAc shell
was able to significantly block the aversion seen following photostimulation of Dyn-containing
cells (Figure A1.5B, C, D) with no observed change in locomotor activity (Figure A1.5E).
These findings identify the aversion behavior mediated following photostimulation of Dyncontaining cells in the ventral NAc as KOR-mediated, acting locally within the NAc itself,
consistent with prior studies using exogenous ligand infusions within this region (Castro and
Berridge, 2014; Land et al., 2009; Shippenberg et al., 2007).
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Figure A1.5 Aversion following photostimulation of Dyn-containing neurons in the ventral
NAc shell requires KOR activity. A. Calendar outlining experimental procedure for the Ymaze paradigm. B. Representative heat map of activity during post-test day 5. C. Mice injected
and photostimulated in the dorsal NAc show a significant increase in % time spent in
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conditioned arm of the Y-maze whereas mice stimulated in the ventral NAc show an aversion
(Data represented as mean ± SEM, n=8-13: One-Way ANOVA, Bonferroni post-hoc, control vs
dorsal **p<0.01, Control vs ventral *p<0.05, dorsal vs ventral ****p<0.0001, dorsal vs ventral
NorBNI ##p<0.01, ventral vs ventral NorBNI #p<0.05. D. Change from baseline measured
across all 5 days of the y-maze paradigm (Data represented as mean ± SEM, n=8-13, Two-Way
ANOVA, interaction effect between groups and days, p<0.0001) E. No significant difference in
locomotor activity measured during a 20 min trial between all groups (Data represented as mean
± SEM, n=8-13). F. Calendar outlining experimental procedure for the operant self-stimulation
paradigm. G. No significant difference in active nose pokes for food reward between all groups
(Data represented as mean ± SEM, n=6-7). H. Data showing number of nose pokes across 5 days
of operant self-stimulation. Dorsally injected mice show significantly increased active nose
pokes, compared to controls and ventrally injected mice, which show a significant reduction in
nose pokes following photostimulation (Data represented as mean ± SEM, n=6-7: Two Way
repeated measures ANOVA, Bonferroni post-hoc; dorsal vs controls, ventral and ventral NorBNI
on day 1,2,3 ****p<0.0001, dorsal vs control and ventral on day 4 *p<0.05, control vs ventral on
day 1 **p<0.01, ventral vs ventral NorBNI ***p<0.001. I. Significant differences in total nose
pokes on day and day 2 following photostimulation (Data represented as mean ± SEM, n=6-7:
One-Way ANOVA, bonferroni post-hoc, control vs dorsal ****p<0.0001, control vs ventral
*p<0.05, dorsal vs ventral ****p<0.0001, dorsal vs ventral NorBNI ****p<0.0001, ventral vs
ventral NorBNI **p<0.01. J. Representative 60 min trials for each group.
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Distinct NAc dynophin populations in operant stimulation produce positive and negative
responses
The operant self-stimulation paradigm is unique in that it demonstrates the ability of a
mouse to establish response habits similar to those exhibited to natural rewards. Here we
assessed the contribution of dorsal and ventral NAc shell Dyn-containing neurons in selfstimulation. Importantly, all groups of mice, whether injected with AAV5-DIO-ChR2-eYFP in
Dyn-Cre mice, in either the dorsal or ventral NAc, were able to learn to poke for a food reward
(Figure A1.5F and G). Following food training the food pellet was replaced with a 2s (10Hz,
10ms pulse width) photo-stimulation, which was delivered following a nose poke. The dorsally
injected mice continued to show positive reinforcement behavior but the number of nose pokes
increased 5-fold following photostimulation, emphasizing the highly rewarding nature of selfstimulation of this NAc shell subregion (Figure A1.5G, H, I). However, both the controls and
the ventrally-injected mice decreased their number of nose pokes following photostimulation.
While both were significantly different compared to the dorsally injected mice, the ventrally
injected mice showed a significant decrease in the number of nose pokes compared to controls
(Figure A1.5G, H, I). The aversive nature of the photostimulation in the ventral NAc shell mice
suggest that it is strong enough to mute the extinction burst seen during the first day of
photostimulation and accelerate extinction following food training. The extinction burst is
characteristic in the operant model but in the case of this experiment is highly interesting as the
ventrally-injected mice show an acceleration in extinction and overall reduced nose pokes for
photostimulation whereas the dorsal mice maintain an increased number of nose pokes due to the
rewarding nature of the stimulation (Figure A1.1G, H, I). These operant self-stimulation data
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further suggest that there is a dynamic relationship between the positively reinforcing and
aversive nature of stimulating distinct subpopulations of NAc shell Dyn-containing cells.
DISCUSSION
In the present study we identify that photostimulation of Dyn-containing cells in discrete
subregions within the NAc shell drive opposing motivational behavioral states. We show that
photostimulation of Dyn cells in the ventral NAc shell drives aversion behavior whereas
photostimulation in the dorsal NAc shell drives a preference/reward behavior. This is the first
study to our knowledge to report a distinction in aversion and reward behavior within the NAc
shell via dynorphin-containing cells and here we demonstrate this using three different
behavioral paradigms; real-time place testing using bidirectional wireless !-ILED technology,
conditioned place testing and operant self-stimulation.
Previous studies reported that the Dyn/KOR system mediates negative emotional states
through increased Dyn expression in the NAc, contributing to the dysphoria associated with
depression, drug dependence and withdrawal but the mechanisms for engagement of dynorphin
circuitry are unknown (Britton et al., 1982; Bruchas et al., 2009; Knoll et al., 2011; Lindholm et
al., 2000; Mucha et al., 1985; Pfeiffer et al., 1986; Rylkova et al., 2009; Schlosburg et al., 2013;
Shippenberg et al., 2007). In this study we are able to show that activation of Dyn-containing
cells within a distinct region of the NAc shell, the ventral NAc shell, drives an aversion behavior,
as demonstrated in a real-time place preference paradigm. Few reports have extensively
investigated regional distinctions within the NAc that might mediate differences in aversion and
reward behaviors. However, it has recently been shown that the rostrodorsal quadrant of the
medial NAc shell contains a specialized opioid hedonic hotspot in rats, which traditionally
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mediates an increase in “liking” following mu opioid receptor (MOR) activation, however a role
has also been identified for both delta opioid receptors (DOR) and KOR (Castro and Berridge,
2014). Within this recent body of work, a separate suppressive cold spot in the caudal half of the
shell was identified in which each opioid stimulation oppositely reduced sucrose positive
“liking” reactions (Castro and Berridge, 2014). In addition to these interesting findings this
group also identified several anatomical differences between NAc opioid control of “liking”
verses “wanting” of feeding (Castro and Berridge, 2014). These results highlight anatomical
heterogeneity of the NAc, but also show that this is localized to opioid reward related functions
in the medial shell that includes a role for KOR system. While using different species and
behavioral model we report here a consistent heterogeneity within the NAc shell, where selective
photostimulation of the endogenous Dyn-containing cells in the dorsal NAc shell drives a
preference/reward behavior but photostimulation of Dyn neurons in the ventral shell drives an
aversion behavior. Further, a recent study has found that prodynorphin content specifically in the
ventral NAc shell is dramatically increased following 12 hour long access heroin selfadministration, and that escalation of this drug-seeking behavior was suppressed following
treatment with the long acting KOR antagonist NorBNI (Schlosburg et al., 2013). These recent
findings further support our present data, and suggest that the release of Dyn in distinct
subregions within the NAc shell drives opposing motivated behavioral states.
To discretely isolate these small subregions of the accumbens within a single animal, we
modified our original wireless, spatially-targeted !-ILED devices (Kim et al., 2013; McCall et
al., 2013) to enable independent illumination of either the ventral or dorsal region of the NAc
within the same mouse. A device with these capabilities has not been previously used, but here
we generated a modified version of them to directly test the question of spatial segregation of
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reward and aversion within the NAc shell. Here we adapted the connection and powering
schemes of the !-ILED devices to provide multiple channels of independent optical control.
Using these devices we were able to drive a real-time aversion and reward behavior within the
same mouse confirming that engaging Dyn neurons in these discrete regions mediates opposing
behaviors. Importantly, we also found that stimulating these distinct regions does not mediate an
anxiety-like behavior, consistent with previous reports that identify the basolateral amygdala and
the central nucleus of the amygdala as the key KOR site involved in the mediation of anxietylike behaviors (Bruchas et al., 2009; Knoll et al., 2011).
These !-ILED devices could be easily modified for other potential uses, for example the
!-ILEDs can be differentially spaced and/or oriented to target different regions or subregions
within the brain. Additional !-ILEDs can be added to the device to target larger brain regions or
multiple subregions in a dorsal-ventral axis, such as layers of the cortex, or other similar
structures. !-ILEDs of different wavelengths could also be added enabling photoactivation or
inhibition of various opsin constructs within the same structure. The wireless capabilities also
enable us to carry out optogenetic experiments within the home cage itself, which are more
difficult using traditional fiber optic tethering.
Looking closely at the neurobiological sources of Dyn and KOR in the NAc, it is widely
known that Dyn is predominantly expressed in medium spiny neurons within the NAc that
coexpress dopamine D1 receptors (Ghazarossian et al., 1980; Raynor et al., 1994); however,
there are also input projections from other structures that could also release Dyn, for example the
ventral pallidum and the lateral hypothalamus (Baldo et al., 2003; Groenewegen et al., 1999;
Haber et al., 1985; Peyron et al., 1998). It is reported that postsynaptic KOR in the NAc are on
dendrites of most medium spiny neurons but reside predominantly on the dopamine D2
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expressing medium spiny neurons (Svingos et al., 1999). KORs are also widely known to be
expressed on presynaptic terminals of glutamate, serotonin and dopamine projections into the
NAc (Bruchas et al., 2011; Hjelmstad and Fields, 2001; Land et al., 2009; Schindler et al., 2012;
Svingos et al., 1999). In light of this we hypothesized that the Dyn-mediated aversion in the
ventral NAc is driven by activation of KOR locally in the NAc. In both a conditioned place
preference and an operant self-stimulation paradigm we show that NorBNI is able to block the
aversion behavior following photostimulation of Dyn neurons in the ventral NAc shell, thereby
identifying that aversion behavior in the ventral NAc is mediated by a local KOR dependent
mechanism.
Photostimulation of Dyn-containing cells in the dorsal NAc drives a preference/reward
behavior in all of the three paradigms. Interestingly, Berridge’s group are the first to report
positive rewarding effects for kappa activation but this was restricted to the rostrodorsal shell
hotspot as all other areas produced negative effects (Castro and Berridge, 2014). They suggest
that the anatomical specificity gates the valence of KOR effects in the NAc. Though this is
certainly a consideration in the present study it is important to note that the Dyn-containing cells
we are photostimulating also express dopamine D1 receptors so it is certainly likely that upon
photostimulation we are in fact likely mimicking D1 receptor activation which would in turn
induce a preference/reward behavior. In fact, optogenetic stimulation of the direct pathway,
Dyn/Dopamine receptor-1 (D1-R) containing neurons in the dorsal striatum has been shown to
be rewarding in several contexts (Kravitz et al., 2012). Here we have shown that we can produce
the same behavior but by targeting a more discrete region dorsal NAc. Further investigation is
warranted to identify whether the preference behavior is KOR-dependent or more likely
consistent with the well-established D1 receptor mediated effect.
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The key finding of the present study is that we have identified two distinct subregions
within the NAc shell that drive opposing behavioral valences. The elegant work of Thompson
and Swanson (2010) identified that within the NAc network nodes exist which are localized and
restricted to specific subdivisions within a region, which is why regions such as the hedonic
hotspot have been considered important (Thompson and Swanson, 2010). Furthermore, it is the
distinct projections to and from these discrete regions that will help us to understand what is
driving the unique behavioral outputs in this present study. To begin investigating these
projections we will use a combination of the Dyn-reporter mouse (Dyn-CretdTomato) generated and
viral tracing approaches. We have characterized Dyn expression across the full brain of these
mice, comparing our results with data freely available from the Allen Institute for Brain Science
(Lein et al., 2007). This mouse line is useful for Cre-dependent expression/excision in selected
Dyn-circuits, provides us with a new map of Dyn expressing cells, and a simple way to easily
trace dynorphinergic axon projections and terminal fields.
Here we identified two distinct subregions within the NAc shell, which drive opposing
behaviors through activation of the KOR/Dyn system. Photostimulation of Dyn-containing
neurons in the ventral NAc shell causes a KOR dependent aversive behavior whereas
photostimulation of Dyn-containing neurons in the dorsal NAc shell causes preference.
Understanding the circuitry that mediate motivated behaviors is critical in furthering our
understanding of positive and negative affective states that contribute to mood disorders,
addiction and depression.
MATERIALS & METHODS
Experimental subjects
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Adult (25–35 g) male preprodynorphin-IRES-Cre (Dyn-Cre) mice were group-housed,
given access to food pellets and water ad libitum and maintained on a 12 h:12 h light:dark cycle
(lights on at 7:00 AM). All animals were kept in a sound attenuated, isolated holding facility in
the lab one week prior to surgery, post-surgery and throughout the duration of the behavioral
assays to minimize stress. All procedures were approved by the Animal Care and Use Committee
of Washington University and conformed to US National Institutes of Health guidelines.
Generation and breeding of Pdyn-IRES-Cre mice and Ai9-x Pdyn-IRES-Cre
Pdyn-IRES-Cre mice were kindly provided by Bradford Lowell’s lab (Krashes et al.,
2014) see for details. The mice were bred in our facilities by crossing the pdyn-IRES-Cre mice
with C57BL/6 wildtype mice and backcrossed for seven generations. These mice were then
crossed to Ai9-tdtomato mice on C57BL/6 background, bred and backcrossed for seven
generations.
Stereotaxic viral injection surgery
After the animals were acclimatized to the holding facility for seven to nine days, the
mice were anaesthetized in an induction chamber (4% Isoflurane) and placed into a stereotaxic
frame (Kopf Instruments, Model 1900) where they were maintained at 1-2% isoflurane. We
performed a craniotomy and unilaterally injected, using a blunt needle (86200, Hamilton
Company, Reno, NV), 300 nl of AAV5-DIO-ChR2-eYFP or AAV5-DIO-eYFP (Hope Center
Viral Vector Core, viral titre 2 x 10^13 vg/ml) into either the dorsal NAc (stereotaxic coordinates
from bregma: +1.30 anterior-posterior (AP), +/(0.5 medial-lateral (ML), (4.25 mm dorsalventral (DV)) or ventral NAc (stereotaxic coordinates from bregma: +1.30 (AP), +/(0.5 (ML),
(4.75 mm (DV), followed by fiber optic implantation (Sparta et al., 2012). We secured the
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implants using two bone screws and constructed a chronic headcap using dental cement (Lang
Dental, Wheeling, IL). Mice were allowed to recover for three weeks prior to behavioral testing,
permitting optimal expression of ChR2 in the Dyn-Cre cell bodies.
NorBNI local Infusion: Two weeks post viral injection the mice were locally injected with
NorBNI in the ventral NAc (2.5µg/1µl) (co-ordinates stated above) followed by the optic fiber
implantation to allow optimal expression of both ChR2 and NorBNI. All mice were allowed at
least one week to recover post surgery before beginning experimentation, well within the ideal
limits of norBNI antagonism and ChR2 expression.
Slice electrophysiology
We performed whole-cell electrophysiology experiments similar to those published
(Sparrow et al., 2012). Briefly, mice were rapidly decapitated under isoflurane anesthesia, and
300uM coronal slices containing the NAc were prepared on a vibratome (Leica VT1200). The
brains were removed and placed in ice-cold modified high sucrose artificial cerebrospinal fluid
(aCSF) (see supplemental experimental procedures for details). Slices were then transferred to
normal aCSF (see supplemental experimental procedures for details) maintained at
approximately 30 degrees (Warner Instruments, Hamden, Connecticut). Slices were placed in a
holding chamber (Warner Instruments, Hamden, CT), and were allowed to rest for one hour, and
remained there until used. Slices were continuously bubbled with a 95% O2 / 5% CO2 mixture
throughout slicing and experiments. Thin-walled borosilicate glass capillary recording electrodes
(3–6 M$) were pulled on a Flaming-Brown Micropipette Puller (Sutter Instruments). Following
rupture of the cell membrane, cells were allowed to rest and equilibrate to the intracellular
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recording solutions (below). Input resistance was monitored continuously throughout the
experiment, and when input resistance deviated by more than 20% the experiment was discarded.
All brains were checked for light-evoked action potentials in the NAc using a potassiumgluconate based internal (see supplemental experimental procedures for details). Those brains in
which action potentials were not obtained or injections were missed were discarded and not used
for further experimentation. Action potentials were light evoked (1msec stimulation) at
frequencies from 5-40 Hz to check spike fidelity of light-evoked responses.
Real-time Place Testing
We used custom-made unbiased, balanced two-compartment conditioning apparatus
(52.5 x 25.5 x 25.5 cm) as described previously (Jennings et al., 2013; Stamatakis and Stuber,
2012). Mice were allowed to freely roam the entire apparatus for 20 min. Entry into one
compartment triggered constant photostimulation at either 5Hz, 10Hz, 20Hz or 40Hz (473 nm,
10 ms pulse width, ~10 mW light power) while the animal remained in the light-paired chamber.
Entry into the other chamber ended the photostimulation. The side paired with photostimulation
was counterbalanced across mice. Time spent in each chamber and total distance traveled for the
entire 20-minute trial was measured using Ethovision 8.5 (Noldus Information Technologies,
Leesburg, VA).
Wireless Powering and RF Powering Scavenger
Wireless powering of the µ-ILED devices was adapted as previously described (Kim et
al., 2013; McCall et al., 2013) The RF scavenger consists of antennas, impedance matching
circuits and Cockcroft-Walton voltage multiplier. The wireless power transmitter includes an RF
signal generator (Agilent N5181A), a power supply (Agilent U8031A), a RF power amplifier
345

(Empower RF Systems 1119-BBM3K5KHM), an RF signal splitter (RF Lambda
RFLT2W0727GN), and two panel antennas (ARC Wireless ARC-PA2419B01). The RF signal
generator is internally modulated to delivery sufficient power to light the µ-ILEDs at the given
stimulation protocol (10 Hz, 50 ms pulse widths). The RF power amplifier that is powered by the
power supply enlarges the modulated RF signal from the RF signal generator. The RF power is
then transmitted from the panel antenna to the headstage power harvesters. The RF signal
generator has a power output from -10 to 0 dBm at 1.5 GHz & 2.4 GHz for each LEDs,
optimized daily to ensure equivalent light power throughout the space of the LDB assay. Mice
with chronically implanted µ-ILED devices were acutely connected to the headstage power
harvesters immediately prior to any wireless photostimulation.
Y-Maze Conditioned Place Testing
Mice were placed in a 3-chambered environment compatible with fiber-optics coupled to
473 nm laser as previous described (Kim et al., 2013). Initially, on day one the mice have free
access to all chambers without stimulation (pre-test) to show no bias between the 2 larger, cuedistinct environments. This is followed by three conditioning days where upon entry into one
chamber photostimulation (10 Hz, 10 ms pulse width) occurs in real-time and when the animal
leaves this compartment photostimulation ends. On post-test day 5 mice have free access to all
chambers without stimulation to assess whether a preference or aversion association has been
made with the paired context. Data were calculated as time spent in each chamber and entries
into the photostimulation- paired chamber with control animals showing equal time spent in each
chamber and an aversive response being time reduced from 50%.
Operant Self-Stimulation
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Mice are initially food deprived to 90% of their body weight and trained to nose-poke for
food pellets for 4 days in a modular test chamber for mice (17.8 cm x 15.2 cm x 18.4 cm) (Med
Associates Inc., St. Albans, VT). This was used in conjunction with either Ethovision (Noldus,
Leesburg, VA) or Med Associates program. This was followed by operant self-stimulation where
upon an active nose poke the mice receive a 2 second photo-stimulation (10 Hz, 10 ms pulse
width stimulation) on a fixed ratio-1 schedule for a 1 hour session. For operant self-stimulation
the mice are connected to a laser via a tether than runs through the top of the chamber. An
Arduino (Arduino, http://www.arduino.cc) is programed and connected to the laser and chamber
so upon nose poking the 2 second 10 Hz, 10 ms pulse width photostimulation is administered.
This was paired with a cue light and a tone. A poke at the inactive nose poke resulted in no
stimulation, cue light or tone. The data were calculated as total number of nosepokes at the active
and inactive for each day over the course of 5 days.
For all behavioral experiments at the end of each study, animals were perfused with 4%
paraformaldehyde followed by anatomical analysis to confirm injection sites and cell typespecific expression.
Statistics
All data are expressed as mean ± SEM. Statistical significance was taken as *p < 0.05, **p <
0.01, ***p < 0.001, ****p < 0.0001 as determined by a One-Way Analysis of Variance
(ANOVA) or a Two-Way Repeated Measures ANOVA followed by a Bonferroni post hoc tests
as appropriate. Statistical analyses were performed in GraphPad Prism 5.0.
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Appendix 2

Supplementary locus coeruleus experiments
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SUMMARY
Stress-induced anxiety and aversion represents only a subset of known behavioral
responses to stress (Bruchas et al., 2011a; Butler and Finn, 2009; Weninger et al., 1999). Several
stress-induced behaviors are known to be influenced or mediated by NE, including stressinduced relapse to drug seeking (Weinshenker and Schroeder, 2007) and stress-induced analgesia
(Butler and Finn, 2009). Exploring the possibility of these behaviors being mediated by LC
efferent projections is a compelling next step. This appendix contains two sets of preliminary
data evoking a high tonic (5 Hz) state of LC. In all cases the LC is targeting using Th-Cre mice
and AAV5-EF1"-DIO-ChR2-EYFP. The controls are AAV5-EF1"-DIO-EYFP The first is a
study of reinstatement of a cocaine conditioned place preference, the second is battery painrelated assays.
Potential role of LC-NE neurons in reinstatement of cocaine place preference
Mice were trained in an unbiased, balanced three-compartment conditioning apparatus as
described (Land et al., 2009; Bruchas et al., 2011). On pre-conditioning day, day 1, mice were
allowed free access to all three chambers for 30 min. Time spent in each compartment was
recorded with a video camera (ZR90; Canon) and analyzed using Ethovision 8.5 (Noldus). Mice
were randomly assigned to saline and drug compartments and received a saline injection in the
morning (10 ml/kg, s.c.) and a cocaine injection (15 mg/kg, s.c.) in the afternoon, at least 4 h
after the morning training on 3 consecutive days (days 2-4). To test for cocaine place preference
(day 5) the mice were allowed free access to the three chambers. Scores were calculated by
subtracting the time spent in the drug-paired compartment post-test minus the pre-test. This was
followed by 3 days of extinction training (days 6–8) during which saline (10 ml/kg, s.c.) was
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injected in both the morning and afternoon prior to placement into isolated conditioning
compartments. Mice were tested for extinction of place preference on day 9 with free access to
all three chambers. Mice were considered to have extinguished cocaine preference if scores fell
within 15% of their initial preference scores. Mice that did not meet these criteria were excluded
from the study. Mice that extinguished continued on to the reinstatement phase. On day 10, mice
were exposed to five minutes of 5 Hz, 10 ms photostimulation.
Reinstatement was measured as time (s) in drug-paired chamber on day 10 minus time
spent in drug-paired chamber following extinction training. Mice that did not reinstate to
photostimulation were exposed on the following day to a priming injection of cocaine (15 mg/kg,
s.c.) and placed in the apparatus and allowed free access to all compartments (data not shown).
Reinstatement scores were calculated by subtracting the time spent in the cocaine side post-test
minus the extinction test as previously described (Bruchas et al., 2011, Land et al, 2009).
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Figure A2.1 Potential role of LC-NE neurons in reinstatement of cocaine place preference.
(A) Time line of CPP/reinstatement experiment (B) Data represent the mean preference (s) ±
SEM, n=4/group. All included animals reached extinction criteria on Day 9 and received 5
minutes of 5 Hz stimulation prior to post-test on Day 10.
High tonic LC-NE activity is antinociceptive
Plantar test (Hargreaves Method)
Mice were acclimated to a 30ºC glass platform for two hours prior to testing. Radiant
heat was applied to each hindpaw and withdrawal latency was measured over 5 trials (15 min
ITI). Conditions were counterbalanced to get baseline withdrawal latency for each mouse. 5 Hz
photostimulation began 5 s before the first trial.
Hot plate test
Mice were habituated to the testing room for two hours prior to testing. The hot plate was
heated to 55ºC. 5 s before the trial, 5 Hz photostimulation began. The animal was placed on the
hot plate and a timer started. Time ended with any of the following behaviors: animal lifts
hindpaw and clearly licks, animal jumps off plate, or timer reaches 30 s. Only one trial per
animal was recorded.
Von Frey test
Calibrated Von Frey filaments were used to assess formalin-induced mechanical
hypersensitity as previously described (Kolber et al., 2010).
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Figure A2.2 High tonic LC-NE activity is antinocieptive. 5 Hz stimulation blunts thermal
20

nociception in the (A) plantar and (B) hot plate tests. 5 Hz stimulation of LC-NE cell bodies
10

reverse mechanical hypersensitivity in (C) the Von Frey test. Data shown as mean +/- SEM.
0

n=6/group. **p<0.01, *p<0.05 Student’s t-test.

ChR2

I"*482&B

Mechanical threshold (g)

'

357

eYFP

2.5
eYFP
ChR2

2.0
1.5
1.0
0.5
0.0
0

1

2
3
Time (hours)

4

24

48

REFERENCES
Bruchas, M.R., Schindler, A.G., Shankar, H., Messinger, D.I., Miyatake, M., Land, B.B., Lemos,
J.C., Hagan, C.E., Neumaier, J.F., Quintana, A., et al. (2011a). Selective p38" MAPK deletion in
serotonergic neurons produces stress resilience in models of depression and addiction. Neuron
71, 498–511.
Bruchas, M.R., Schindler, A.G., Shankar, H., Messinger, D.I., Miyatake, M., Land, B.B., Lemos,
J.C., Hagan, C.E., Neumaier, J.F., Quintana, A., et al. (2011b). Selective p38" MAPK deletion in
serotonergic neurons produces stress resilience in models of depression and addiction. Neuron
71, 498–511.
Butler, R.K., and Finn, D.P. (2009). Stress-induced analgesia. Prog. Neurobiol. 88, 184–202.
Kolber, B.J., Montana, M.C., Carrasquillo, Y., Xu, J., Heinemann, S.F., Muglia, L.J., and
Gereau, R.W. (2010). Activation of metabotropic glutamate receptor 5 in the amygdala
modulates pain-like behavior. J. Neurosci. Off. J. Soc. Neurosci. 30, 8203–8213.
Land, B.B., Bruchas, M.R., Schattauer, S., Giardino, W.J., Aita, M., Messinger, D., Hnasko,
T.S., Palmiter, R.D., and Chavkin, C. (2009). Activation of the kappa opioid receptor in the
dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking. Proc.
Natl. Acad. Sci. U. S. A. 106, 19168–19173.
Weinshenker, D., and Schroeder, J.P. (2007). There and back again: a tale of norepinephrine and
drug addiction. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 32, 1433–
1451.
Weninger, S.C., Dunn, A.J., Muglia, L.J., Dikkes, P., Miczek, K.A., Swiergiel, A.H., Berridge,
C.W., and Majzoub, J.A. (1999). Stress-induced behaviors require the corticotropin-releasing
hormone (CRH) receptor, but not CRH. Proc. Natl. Acad. Sci. 96, 8283–8288.

358

